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Preface 
This thesis compiles published and unpublished work on the biochemical and structural 
characterization of pro-folding and pro-degradation functions of molecular chaperone proteins. 
Heat shock protein 70 (Hsp70) as well as the small heat shock proteins (sHsps) Hsp27 and αB 
crystallin (HSPB5), are of interest for their roles in protein homeostasis. In addition, a thioredoxin 
peroxidase, peroxiredoxin (Prx), was examined for its additional functions as a protein chaperone. 
The thesis begins with an introduction section, detailing the biochemical and structural insights and 
outstanding questions that motivate the study of these various chaperone systems. In addition, I 
give a brief overview of electron microscopy, of one of the main technologies utilized in my thesis 
work. In Chapter 1, human Hsp70 is studied together with the C-terminus of Hsp70 Interacting 
Protein (CHIP), an E3 ubiquitin ligase to characterize a pro-degradation pathway dependent on the 
Hsp70 and its ability to target microtubule binding protein tau (MAPT or tau) to become 
polyubiquitinated. This work was done in collaboration with the Andrews lab at University of 
Michigan and is currently being formatted into a manuscript in preparation for submission. Next in 
Chapter 2, in collaboration with the Gestwicki lab at UCSF, another Hsp70 co-chaperone, a 
nucleotide exchange factor BAG3, is studied together with Hsp70 and the sHsp Hsp27 as an example 
of the coordination between the Hsp70 and the sHsp systems in facilitating protein refolding. This 
work has been published as Rauch JN, Tse E, Freilich R, Mok SA, Makley LN, Southworth DR, 
Gestwicki JE., BAG3 Is a Modular, Scaffolding Protein that physically Links Heat Shock Protein 70 
(Hsp70) to the Small Heat Shock Proteins J Mol Biol. 2017 Jan 6;429(1):128-141. Chapter 3 focuses 
on another sHsp system αB crystallin or HSPB5 and its ability to delay aggregation, triggered in a 
response to changes in pH. This work is due to collaboration with the Klevit lab at the University of 
Washington, and was published as Rajagopal, P. Tse, E. Borst, A. J. Delbecq, S. P. Shi, L. Southworth, 
D. R. Klevit, R. E., A conserved histidine modulates HSPB5 structure to trigger chaperone activity in 
response to stress-related acidosis Elife, 2015. 4. Chapter 4 describes work with the Jakob lab at the 
University of Michigan on the Prx decamer form which is capable of preventing protein aggregation 
in the presence of heat stress. Parts of this work have been published in Teixeira, F. Castro, H. Cruz, 
T. Tse, E. Koldewey, P. Southworth, D. R. Tomas, A. M. Jakob, U., Mitochondrial peroxiredoxin 
functions as crucial chaperone reservoir in Leishmania infantum Proc Natl Acad Sci U S A, 2015. 
112(7): p. E616-24 and an additional manuscript is currently in preparation. In Chapter 5 we 
summarize the conclusions of the observations made on the various pro-folding and pro-
degradation pathways as well as provide an outlook on the future directions of the works presented.  
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Abstract 
Molecular chaperones are essential proteins that assist in the folding of substrate ‘client’ proteins to 
adopt their functionally active three-dimensional structures. The process of protein folding in the cell 
occurs in a highly concentrated crowded cellular environment among various other macromolecules and 
amidst various cell stresses which result in issues of aberrant protein folding into toxic species and 
aggregates. Thus, to counteract these stressors, cells have evolved a complex network of chaperone 
proteins to maintain protein homeostasis, or proteostasis. Hsp70 is an essential molecular chaperone 
that acts on clients important for a wide variety of cellular functions. Hsp70 can facilitate refolding of 
clients to regain their function. However, it can also target client proteins to proteasomal degradation. 
Turnover of aberrantly folded or aggregation prone proteins such as tau implicates Hsp70 in various 
pathologies including neurodegenerative diseases.  
Another class of protein chaperones, termed ‘holdases’, act to delay protein aggregation. The small heat 
shock proteins (sHSP) systems possess such activity, binding to non-native conformations of clients. 
sHsps such as Hsp27 and αB crystallin exist as distributions of large oligomeric species that respond 
dynamically to pH and temperature stresses. Recent studies have demonstrated oligomeric 
rearrangements occur for sHsps to protect client proteins. A major outstanding question is how do these 
oligomeric assemblies’ complex structures sense cell stress or protein unfolding or aggregation. In 
addition to sensing cell stress, sHsps and holdase chaperones are also capable of bridging with the 
activities of other classes of chaperones, including the Hsp70 chaperone system. Hsp70 functions in 
concert with a network of co-chaperone proteins which diversify its protein folding capabilities. BAG3 is 
a nucleotide exchange factor (NEF) that facilitates the exchange of ADP and ATP in Hsp70. In addition, 
interactions with sHsp family chaperones have emerged, making it a promising target in elucidating the 
link between these two functionally distinct chaperone systems.  
The overall theme to my thesis work has been to characterize protein homeostasis achieved through 
pro-folding and pro-degradation pathways. A major focus of my thesis concerns the ability of Hsp70 to 
work in concert with the CHIP E3 ubiquitin ligase to target tau for polyubiquitination in a chaperone 
dependent manner, thus facilitating protein turnover. Another focus has been on a pro-folding function 
of chaperones, the so-called holdase function, where I have explored the structural rearrangements of 
the sHsp αB crystallin as well as another multifunctional chaperone, peroxiredoxin, and how these 
conformational changes and oligomeric rearrangements trigger with external stress and correlate with 
activation of chaperone activity. This thesis also explores the cooperation between sHsps and Hsp70 to 
xiii 
 
facilitate protein refolding, where I characterize rearrangements that occur in the Hsp27 oligomer 
distribution modulated by BAG3, and its implications on Hsp70 binding. One of the major techniques 
utilized in my thesis work is electron microscopy, obtaining structural information of protein complexes, 
from obtaining low resolution size distributions of sHsp oligomers to pushing resolution of Hsp70 in 
complex with CHIP beyond quaternary structural information to sub-nanometer resolution of the 
peroxiredoxin in its active chaperone form in complex with substrate. EM has provided useful 
information to corroborate biochemical assays that characterize when chaperones protect, refold or 
degrade client substrates. Altogether, this work has examined a wide spectrum of chaperone activities, 
providing support for emerging views on chaperone oligomer holdase activity as well as direct evidence 
of Hsp70 mediated ubiquitination of its important client tau. These studies serve as a foundation for 
future work on obtaining the structural basis of the decision process where chaperone proteins decide 
the fate of their client substrates. 
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Introduction- Quality Control Mechanisms of Molecular Chaperones in the Folding and Degradation of 
Client Proteins 
• 0.1 The Hsp70 chaperone cycle- conformational dynamics in facilitating client refolding 
Heat shock protein 70 (Hsp70) is a molecular chaperone capable of binding to partially misfolded 
proteins, making it essential to the folding of nascent polypeptides, functioning by binding and refolding 
unfolded proteins and preventing of aggregation of toxic species [1-3]. Two major families of Hsp70 are 
of particular interest, namely the constitutively expressed Hsc70 and the heat induced Hsp70 of which 
most of my studies focus on the Hsp70 isoform. Hsp70 carries out its function by repeated cycles of 
binding and release of client substrates, resulting from ATP hydrolysis at the Hsp70 N-terminal 
nucleotide binding domain (NBD) [4-7]. Hsp70 binds to solvent exposed hydrophobic patches at its C-
terminal substrate binding domain (SBD), acting as both a holdase to prevent aggregation as well as 
aiding protein refolding (Figure 0.1). Because Hsp70 binds to short hydrophobic sequences, the clientele 
for Hsp70 is vast because it isn’t restricted by shape or size of the client protein [8, 9]. And unlike typical 
holdase chaperones, Hsp70 allows proteins to renature and obtain their functional three-dimensional 
structure as in the case with the model substrate luciferase [10, 11].  
 
Figure 0.1 Hsp70 chaperone cycle. Two major conformations for Hsp70 have been extensively characterized, a high client 
affinity ADP state and a low client affinity ATP state. Co-chaperones such as J-proteins or other chaperone systems such as the 
small heat shock proteins (sHsps) are thought to intercept unfolded proteins or nascent polypeptides holding them in a folding 
competent state to be handed off to the Hsp70 system. After J-proteins accelerate the rate of ATP hydrolysis Hsp70 enters a 
high client affinity ADP state. When ADP is displaced by ATP, catalyzed by the assistance of co-chaperones known as nucleotide 
exchange factors, (NEFs), Hsp70 returns to its low client affinity state and releases the client for a chance to refold on its own or 
reenter the Hsp70 chaperone cycle. In this process Hsp70 repeatedly binds and releases client proteins and facilitates the 
folding and refolding of clients 
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Hsp70 function is further modified by its interaction with protein partners called co-chaperones that 
alter the function of the protein chaperone complex. These co-chaperones interact with Hsp70 at its 
NBD or the C-terminal consensus motif IEEVD in higher eukaryotes [12]. The network of co-chaperones 
vary in functional effects , from different modulators of Hsp70’s intrinsic ATPase activity as in J-proteins, 
to nucleotide exchange factors (NEFs) that exchange ADP for ATP [13]. In addition, the IEEVD motif 
interacts with tetratricopeptide (TPR) domain containing proteins which include a wide array of 
functions from protein phosphatases to E3 ubiquitin ligases [14]. Because these sites of interaction are 
often shared between co-chaperones, competition between these various proteins adds another layer 
of complexity to the already complicated Hsp70 cycle. These interactions expand the repertoire of 
Hsp70 function to include protein trafficking to organelles, signal transduction, and proteasomal 
degradation [15]. 
• 0.1.1 Structure and Function of Hsp70 
As mentioned above, Hsp70 consists of two major domains, the N-terminal nucleotide binding domain 
and the C-terminal substrate binding domain, linked together by a flexible linker. The chaperone 
function of Hsp70 occurs through client interactions in its SBD, which in turn is modulated by the 
nucleotide state of the NBD, communicating allosterically to give two distinct structural and functional 
conformations, the ATP and ADP states [16, 17]. In the ATP conformation client affinity has been 
reported at Kd 1-10 μM, with fast on-off rates for client proteins, compared to when bound to ADP, 
those same clients were reported at binding affinities of Kd 1-10 mM [19, 20].  
The 45 kDa NBD consists of a two-lobe v-cleft structure. Each lobe of the NBD is subdivided into two 
subdomains (IA, IB, IIA, IIB) and form a nucleotide binding cleft in which ATP hydrolysis occurs (Figure 
0.2). Subdomains of the NBD undergo continuous dynamic structural changes in response to nucleotide 
binding [4, 5, 21], as well as co-chaperone binding such as NEF or J-proteins [2].  
The SBD is composed of a 25kDa β-sheet subdomain and a 10 kDa α-helical lid [16, 17] (Figure 0.2). In 
the ADP bound state, there are two sets of four stranded twisted β-sheets which, together with the 
loops connecting the β strands, make contact with the peptide backbone of peptide substrates. The α-
helical lid domain forms hydrophobic faces that pack together with substrate and the β-sheet 
subdomain to form a hydrophobic core surrounding the client, closing the substrate binding pocket [22].  
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Figure 0.2 Hsp70 domain organization. Hsp70 consists of two domains, a nucleotide binding domain (NBD) and a substrate 
binding domain (SBD) connected by a flexible linker in the ADP state. When ADP is displaced by ATP, catalyzed by the assistance 
of co-chaperones known as nucleotide exchange factors, Hsp70 undergoes a dramatic conformational change where the α 
helical lid of the SBD folds back and the linker, along with many other areas of the SBD form extensive contacts with the NBD, in 
a low client affinity state. J-proteins accelerate the rate of ATP hydrolysis returning it to the high client affinity ADP state.  
Various structural rearrangements in the NBD cause important interactions to occur between the NBD 
and the flexible linker which connects to the SBD [23]. This linker confers interdomain allostery, where 
information regarding the nucleotide state of Hsp70 is transmitted between the two domains [24]. 
Depending on the NBD nucleotide state the linker ranges from flexible when bound to ADP and 
structured when bound to ATP, evidenced by accessibility in proteolytic digest and hydrogen-deuterium 
exchange. The full length Hsp70 structure has been determined for the bacterial homologue DnaK in 
both the ADP and ATP bound states and has served as guides for the investigation of human Hsp70 
structure [17, 22, 25]. These structures provide direct evidence of the role of the interdomain linker in 
allostery. In the ADP state, the linker region exists as a dynamic random coil whereas upon ATP binding 
the linker becomes buried between subdomain IA and IIA of the NBD and thus propagate structural 
changes through the linker into the SBD.  
Binding of ATP transmits conformational changes through the linker to the SBD, most remarkably 
causing a complete opening between the α-helical lid and the β-sheet subdomain of the SBD [8] (Figure 
0.2). In the ATP state, Hsp70 exists in a low affinity state for clients, unable to form the hydrophobic 
binding pocket. Affinity for the substrate decreases by an order of 100 to 1000, with faster on/off rates 
[18]. Substrate binding reciprocally increases Hsp70 rate of ATP hydrolysis, which will cause Hsp70 to 
cycle back to its ADP conformation.   
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Cycling between the ATP and ADP states has been shown to be a major factor in facilitating the refolding 
activity of Hsp70, driving the continued cycling of binding and release of clients [26]. Mutations made in 
the NBD are capable of impairing Hsp70 folding function by limiting the ATP turnover [21, 27]. However, 
certain mutations have been found to impair nucleotide hydrolysis without impacting Hsp70 capacity to 
refold proteins, implying other cellular factors are at play tuning Hsp70 driven folding [28]. Studies have 
shown that client retention on Hsp70, where the cycle of client release and nucleotide hydrolysis is 
interrupted, promotes degradation of clients through the ubiquitin-proteasome pathway [29]. Given the 
diverse nature of client proteins and the complex network of co-chaperones that work in concert, the 
cycling of Hsp70 states behaves as a process of protein triage rather than a process dedicated to 
refolding. 
Thus, questions focus on how Hsp70 directs protein folding and degradation remains paramount to 
understanding proteostasis, which require understanding of Hsp70 interactions with co-chaperones and 
clients during this triage process.  Limited structural information is available for the full length Hsp70 
bound to clients and co-chaperones due to the dynamic nature of the Hsp70 chaperone cycle. Crystal 
structures have elucidated how the NBD interact with J-proteins [30] and NEFs [13], and NMR has 
proven a powerful tool in determining conformational changes that occur with substrate binding in the 
context of the full length Hsp70 [9]. However, structural studies have been restricted to truncations of 
the bacterial homologue DnaK which lack the c-terminal IEEVD responsible for interactions with the E3 
ubiquitin ligase linking Hsp70 to the proteasome in eukaryotes. Recently, studies utilizing electron 
microscopy have been able to elucidate the structures of chaperone complexes with client, presenting a 
lucrative direction in which to study multi-chaperone complexes [31, 32]. Structural and biochemical 
studies utilizing the full length human Hsp70, co-chaperones and clients are needed to understand 
proteostasis pathways and the triage process. 
• 0.1.2 Co-chaperones diversify Hsp70 chaperone structure and function 
The major families of co-chaperones bind to distinct yet potentially overlapping interaction surfaces on 
Hsp70, including the C-terminus IEEVD motif, C-terminal lid domain and various regions along the NBD 
[2]. The J protein co-chaperones, such as Hsp40, bind Hsp70 at NBD subdomain IIA to accelerate the rate 
of ATP hydrolysis [30, 33]. The NEF co-chaperones, such as BAG3, bind lobes IB and IIB, opening the 
nucleotide binding cleft and facilitate the release of ADP [34]. By accelerating nucleotide exchange on 
Hsp70 to return to the ATP state, NEFs cause substrate release from Hsp70 for a new cycle of client 
binding. TPR domain containing co-chaperones bind Hsp70’s C-terminus and include the C-terminus of 
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Hsp70 binding protein (CHIP) an E3 ubiquitin ligase, linking the Hsp70 chaperone system to the 
proteasomal degradation of client proteins [35]. 
NMR studies on interactions of Hsc70 with CHIP have indicated that the flexible nature of the C-
terminus of Hsc70 allows for a loose tethered complex to allow CHIP to accommodate the extended and 
heterogenous nature of unfolded clients and space to recruit other enzymes of the ubiquitin 
proteasome pathway [36]. Other modes of binding have also been discovered for Hsc70 where 
additional contacts between the CHIP TPR and the lid region of Hsc70 have been shown to be important 
for their interaction as well as the ubiquitination of clients [37]. This suggests that although in solution 
the complex remains flexible, additional contacts may bring the chaperones and client into closer 
proximity for productive ubiquitination. The interactions between Hsp70 c-terminus and TPR containing 
co-chaperones and with other chaperone systems such as Hsp90 have been aided by the use of chemical 
crosslinking to stabilize these multi-protein complexes to obtain structural information on the low 
energy states in the protein folding cycle [31, 38]. Thus, major efforts are being made to elucidate the 
nature of the vast combinations of chaperones, co-chaperones and clients as well as pushing the 
resolution limit to obtain information beyond their quaternary structures.  
• 0.1.3 Significance of Hsp70 in neurodegenerative diseases 
Disruption of proteostasis causes protein misfolding diseases, including Alzheimer’s, Parkinson’s and 
other neurodegenerative disorders [3, 39]. These pathologies exhibit a propensity to form protein 
aggregate species in neurons, spurred by patterns of unfolding, post-translational modification and 
mutations [40, 41]. It has been shown that the decline of various chaperone systems, such as Hsp70 and 
Hsp90, leads to the advance of neurodegeneration in mouse and neuronal cell culture models [42, 43].  
Upregulation of Hsp70 has been shown to counteract neurodegenerative pathologies and small 
molecules that promote Hsp70 client binding have also been shown to promote turnover of aggregation 
prone clients such as tau protein [29, 44, 45]. The role of ubiquitination has been essential in linking 
Hsp70 chaperone activity to lowering cellular levels of tau [45]. Thus, elucidation of the mechanism of 
client ubiquitination serves as another step towards uncovering the process of Hsp70 triage of clients.  
• 0.1.4 The E3 ubiquitin ligase CHIP- maintaining balance and proteostasis 
The pathway to proteasomal degradation begins with the process of poly-ubiquitination, which consists 
of the formation of a poly-ubiquitin chain linked to a lysine of the target substrate [46]. The small 76 
amino acid polypeptide ubiquitin is built into a chain of ubiquitin proteins, utilizing the carboxy terminus 
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of ubiquitin to form an isopeptide bond with the substrate and specific lysines on ubiquitin to assemble 
additional subunits. This serves as a post translational modification which then can target the substrate 
to the proteasome, on its own or in concert with other factors that disassemble or unfold the client. 
Inhibition of the proteasome has allowed identification of the various patterns of linkages that occur to 
promote degradation, such as the K48 or K11 [47]. Other lysines have been identified in poly-ubiquitin 
chains, such as the K63, but are involved in signaling and have been shown to be protect substrate from 
proteasomal degradation.  
 
Figure 0.3 The ubiquitin-proteasome pathway. Proteins are directed to the proteasome protease by the post-translational 
modification of ubiquitin-chain conjugation, a complex energy dependent process that transfers a series of ubiquitin molecules 
onto a lysine of a target molecule. Ubiquitin is transferred between an E1 activating enzyme and E2 conjugating enzyme as well 
as an E3 ligase enzyme which catalyzes the final step either directly or indirectly. The ability of protein chaperones such as 
Hsp70 and Hsp90 to direct client ubiquitination allows for chaperones to both maintain a pool of functional protein as well as 
degrade them, facilitating protein turnover. 
Transfer of ubiquitin involves a very complex chain of events carried out through three major classes of 
enzymes (Figure 0.3). An E1 activation enzyme first forms a high energy thioester bond between the E1 
and ubiquitin though the use of ATP. The ubiquitin is then transferred to a second enzyme termed the 
E2 conjugation enzymes where it is poised for transfer onto the substrate. This is catalyzed through the 
third class called E3 ligase enzymes, which either acts as a catalyst or scaffold between the E2 and the 
substrate (the RING family of E3 enzymes) or as an additional receptor of ubiquitin where it is 
transferred first to the E3 before the substrate (HECT or RBR) [48]. These multi-tiered steps serve as 
checkpoints for substrate recognition and regulation. 
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An additional level of substrate selectivity is seen with the proteostasis chaperone machinery, namely 
the Hsp70, Hsp90 and CHIP proteins [49, 50]. CHIP acts as a RING class E3 ubiquitin ligase, and has been 
shown to selectively ubiquitinate clients bound to chaperone [35]. The structure of CHIP has been solved 
and reveals three domains responsible for its function in facilitating the protein degradation aspect of 
proteostasis [51, 52] (Figure 0.4). CHIP consists of an N-terminal tetratricopeptide domain (TPR) 
responsible for interactions with the EEVD motifs of Hsp70 and Hsp90, a middle helical hairpin domain 
which allows CHIP dimerization and a U-box domain, structurally related to the RING E3 domains. 
Dimerization of CHIP has been shown to be essential for its ability to ubiquitinate substrate [53]. This 
raises the questions of the function of having two TPR domains and two U-box domains in the 
mechanism of chaperone bound client ubiquitination. Structural studies have suggested that the 
restricted area and binding surfaces of the U-box domain for E2 enzymes allows for one U-box accessible 
for recruitment [54].  
 
Figure 0.4 Crystal structure of murine CHIP. CHIP exists in solution as an obligate homodimer, essential for its function in 
ubiquitin transfer. In addition it contains the canonical tetratricopeptide repeat domain responsible for interactions with Hsp70 
and Hsp90 EEVD motifs. 
 
The affinity of CHIP for Hsp70 is greater than for Hsp90 or Hsc70, demonstrating preferential and 
varying capacities for ubiquitination to occur in the different chaperone systems [14]. These layers of 
regulation make it essential to understand the biochemical and structural properties of various 
chaperone:E3 complexes. Work detailing the Hsp70:CHIP interaction is discussed in chapter 1. 
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• 0.1.5 The nucleotide exchange factor BAG3 – bridging multiple chaperone systems 
Another significant co-chaperone aiding in the function of Hsp70 are NEF enzymes such as the Bcl-
2associated AnthanoGene (BAG) proteins. NEFs bind to the NBD of Hsp70 and facilitate the exchange of 
ADP for ATP to allow continued cycling of nucleotide states [55]. The families of human NEF proteins are 
numerous and differentially expressed, and have been implicated in various disease states including 
Alzheimer’s disease [56]. Of particular interest in my thesis is the BAG family of proteins, namely BAG3 
which contains multiple binding motifs that in addition to acting as an Hsp70 NEF can interact with other 
chaperone systems [13]. 
BAG proteins consist of a C-terminal BAG domain which is capable of binding the bottom of the two 
lobes of the Hsp70 NBD, IB and IIB (Figure 0.1), to open the nucleotide binding pocket [34]. The BAG 
domain has been characterized as a three-helix bundle, but efforts to solve the structure of the N-
terminal regions have proved elusive. This is due to the variability and flexibility of the domains that 
have been classified for the various BAG proteins [26]. BAG3 is one of the largest enzymes of the BAG 
family, containing many distinct protein-protein interaction domains [57, 58] (Figure 0.5). Its WW 
domain facilitates binding with PPxY motifs of clients, multiple PXXP motifs allow interactions with SH3 
domains and two IPV motifs are responsible for binding with members of the sHSP chaperone family 
[59]. Though the structural characterization of BAG3 itself is challenging, the ability of these many 
domains to act as a scaffold was of great interest as to how BAG3 can modify the structure and function 
of chaperone complexes and for instance influence cell processes such as autophagy [57]. In chapter 2, a 
study on the BAG3 co-chaperone explores the Hsp70 pro-folding functions and the structural 
implications this protein has on bridging the Hsp70 and sHsp systems. 
• 0.2 Tau- a model Hsp70 client implicated in protein folding diseases and neurodegeneration 
The accumulation of the microtubule-associated protein Tau (MAPT or tau) in neurofibrillary tangles 
(NFTs) is a hallmark of various neurodegenerative diseases, including Alzheimer's disease, 
frontotemporal dementia and chronic traumatic encephalopathy [39]. Hsp70 has been shown to affect 
the rate of tau accumulation, engaging tau at various pathological events [60]. However, structural 
modifications that occur to tau in route to its toxic oligomeric or aggregate species have been difficult to 
characterize owing to its intrinsic disorder [61]. 
Effective therapies directly targeting the tau protein are currently lacking. The molecular mechanisms 
regulating tau stability are not yet clear, therefore one focus of tauopathy treatment has been to 
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accelerate tau clearance, its degradation via the ubiquitin-proteasome pathway to alleviate the 
accumulation of potentially toxic species [29]. This has been shown to promote the viability of neurons 
as well as survival rates in mouse, drosophila and neuronal cell models [62-64].  
• 0.2.1 Structural modifications of tau protein and disease 
Tau has six isoforms in humans, with the 0N4R the most common isoform in the central nervous system 
of the adult mouse brain [65]. The 0N4R name indicates the number of N-terminal inserts and 
microtubule binding repeat domains (R). The varying ratios of isoforms play a role in the propensity for 
NFTs to form in neurons, however the cellular levels of the 0N4R isoform make it of particular interest in 
neurodegenerative pathologies. Paired helical filaments (PHFs), the subunits that assemble into NFTs, 
have been characterized structurally and consist of tau heavily modified by post-translational 
modifications [66, 67]. 
 
Figure 0.5 Structural elements of tau. The microtubule binding repeat domains confer tau the ability to stabilize microtubules 
and axonal cytoskeletal elements. Hsp70 binding sites, marked with diamonds, have also been mapped to this region by the 
Gestwicki and Dickey labs. Tau is an intrinsically disordered protein when not bound to protein partners and adopts mostly 
random inconsistent structures. Tau is found to aggregate in various neuropathologies and protein chaperones are thought to 
prevent this. 
Tau can be phosphorylated multiple sites and hyperphosphorylation, or near saturation of these sites, is 
observed in NFTs and disease states [41, 68]. However, the physiological functions of tau 
phosphorylation or how it may contribute to neurodegenerative pathology are not completely 
understood. Ubiquitination is commonly found as post-translational modifications, and site and linkage 
specificity has been shown to accelerate turnover or protect tau from degradation [69]. The mechanism 
of how tau becomes ubiquitinated and targeted for degradation before forming into PHFs remains an 
important question underlying tau proteostasis.    
• 0.2.2 Regulation of tau homeostasis by protein chaperones 
Underlying the observation that depletion of tau leads to increased viability [42, 62], studies on how the 
protein chaperone systems affect tau have shown that Hsp70 directly impacts the prevention of tau 
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aggregation as well as degradation [70]. Hsp70 has been shown to bind to the microtubule binding 
repeats of tau, preventing the formation of PHFs and assisting tau function in the binding and 
stabilization of axonal microtubules [29, 71]. Increasing affinity of Hsp70 for client suggests that the 
overall time Hsp70 spends bound to tau is a major determinant of cellular levels of tau, where 
specifically the stress inducible isoform Hsp72 or HSPA1A has been shown to better promote client 
ubiquitination and degradation over Hsc70 or other chaperones such as Hsp90 [72-74]. Thus, Hsp70 acts 
on a critical stage of tau pathology although the direct interaction is unknown. Because of the 
connection of Hsp70 to the proteasome through CHIP, the direct interaction between Hsp70 and CHIP is 
an important regulatory process in facilitating triage for tau proteostasis. To further investigate 
mechanisms which can be chemically probed to enhance tau turnover, Chapter 1 describes a study of 
the molecular events that take place during tau poly-ubiquitination. 
• 0.3 Small heat shock proteins - oligomeric assemblies stalling client aggregation 
Small heat shock proteins (sHSPs) are a class of ATP independent protein chaperones that function in 
binding and stabilizing unfolded or aggregation prone client proteins [11]. Their primary function has 
been characterized as delaying protein aggregation, where protein refolding has typically been 
attributed to the assistance of other chaperone systems such as Hsp70. Usually consisting of small 
molecular weight species, sHsps exist as oligomers in solution of variable size and shape [75]. Studies 
have shown that upon activation, structural changes occur that alter the multimeric assemblies to form 
distinct ‘activated’ chaperones that protect exposed hydrophobic patches of unfolding or aggregating 
clients [76]. Thus, sHsps act as a reservoir of chaperones that serve as a buffer against protein 
aggregation, potentially connecting various chaperone families [13, 59]. Characterizing how this 
crosstalk occurs as well as what triggers the activation of sHsps is an outstanding question that will be 
further explored in chapters 2 and 3.  
• 0.3.1 sHSP nucleotide independent holdase functions increase cell viability 
sHSPs participate in many biological processes, including the cell cycle, cell differentiation, stress 
response, and apoptosis [77].  Mutations of sHsp have been implicated in various diseases in 
development and peripheral nervous system pathologies [78]. Diseases such as cardiomyopathy, motor 
neuron diseases and cataracts have directly linked sHsp function to stabilizing various cytoskeletal 
elements as well as preventing protein aggregation [79-81]. One class of sHsps, Hsp27 or HSPB1, has 
been shown to alleviate the toxic effects of protein aggregates such as amyloid β in vitro, revealed to 
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bind to the oligomeric amyloid β and cause formation of larger aggregates without disrupting the 
secondary structure of the client proteins [82], demonstrating the varied structures of the holdase 
clients and the ambiguity of what constitutes toxic species to the cell. Another sHsp, αB crystallin or 
HSPB5, is directly involved in the buffering of stress in eye lens fiber cells, where high protein 
concentrations are necessary to provide adequate refractive index [81]. The environment causes pH 
stress relative to other cells where HSPB5 is expressed and may be a factor activating its holdase 
function [83]. Given the wide breadth of processes sHsp affects in the cell, the oligomeric distribution of 
sHsp proteins is one method of regulation and diversifying sHsp function. Although the general effect of 
slowing aggregation has been known, it has been difficult to characterize a structural mechanism in 
which they protect clients. Another major outstanding question is how binding partners and the 
chemical stressors modulate and activate sHsp oligomeric distribution. 
• 0.3.2 The ensemble of structural states for the sHSP, αB crystallin (HSPB5) 
HSPB5 is an example of a sHsp existing as multimeric assemblies in solution, consisting of oligomers of 
very small gene products [84]. It shares many architectural features common among sHsps, including a 
conserved central α crystallin domain (ACD) which is flanked by variable N- and C-terminal regions. The 
basic HSPB5 subunit or protomer exists as an anti-parallel homodimer, with the ACD domains forming a 
dimer interface [85] (Figure 0.6). Structures of the core ACD dimer reveal an 8 β sheet stranded 
structure and is very similar between different classes of sHsps and across different species [75]. Within 
the variable regions, the C-terminus contains short sequence motifs of isoleucines, “IXI/V”, that have 
been observed to bind to the ACD of neighboring dimers, forming interdimer contacts important for 
oligomeric assemblies of protomers [86]. HSPB5 assembles into a distribution of oligomeric states that 
undergo dynamic structural rearrangements and subunit exchange into different sized oligomers 
ranging from dimers to 40-mers [87]. Because of the lack of structural information regarding the 
unstructured variable regions, and the heterogeneity of the distribution of oligomers in solution, it has 
been challenging to obtain high resolution information on the arrangement of protomers and the 
protomer structures within the oligomers.  Which forms of HSPB5 oligomers are active remains a central 
question. 
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Figure 0.6 HSPB5 building blocks of higher order oligomers. The solution NMR structure of the HSPB5 dimer is represented in 
light blue and green, with an extensive β sheet interface describing the α-crystallin domains across between each monomer. 
Although it is not clear what exactly the building blocks are for many sHsp proteins, models have been proposed for symmetric 
assemblies of oligomers that reflect their average molecular weight in solution, such as the 24mer HSPB5. Because of the 
importance of the C-terminal IXI/V motif and the variable N-terminus, this particular model proposed by the Klevit lab has many 
random coils joining inter-dimer contacts as well as extend out into solution due to their non-structured nature. 
HSPB5 and other sHsp proteins must engage in heteromeric interactions with their clients [76]. As 
mentioned previously, the diverse clientele that engage with sHsp proteins makes many modes of client 
modes possible. In support of this notion, one study demonstrated that a mixture of sHsps and clients in 
cell lysate demonstrated much better capacity to prevent aggregation than with individual recombinant 
substrates, illustrating the importance of the client structure. The dynamic nature of protomer exchange 
in sHsp oligomers on their own has also been shown to be dependent on stress conditions, as well as 
post-translational modifications [88]. However, it is unclear how these cellular stressors and changes 
affect the oligomeric distributions of sHsp species and how they protect clients. In chapter 3, these 
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questions of how the individual HSPB5 dimers react to pH stress are analyzed and the effects on 
oligomeric distribution and subsequent client binding are assessed. 
• 0.4 Peroxiredoxin - emerging chaperone activities for multi-functional proteins  
Peroxiredoxins (Prxs) are highly conserved and ubiquitous peroxidases that are essential for antioxidant 
protection and cell signaling and relatively recently characterized as holdase chaperones [89]. Typical 2-
Cys-Prxs are obligate homodimers of two inverted subunits that rely on two cysteines for hydroperoxide 
detoxification: the peroxidatic cysteine (Cp), which interacts directly with peroxides, and the resolving 
cysteine (Cr), which condenses with the oxidized Cp of the other subunit by forming a disulfide bond 
(Figure 0.7). The disulfide bond subsequently is regenerated by a thiol-containing oxidoreductase, such 
as thioredoxin or another member of the thioredoxin family [90].  
 
Figure 0.7 Peroxiredoxin function in protecting against oxidative stress. Members of 2-cys-peroxiredoxin family are obligate 
homodimers that are responsible for the clearance of a majority of peroxides produced for instance in the mitochondria. There 
are two active sites in each dimer responsible for the peroxidase activity, once oxidized it must become reduced by a thiol 
containing oxidoreductase to begin the next cycle. The Leishmania infantum mTXNPx uses tryparedoxin for this role hence the 
name. This figure was generated by Filipa Teixeira from Ursula Jakob’s lab. 
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2-Cys-Prxs have been studied extensively in regard to their role in the detoxification of reactive oxygen 
and nitrogen species [91]. They also have been implicated in other biological activities, including H2O2 
signaling, protein oxidation, and chaperoning functions under stress conditions [92]. The chaperone 
activity of 2-Cys-Prxs was first reported in 2004, when Jang et al. [93] proposed that peroxide-mediated 
overoxidation of the active cysteine Cp in yeast cytosolic 2-Cys-Prx (Tsa 1) inactivates the peroxidase 
function and triggers its conversion into high molecular weight oligomers that prevent in vitro protein 
aggregation. 
• 0.4.1 Cell stress triggers various modifications to Prx structure and function 
Various conditions have been characterized that act as a functional switch converting Prx from a 
peroxidase to a holdase chaperone, including heavy oxidative stress, heat or site-specific post-
translational modification [94-96]. These stimuli trigger structural changes in Prx that cause the 
homodimeric proteins to noncovalently associate into ring like decameric or dodecameric structures 
[97]. Reports have shown that the dimer-decamer conversion regulate the efficiency of peroxidase 
catalytic activity and chaperone activity, however the exact nature of the higher molecular weight 
species and which forms are active antioxidants or chaperones is unclear. It has been proposed that 
oxidative stress causes the shutdown of peroxidase activity with the overoxidation of disulfides to 
sulfenic acid, and causes structural changes that result in the stacking of decameric Prx [98]. Stress 
conditions such as pH has been shown to promote the formation of higher molecular weight species, 
with unfolding of the C-terminal domains which protrude from the outer Prx ring as putative substrate 
interaction sites [96, 99, 100]. Major questions remain of how the decameric Prx can account for some 
of these active high molecular weight species and their chaperone activity in the presence of heat shock.  
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Figure 0.8 Chaperone activity of Leishmania infantum mTXNPx. The Jakob Lab has shown that heat shock activates a 
chaperone function in this mTXNPx molecule, using luciferase as a model substrate that aggregates over time during heat stress 
(top left panel, increased light scattering), however mTXNPx, specifically in the the reduced decamer form, is capable of 
preventing aggregation. This figure was generated by Filipa Teixeira from Ursula Jakob’s lab. 
Of particular interest is work by Castro et. al, detailing the relevance of another 2-Cys-Prx family protein, 
mitochondrial tryparedoxin-peroxidase (mTXNPx) in its ability to act as a chaperone to allow survival of a 
protozoan parasite [101]. The parasite Leishmania Infantum has a digenic life cycle, where it must 
survive between the cells of invertebrates (insects) and mammals and thus two different ambient 
temperatures (Figure 0.8). It was demonstrated that the mTXNPx deficient parasites were much more 
sensitive to temperature shifting from 25 °C and 37 °C, the transition from insect to mammalian hosts 
[94]. Through mutagenesis of mTXNPx abolishing its peroxidase activity, it was suggested that an 
alternative function of mTXNPx was responsible for ensuring viability of the parasite. Using this model 
system, we were able characterize a chaperone mechanism of a Prx class enzyme dependent on the 
specific decamer form of mTXNPx, presenting a case study on the importance of protein folding in the 
face of stressors such as heat shock. The published mechanism of temperature-sensitive activation, as 
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well as further studies into the structure of the client bound chaperone complex and their binding 
interface is presented in chapter 4.   
• 0.5 Electron microscopy: a powerful technique providing structural information from both 
high and low resolutions 
In my thesis work, I use the term electron microscopy (EM) generally to refer to the practice of single 
particle analysis of protein molecules embed in heavy metal stain (negative stain EM) or vitrified ice 
(cryo-EM) [102-104]. A very basic overview of how these techniques allow the visualization of protein 
structure follows. By subjecting the immobilized proteins to high vacuum and an incident electron beam, 
an electron microscope, through the use of symmetric magnetic fields, can reconverge the diffracted 
electrons to obtain a two-dimensional image of the particles, an electron micrograph containing 
particles in various orientations (Figure 0.9). 2D projections correlate with the 3D object they represent 
described by the central section theorem [105], which states that the fourier transforms of the 2D 
projections are ‘central slices’ through the origin of the fourier transform of the 3D object. The 
fundamental goal of electron microscopy aims to determine a complete 3D fourier representation of the 
object by assigning for each projection the pose, or orientation parameters relating the 2D projections 
to one another by rotational and translational shifts, so that the reverse fourier transform can be used 
to recover the 3D object in real space.  
In practice, the process of determining 3D structure from cryo-EM is very challenging, with one of its 
most fundamental issues arising from the intrinsically noisy images owing to the physics involved in 
electron diffraction by proteins [106, 107]. Solutions to these issues have steadily advanced over the 
decades. Freezing proteins in solution at liquid nitrogen temperatures has helped alleviate the amount 
of radiation damage incurred by electron exposure, and the use of liquid ethane to trap proteins in non-
crystalline or vitreous ice has allowed imaging of proteins with low background signal [103, 108]. This, 
alongside the development of specialized hardware of more coherent electron sources, more powerful 
and stable microscopes, has made electron microscopy into a routine procedure for determination of 
protein structure [109, 110] .  
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Figure 0.9 Simplified schematic for structural determination by EM. From an electron microscope, one can obtain 2D 
projections of the 3D object of interest such as protein particles. In an ideal scenario, we can prepare the protein sample 
suspended in random orientations and thus obtain multiple projections of the same object. Care must be taken to remove 
projections that are of a different object or conformation. Any 3D or 2D object can be represented in Fourier space, by 
calculating the Fourier transform of something in spatial coordinates one can obtain a representation of that object in terms 
the frequencies which in this case reflect spatial frequency of contrast. The main problem of EM is the assignment of pose, or 
the orientation of each Fourier slice, because one must have some idea of the 3D object to project this test model and match 
each projection to the best orientation of the test model.  
The past decade in particular has seen major advances that have directly contributed to the cryo-EM 
studies I have carried out in my thesis in chapters 1 and 4. The development of semiconductor 
detectors, termed ‘direct detectors’, has succeeded the use of CCD technology [111]. These cameras 
have the ability to precisely count electrons at any given position on the detector and has both greatly 
improved the resolution and signal of electron micrographs and enables the ability to split an image 
exposure into short subframes in order to realign each subframe to account for any movements induced 
by the electron beam or instabilities in the microscope [112]. Recent efforts in the development of 
‘phase-plates’ have also gained traction, and is further detailed as a future direction in chapter 5 [113]. 
This technology can be simplified as a method to obtain better contrast for smaller protein particles, an 
issue that generally limits the ability of cryo-EM to resolve higher resolution information for particles on 
the order of 300 kDa or smaller [114].  
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Development of software to handle the complex problem of assigning the pose for each 2D projection 
has been an ongoing effort [115, 116] . A developer of one popular and robust software package, Sjors 
Scheres, has described two major hurdles in solving the structure through EM: data such as orientation 
parameters are not experimentally observed and the dataset is finite without a unique solution [117]. 
With these issues in mind, the RELION software package has proven to be very effective in establishing a 
pipeline to solving 3D structure. Taking classical approaches of bootstrap refinement of orientation 
parameters, it utilizes marginalization and Bayesian statistic approaches to weight noisy particle images 
by the likelihood of pose being correct. This software package has been instrumental in obtaining 3D 
information from cryo-EM. Software for the automation of image acquisition from an electron 
microscope has also allowed a greater throughput in obtaining enough EM data to overcome the issues 
of noise and has been extremely helpful in pushing the resolution of cryo-EM structures.  In addition, 
optimization of software to run these calculations utilizing GPUs have sped up the ability to process EM-
data [118]. I have placed much effort in understanding and establishing automation and processing of 
EM data in my graduate career, and these developments are further detailed as exciting future 
directions in chapter 5.  
Negative stain EM has also been an effective and high throughput method to analyze structural 
information of various protein complexes in my graduate work. Because of the challenges presented 
earlier on producing a unique, high resolution solution through cryo-EM, it is not always feasible to 
determine structure for every protein sample. Negative stain EM has advantages in the overall time 
spent and consistency of sample preparation can allow immediate visualization [104]. This low-
resolution technique embeds protein sample in heavy metal stain, such as uranyl formate, producing 
high contrast between stain and protein to allow visualization of quaternary structure. Useful structural 
information can be obtained about the overall conformations that occur with biochemical conditions. 
• 0.6 Notes 
Section 0.4 of this introduction is adapted from the publication Teixeira, F. Castro, H. Cruz, T. Tse, E. 
Koldewey, P. Southworth, D. R. Tomas, A. M. Jakob, U., Proc Natl Acad Sci U S A, 2015. 112(7): p. E616-
24. Motivations behind the Prx project biochemistry and guidance provided by Filipa Teixeira and Ursula 
Jakob. 
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Chapter 1 
Hsp70 Dependent Triage Mechanisms of CHIP E3 Ubiquitin Ligase Facilitate Poly-ubiquitination of Tau 
• 1.1 Abstract  
Heat shock protein 70 (Hsp70) is a ubiquitous molecular chaperone that is essential in cellular protein 
homeostasis, or proteostasis, binding to exposed hydrophobic patches of client substrate to protect 
proteins from aggregation and facilitate refolding. This process is described by two major conformations 
of Hsp70 where its N-terminal nucleotide-binding domain (NBD) and C-terminal substrate binding 
domain (SBD) rely on allosteric communication to couple ATP hydrolysis with substrate binding. 
Alternation between a high affinity ADP state and a low affinity ATP state constitutes a cycle of client 
binding and release essential for its foldase activity. In addition, Hsp70 has been shown to interact with 
the CHIP (C-terminus of Hsp70 Interacting Protein), an E3 ubiquitin ligase, to promote client 
ubiquitination, and proteasomal degradation, leading to protein turnover. How this process of triage 
occurs or how Hsp70 directs ubiquitination is not clearly understood. To better understand Hsp70 
dependent ubiquitination, we examined the role of nucleotide binding on CHIP recruitment and 
identified the formation of an ADP-specific Hsp70:CHIP tetramer complex. Utilizing a pathologically 
important client protein tau, we found that conditions that favor Hsp70 recruitment of CHIP result in the 
Hsp70 dependent poly-ubiquitination of tau, suggesting the importance of Hsp70 in homeostasis of tau 
that precedes development of pathological forms of tau. In addition, we found evidence that Hsp70, 
CHIP and tau must remain associated for efficient poly-ubiquitination to occur. These studies show 
direct evidence for how slowing down the Hsp70 chaperone cycle in the ADP state promotes client 
turnover, suggesting a mechanism where conditions that favor Hsp70 dwell time on clients allows 
sufficient time for CHIP binding and poly-ubiquitination. We characterized the structure of the 
Hsp70:CHIP complex utilizing cryo-EM and mass spectrometry, revealing a W-shaped architecture that 
positions Hsp70 SBD and CHIP U-box domain for efficient ubiquitin transfer. By identification of 
crosslinks in the Hsp70:CHIP as well as the Hsp70:CHIP:tau complex we are able to validate our cryo-EM 
structure as well as examine the changes in interaction surfaces when these proteins bind together. 
Overall, we provide a structural model that describes the binding events that poise Hsp70 bound tau for 
ubiquitination.  
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• 1.2 Introduction 
Heat shock protein 70 (Hsp70) is a molecular chaperone capable of binding to partially misfolded 
proteins, making it an essential component in folding of nascent polypeptides, binding and refolding 
unfolded proteins and preventing of aggregation of toxic species [1, 2]. It carries out its function by 
repeated cycles of binding and release of its client substrates, resulting from ATP hydrolysis [3]. Hsp70 
consists of two major domains, the N-terminal nucleotide binding domain (NBD) and the C-terminal 
substrate binding domain (SBD), joined together by a flexible linker. The chaperone function of Hsp70 
occurs through client binding at the SBD modulated allosterically by the nucleotide state of the NBD, 
characterized by distinct ATP and ADP conformations [4, 5]. In the ATP conformation, Hsp70 has fast on-
off rates for client proteins, resulting in overall low substrate affinity [6]. When bound to ADP, Hsp70 
possesses much higher substrate affinity, with model client peptides reported at Kd 1-10 μM [7, 8]. 
Hsp70 binds to solvent exposed hydrophobic patches, acting as both a holdase to prevent aggregation 
as well as allow protein refolding [9]. Because Hsp70 binds to short hydrophobic sequences, the 
clientele for Hsp70 is vast because it isn’t restricted by shape or size of the client protein [10].   
An important client of Hsp70 is the microtubule-associated protein Tau (MAPT or tau) [11]. The 
accumulation of tau in neurofibrillary tangles (NFTs) is a hallmark of various neurodegenerative 
diseases, including Alzheimer's disease, frontotemporal dementia and chronic traumatic 
encephalopathy [12-14]. The molecular mechanisms regulating tau stability are not yet clear, therefore 
one focus of tauopathy treatment has been to accelerate tau clearance via ubiquitin-dependent 
degradation by the proteasome [15]. This has been shown to promote the viability of neurons as well as 
survival rates in mouse, drosophila and neuronal cell models [16]. Hsp70 has been shown to interact 
with tau, promoting its stability or facilitating its degradation in conjunction with the CHIP E3 ubiquitin 
ligase [17, 18]. However, structural modifications that occur to tau en route to its toxic oligomeric or 
aggregate species have been difficult to characterize owing to its intrinsic disorder [19]. Studies on how 
the protein chaperone systems affect tau have shown that Hsp70 directly impacts the prevention of tau 
aggregation as well as degradation [20]. Hsp70 has been shown to bind to the microtubule binding 
repeats of tau, preventing the formation of PHFs and assisting tau function in the binding and 
stabilization of axonal microtubules [17]. Studies using small molecules increasing the affinity of Hsp70 
for client suggest that the overall time Hsp70 spends bound to tau is a major determinant of cellular 
levels of tau [21]. The stress inducible isoform Hsp72 or HSPA1A has also been shown to better promote 
client ubiquitination and degradation than the Hsc70 isoform or other chaperones such as Hsp90 [17]. 
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Although it is clear that Hsp70 is critical for the turnover of tau, direct evidence of the mechanism by 
which Hsp70 directs tau or general client ubiquitination is lacking. 
Tetratricopeptide (TPR) domain containing co-chaperones bind Hsp70’s C-terminus and include the C-
terminus of Hsp70 binding protein (CHIP) an E3 ubiquitin ligase [22, 23], linking the Hsp70 chaperone 
system to the proteasomal degradation of client proteins [24, 25]. CHIP acts as a RING class E3 ubiquitin 
ligase, and has been shown to selectively ubiquitinate clients bound to chaperone [26]. The structure of 
CHIP has been solved and reveals three domains responsible for its function in facilitating the protein 
degradation aspect of proteostasis [23]. CHIP consists of a N-terminal tetratricopeptide domain (TPR) 
responsible for interactions with the EEVD motifs of Hsp70 and Hsp90, a middle helical hairpin domain 
which allows CHIP dimerization and a U-box domain, structurally related to the RING E3 domains. 
Dimerization of CHIP has been shown to be essential for its ability to ubiquitinate substrate [27]. This 
raises the questions of the function of having two TPR domains and two U-box domains in the 
mechanism of chaperone bound client ubiquitination. Structural studies have suggested that the 
restricted area and binding surfaces of the U-box domain for E2 enzymes allows for one U-box accessible 
for recruitment [23]. Adding to the complexity, the affinity of CHIP for Hsp70 is greater than for Hsp90 
or Hsc70, demonstrating preferential and varying capacities for ubiquitination to occur in the different 
chaperone systems [28]. These layers of regulation make it essential to understand the biochemical and 
structural properties of various chaperone:E3 complexes. NMR studies have demonstrated that the 
flexibility of the Hsp70:CHIP interaction is an important feature of this interaction, making an exact 
structure difficult to obtain [25]. However a crystal structure now exists for fragments of CHIP and 
Hsp70 the Hsc70:CHIP complex describing CHIP TPR and the C-terminus of Hsp70 demonstrating that 
specific interactions between Hsp70 and CHIP describe low energy states that are important for the 
binding between these two proteins  [24, 25]. Previous structural studies characterizing the full-length 
Hsp70 have focused on the Escherichia coli ortholog DNAK, which lacks the C-terminal IEEVD motif. 
Further structural studies are needed to clarify the mechanism of Hsp70 binding to CHIP and how it 
directs client ubiquitination.  
In this study, we establish conditions regulating the interaction of human proteins Hsp70, HSPA1A, and 
CHIP, revealing that the specific ADP conformation of CHIP stabilizes a 2:2 Hsp70:CHIP complex. 
Formation of this complex becomes less efficient in conditions that favor the ATP form of Hsp70 and 
that the tetramer formation is mediated by the IEEVD:TPR interaction. We also found that the ADP form 
of Hsp70 favored both the binding of tau as well as the formation of a Hsp70:CHIP:tau ternary complex. 
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To test the downstream effects of the formation of this ternary complex, we reconstituted an in vitro 
poly-ubiquitination assay to show Hsp70 dependent ubiquitination of tau, and demonstrate that though 
ATP is required for ubiquitination, conditions that would drive Hsp70 equilibrium towards its ADP state 
result in more efficient poly-ubiquitination. This raises the possibility of the Hsp70:CHIP tetramer 
complex playing a role in client ubiquitination. In collaboration with the lab of Phil Andrews at the 
University of Michigan, we use mass spectrometry to validate native contacts between Hsp70 and CHIP 
as well as identify regions of flexibility. We are also able to obtain crosslinking map with the 
Hsp70:CHIP:tau ternary complex and observe changes in the structure of tau upon chaperone binding as 
well as displacement of some of the lid region-TPR contacts by tau supporting a model where Hsp70 
positions the substrate near the U-box. Finally we report a cryo-EM structure of the Hsp70:CHIP complex 
and propose a model for its quaternary structure based on our biochemical evidence. These results 
show that the binding between Hsp70, CHIP and tau allows productive ubiquitination to occur and we 
provide a structural model that brings together the client with the ubiquitin transfer machinery 
suggesting how multi-valent Hsp70 binding events to tau push it towards a high efficiency state for CHIP 
ubiquitination as a mechanism for protein triage.   
• 1.3 Results 
• 1.3.1 Hsp70:CHIP form an ADP-specific tetramer complex 
Previous studies identified that Hsp70 and CHIP bind via the canonical EEVD:TPR interaction with a Kd of 
0.95 μM [29]. CHIP has also been reported to have higher affinities for Hsp70 c-termini peptides at 0.51 
μM, making it unclear how the nucleotide dependent conformations of the full length Hsp70 affects its 
interaction with CHIP [30]. Hsp70:CHIP complex formation was investigated using size exclusion 
chromatography in tandem with multi-angle light scattering (SEC-MALS). This method obtains an 
average molecular weight (Mwavg) value for proteins across an elution fraction, independent of their 
shape [31]. The Mwavg for the CHIP elution was determined to be ~75 kDa, corresponding to a dimer 
species based on the 35 kDa molecular weight of the monomer, calculated from the sequence (Mwcalc) 
(Figure 1.1A and Table 1.1). This is in agreement with the known dimerization of the HH and U-box 
domains [23]. Purified Hsp70 elutes in a similar position, but with a Mwavg of ~100 kDa, potentially 
corresponding to a mix of monomeric and dimeric species based on a Mwcalc of 70 kDa for the monomer 
(Figure 1.1A and Table 1.1). Notably, Hsp70 has previously been characterized to exist in both monomer 
and dimer forms [32, 33]. 
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 Figure 1.1 Binding with the TPR of CHIP is dependent on the nucleotide state of Hsp70. CHIP and Hsp70 were analyzed by 
SEC-MALS, showing both the elution profile of the protein samples (refractive index, right Y-axis) with Mwavg (Horizontal traces 
beneath peaks corresponding to left Y-axis). A) Incubation of CHIP and Hsp70 result in a leftward shift compared to elution 
profiles of either protein alone (green vs blue and black), the presence of substoichiometric Hsp40 results in Mwavg improving in 
homogeneity (red, consistent Mwavg value across peak). B) After forming the Hsp70:CHIP complex using the conditions in A (red 
trace), titration of increasing amount of ATP causes complex dissociation. C) Hsp70:CHIP was prepared without Hsp40 in the 
presence of 5mM ATP (green) or ADP (red) showing stable complex formation in saturating ADP conditions. D) Hsp70K71M, in 
which nucleotide hydrolysis activity is abolished and allostery between NBD and SBD are decoupled, exists primarily in the ADP 
conformation [34, 35], and can form a stable complex with CHIP regardless of nucleotide present (red and blue). This is in 
contrast to the T204A mutation which also ablates ATPase activity but has been used to characterize Hsp70 structure in the ATP 
conformation [34, 36]. 
Following incubation of equimolar Hsp70 and CHIP a broad peak is observed that is shifted substantially 
from the Hsp70 and CHIP peaks (Figure 1.1A). The Mwavg for this peak was determined to be 140 kDa, 
indicating Hsp70 and CHIP form a complex. Gel analysis confirmed that both Hsp70 and CHIP were 
equally present in the corresponding fraction (Figure 1.2). While the Mwcalc of Hsp70:CHIP with a 1:2 
stoichiometry is ~140kDa, the broad peak shape indicated potential dissociation of the complex and 
multiple species may be present.  
30 
 
 
Figure 1.2 SEC profiles and SDS-PAGE analysis of SEC fractions. SEC experiments for the Hsp70:CHIP complexes under various 
conditions were performed and fractions were collected at the same positions for each SEC run and analyzed by SYPRO ruby 
protein gel stain (Invitrogen). 
We surmised that Hsp70 may exist in both ATP- and ADP-bound states in the purified sample, thereby 
resulting in altered interactions with CHIP due to different conformations or dimerization [37]. 
Therefore, Hsp70 and CHIP were incubated with a sub-stoichiometric amount of Hsp40 to catalyze ATP 
hydrolysis and convert Hsp70 to the ADP state. SEC-MALS analysis of this sample revealed Hsp70:CHIP 
elutes primarily as a large mono-dispersed peak with a Mwavg of 200 kDa, indicating a tetrameric 
complex based on the 210 kDa Mwcalc (Figure 1.1A). Analysis of Hsp70 alone following incubation with 
Hsp40 revealed an elution shift and a ~70kDa Mwavg, supporting an Hsp40-driven conversion to a 
monomeric, ADP-state (Figure 1.3). 
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Figure 1.3 Hsp70 conformational changes from nucleotide binding. By SEC-MALS we observe differences in Hsp70 depending 
on the nucleotide state. After our protein purification protocol, Hsp70 remains in an ATP bound state, evidenced by the change 
in elution profile and Mwavg upon incubation with Hsp40 which accelerates Hsp70 ATPase activity (left). Glutaraldehyde 
crosslinking reveals that Hsp70 has a higher propensity to form dimers in the ATP state compared to when incubated with 
Hsp40 (right panel, compare xl 0.1M KCl conditions). These interactions are transient since dimer formation is reduced under 
high salt concentrations (right panel, 0.5M KCl lanes) [32]. 
To further explore the nucleotide specificity, Hsp70 was purified following incubation with Hsp40 to 
form the ADP-state (Hsp70ADP) and tested for interaction with CHIP. With 5 mM ADP present, Hsp70ADP 
and CHIP co-elute with a Mwavg of 210 kDa, indicating a tetrameric species (Figure 1.1C, 1.2). However, 
when Hsp70ADP is incubated with increasing amounts of ATP (0.1-5mM), which would cause nucleotide 
exchange, the peak corresponding to the 210 kDa species reduces substantially, while the peak for the 
unbound proteins increases, indicating a loss of the tetrameric complex. 
Established Hsp70 ATPase mutants, K71M [34, 35] and T204A [34, 36] were also tested for interaction 
with CHIP. Strikingly, Hsp70-K71M and CHIP co-elute with a 210 kDa Mwavg in the presence of saturating 
amounts of either ATP or ADP, indicating an Hsp70:CHIP tetramer complex is stabilized independently of 
the bound nucleotide for this mutant (Figure 1.1D, 1.2). In comparison, T204A shows a reduced Mwavg in 
the presence of either ATP or ADP, indicating the tetrameric complex is destabilized. An increase in size 
is identified with ADP relative to ATP for T204A, suggesting some tetramer complex is formed, however, 
this is reduced in comparison to wt and K71M under the same conditions. Notably, the K71M mutation 
is proposed to decouple allosteric communication between the NBD and SBD and favor the ADP-state 
conformation [34, 35, 38], while the T204A mutation likely favors ATP state [34, 36, 39]. The CHIP TPR 
mutation, K30A, was also tested and showed a substantially reduced binding to wt Hsp70ADP, indicating 
the complex is indeed stabilized via the EEVD:TPR interaction (Figure 1.1D).  Overall, these data 
demonstrate that CHIP interaction specifically favors the ADP-state conformation of Hsp70, with the TPR 
domains contributing to the formation of a stable tetramer complex. 
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• 1.3.2 The ADP specific Hsp70:CHIP complex can stably interact with client protein tau  
Cellular levels of tau have been shown to be regulated by Hsp70 isoforms, where the inducible Hsp70 
can facilitate tau clearance. Previous studies established that Hsp70 and CHIP reduce levels of tau in 
various cell models [18, 40, 41], however the molecular mechanism is not well-understood. Thus we 
sought to characterize whether the ADP-specific Hsp70:Chip tetramer complex we identified binds and 
ubiquitinates tau. For these studies, we focused on the 0N4R human tau isoform, which has previously 
been established to be ubiquitinated by CHIP [42, 43]. In vitro, tau is soluble and unfolded when 
unbound to microtubules [19]. By SEC-MALS analysis, purified 0N4R tau elutes at 9.4 mL, with a Mwavg of 
55kDa, indicating a primarily monomeric form, based on the Mwcalc of 45kDa (Figure 1.4A, C). A tail is 
identified on the right side of the elution peak and a lower Mw smear is observed in the corresponding 
fractions indicating additional species are present, likely due to minor degradation. Binding and complex 
formation with Hsp70 in the ATP and ADP states was then tested. In the presence of saturating ATP, no 
elution shift was observed following incubation with tau compared to Hsp70-ATP alone, however Hsp70 
and tau co-elute in the peak (compare Figures 1.4A and 1.1A and Figures 1.2 and 1.4C). Following 
incubation with saturating ADP, resulting in conversation of Hsp70 to the ADP state, a substantial 
change in the elution profile was identified, and a broad, predominant peak is observed eluting at 8.8 
mL with a 160 kDa Mwavg, indicating the formation of a larger complex (Figure 1.4A). Both Hsp70 and tau 
are present in this peak, and considering the Mwcalc for Hsp70:tau is 115 kDa, the stoichiometry is likely 
greater than 1:1 (Table 1.1). A substantial amount of Hsp70 is present in the peak compared to tau 
(Figure 1.4C) and multiple Hsp70 binding sites on tau have been previously characterized [17]. Thus, we 
conclude that 2 or more Hsp70s are likely bound to tau in the elution peak. Indeed, when fractions from 
this peak are crosslinked and analyzed by SDS-PAGE and western blot, distinct higher molecular weight 
bands are observed above a 1:1 complex (Figure 1.4D). These results identify that tau binding by Hsp70 
is specific for the ADP-state, supporting a native Hsp70-substrate interaction, and the resulting complex 
is stable and likely multi-valent for Hsp70. 
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Figure 1.4 Detection of Hsp70 client tau binding and the formation of a Hsp70:CHIP:tau ternary complex. A) SEC-MALS 
analysis for Hsp70 binding with tau show that in the presence of ADP, we are able to detect a stable complex by SEC with a 
Mwavg suggesting multiple Hsp70 binding to tau.  B) The inclusion of tau shows complex formation with higher Mwavg than the 
210 kDa Hsp70:CHIP complex, suggesting the binding of all three protein components. C) SEC profiles and SDS-PAGE analysis of 
peak fractions show co-elution of Hsp70:tau and Hsp70:CHIP:tau complexes. D) Glutaraldehyde crosslinking of tau indicate the 
presence of higher order Mw species in solution that show multi-valent Hsp70 binding to a tau molecule. 
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To determine whether the Hsp70:CHIP tetramer complex we identified interacts with tau, all three 
proteins were incubated together in equimolar concentrations and analyzed by SEC-MALS. Compared to 
Hsp70ADP:CHIP, a predominant peak is identified that elutes earlier with a Mwavg of ~270 kDa (Figure 1.4B, 
C). All three proteins are present in fractions, indicating the presence of a stable Hsp70:CHIP:tau ternary 
complex. Although there is variability in the Mwavg, indicated by the slope of the Mw calculation across 
the peak, 270 kDa corresponds approximately to an Hsp70:CHIP tetramer bound to 1 tau molecule. 
Based on the broad shoulder to the right of the main peak there is likely a substantial presence of the 
Hsp70:CHIP tetramer and Hsp70:tau complexes. Different ratios of the proteins were tested during the 
incubation but did not improve the homogeneity or increase the Mwavg of the ternary complex (data not 
shown).  No changes in the elution were observed when CHIP and tau were incubated together, 
indicating CHIP and tau do not form a complex in the absence of Hsp70 (data not shown). Overall these 
results indicate that the ADP-specific Hsp70:CHIP tetramer complex forms stable interactions with the 
tau substrate, and potentially one molecule of tau could be making dual interactions across the two 
Hsp70 molecules. 
 
Table 1.1 Mwcalc was obtained from the primary sequences of the proteins used for our experiments and their combination in 
various stoichiometries. Relative elution volumes are compared, listing from experiments run on the KW-804 (Shodex) column. 
• 1.3.3 Tau ubiquitination occurs in an Hsp70 dependent mechanism 
To investigate the events following association of the Hsp70:CHIP:tau ternary complex, we designed a 
ubiquitination assay to measure tau ubiquitination in conditions that favor Hsp70 association with CHIP. 
When we added ubiquitin, E1 and E2 enzymes to a mixture of pre-formed Hsp70:CHIP:tau complex 
under the conditions used for SEC-MALS, we found that tau poly-ubiquitination occurred only in the 
presence of Hsp70 (Figure 1.5A). Since ubiquitination requires the presence of ATP for conjugation to 
substrates [44], Hsp70 is expected to exist in both ADP and ATP conformations under our assay 
conditions. Therefore to further test our observations of nucleotide dependent CHIP recruitment, the 
Hsp70 K71M and T204A mutants were used. We found that in the presence of only ATP, where 
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previously the Hsp70 K71M but not the T204A mutant was shown to stably associate with CHIP (Figure 
1.1D), ubiquitination of tau was robust with the K71M mutation in contrast to the reduced 
ubiquitination in the T204A mutant (Figure 1.5B), suggesting that it is possible for the tetramer form of 
Hsp70:CHIP to be involved during tau ubiquitination.  
 
Figure 1.5 Ubiquitination of tau proceeds through CHIP in an Hsp70 dependent manner. A) In vitro ubiquitination assay 
system analyzed by αtau western blotting in the presence of wheat E1, UbcH5c E2, CHIP and tau in the presence or absence of 
Hsp70. Following a 10 minute reaction, only in the presence of Hsp70 do we get efficient poly-ubiquitination of tau. B) 10 
minute ubiquitination reactions carried out using various mutants of Hsp70 and CHIP, show that the K71M mutant promotes 
poly-ubiquitination compared to the Hsp70T204A mutant and CHIPK30A mutant which decrease the ability for Hsp70 to bind 
CHIP. C) Quantitation of fluorescent signal of western blots in A and B, accounting for the area of the blot above the mono-
ubiquitinated tau band. D) Signal intensities specific to the mono- di- and tri- ubiquitin bands show more drastic decrease in 
signal for the Hsp70T204A and CHIPK30A conditions to add multiple ubiquitins.  
36 
 
The decrease in signal seemed to occur more noticeably in the upper bands corresponding to poly-
ubiquitinated tau, thus we quantified the fluorescent intensities of these higher order bands as ratios 
relative to the wildtype ubiquitination signal, normalized by the signal present for tau at the zero time 
point. We see that there are large differences in processive ubiquitination upon destabilizing the 
Hsp70:CHIP interaction (Figure 1.5C). Furthermore the ratios of signals for the bands for mono-, di- and 
tri- ubiquitinated tau show that as more ubiquitin is added to the chain, the more pronounced the effect 
of destabilizing the Hsp70:CHIP interaction becomes (Figure 1.5D). This points to a model in which 
conditions where Hsp70 can simultaneously bind client and recruit CHIP allows for increased efficiency 
in adding multiple ubiquitins onto client, resulting in protein turnover. 
To further test the effects of client retention on Hsp70 dependent ubiquitination, we combined a 
competition experiment with our ubiquitination assay. Utilizing a synthetic substrate peptide that has 
been well characterized to bind to the Hsp70 SBD with a Kd of ~10 μM [7, 8], we compared the 
untreated ubiquitination reaction with conditions where we incubate Hsp70, CHIP, and tau at 10 uM, 
1mM ADP and the NRLLLTG peptide at an excess 50 μM or 100 μM. This peptide would, in theory, 
compete for occupancy of the Hsp70 SBD with tau. Under these conditions, we observe decreased poly-
ubiquitination in the presence of peptide (Figure 1.6 compare green and blue lanes). Previous studies 
have shown that utilizing peptide concentrations 2-3 times above that of Hsp70 was enough to see 
extensive changes in binding via the SBD [45], thus we expect competition with tau binding and 
ubiquitination. However, when we pre-incubate the Hsp70:CHIP:tau complex without peptide, and it is 
subsequently added at the start of the ubiquitination reaction, we find that under ADP binding 
conditions, poly-ubiquitination appears to be restored comparing these 10 minute ubiquitination 
reactions (Figure 1.6, compare blue and red lanes).  
These reaction conditions were replicated and show that the NRLLLTG peptide competition is consistent 
and only occurs when it is pre-incubated together with tau, CHIP and Hsp70 (Figure 1.7).  This suggests 
that the slow client off-rate in the Hsp70:CHIP:tau complex allows for poly-ubiquitination to occur, 
substrate peptide is unable to displace tau suggesting that Hsp70 cycling does not occur during poly-
ubiquitination. 
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Figure 1.6 Hsp70 substrate peptide inhibition of substrate binding and effects on client ubiquitination. Western blots of 10 
minute ubiquitination assay, carried out on samples where no peptide was added (green), 50 or 100 μM peptide was added 
(blue) and 50 or 100 μM peptide was added after Hsp70:CHIP:tau complexes were pre-formed (red).  
This is in agreement with our previous analysis of Hsp70 mutants, where the efficient poly-
ubiquitination is carried out by the Hsp70K71M mutant which remains in the ADP conformation and 
does not cycle between nucleotide states. Together, these results suggest a model where the ADP state 
of Hsp70 or slowing down the Hsp70 chaperone cycle promotes ubiquitination of tau.  
 
Figure 1.7 Quantitation of the fluorescence intensities of the competition-ubiquitination assays, where NRLLLTG peptide was 
absent (green), added together with tau (blue), or added after tau (red), using 100 μM peptide and carrying out the pre-
incubation period for 10 minutes and ubiquitination for 10 minutes 
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• 1.3.4 Hsp70:CHIP crosslinking maps reveal structural changes upon client binding 
In order to obtain structural data of the Hsp70:CHIP complex we utilized cryo-EM and a lysine reactive 
crosslinker (bis-succinimidyl 1,4 diazabicyclo[2.2.2]octane) designated as ‘DC4’ [46]. These crosslinkers 
have standard linker arms with reactive NHS esters but a central connecting domain containing one or 
more quaternary cyclic amines. We sought to stabilize a low energy state of the Hsp70:CHIP 
heterotetramer to observe the interactions between the Hsp70 SBD and CHIP U-box domains. By 
obtaining crosslink identities we would be able to map the connectivity between the two proteins, since 
the unique MS2 pattern of crosslinked peptides allows them to be easily identified and subsequent MS3 
identifies the component peptides.  
 
Figure 1.8 DC4 crosslinking profiles. The appearance and amount of protein present in the higher molecular weight bands is 
dependent on concentration of protein and crosslinker. Bands corresponding to uncrosslinked Hsp70 and tau (lane 1) are 
greatly diminished as the protein shifts to species at ~140, ~210 and higher Mw (lanes 2 and 3). Hsp70:CHIP:tau crosslinked into 
a band distinct from the ~200 kDa band of Hsp70:CHIP (lanes 4 and 5) and western blotting demonstrated that tau was present 
in the complex (data not shown).  
We demonstrated that reconstituted Hsp70 dimer, the CHIP dimer, and the Hsp70:CHIP complex, 
crosslink with DC4 efficiently, resulting in 70, 140 and 210 kDa bands by SDS-PAGE (Figure 1.8). After 
optimizing conditions to produce mostly crosslinked Hsp70:CHIP we subjected the samples through an 
additional SEC purification to remove higher molecular weight species to isolate the 200 kDa band of 
proteins.  
Because the DC4 has specific cleavage products and fragmentation patterns within the crosslinker 
moiety in matrix-assisted laser desorption ionization (MALDI) mass spectrometry, we sought to identify 
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the peptides crosslinked between Hsp70 and CHIP [46]. With the help of Angela Walker, Loli Piersimoni 
and Phil Andrews, we performed trypsin digestion and tandem liquid chromatography and mass 
spectrometry (MALDI-TOF-TOF) to identify the crosslinked regions.  Oversampling of crosslink sites 
identified many intra-subunit crosslinks that were consistent with the structures of the individual 
proteins [4, 5, 23] (Figure 1.9A). In the Hsp70:CHIP dataset, certain lysines exhibited patterns of 
crosslinking with multiple residues, indicating inconsistency in its structure or position. These 
hyperconnected residues indicate flexibility in the region of the lysine [47]. Residue K417 of Hsp70 
resides within the linker region suggesting this crosslinking profile to be consistent with the ADP 
conformation of Hsp70 when it is flexible rather than when docked into the NBD in the ATP form [48]. 
Lysine K131 of CHIP is present at the helical hairpin domain of CHIP, and exhibits hyperconnectivity to 
the Hsp70 molecule, indicating flexibility in this dimerization domain region which have had conflicting 
reports on its structure [22, 23]. Substantially different patterns of crosslinked peptides and dead-end 
peptides were observed between the Hsp70, CHIP and Hsp70:CHIP datasets, providing additional 
validation that they were crosslinked in complex (data not shown). In the crosslinking profile of the 
Hsp70:CHIP complex, we observe that most of the crosslinks are made in the TPR region of CHIP and the 
C-terminus of Hsp70, consistent with known interactions [25] (Figure 1.9A).  
Furthermore, we were able to obtain a crosslinked client bound Hsp70:CHIP:tau ternary complex for 
analysis by mass spectrometry (Figure 1.9B). The crosslinking profile of the ternary complex shows 
consistency with known interactions among the three proteins, maintaining the Hsp70 C-terminus 
interactions with the CHIP N-terminal TPR domain, as well as showing areas in the Hsp70 substrate 
binding domain interacting with the microtubule repeat domains in tau [17]. Comparison of the crosslink 
profiles between the Hsp70:CHIP and Hsp70:CHIP:tau complexes reveal that contacts between Hsp70 
SBD and CHIP TPR are displaced by new contacts between Hsp70 and tau, thus it may be possible that 
tau is brought to the space previously occupied by the Hsp70 SBD near the CHIP U-box. We also 
observed that upon complex formation, tau becomes relatively rigid, evidenced by the larger number of 
crosslinks observed for shorter distances in primary sequence of tau (Figure 1.9C). This is in contrast to 
the crosslink map of tau on its own, where it has more freedom to sample conformations that allow 
lysines to reach each other separated by more amino acids (Figure 1.9D). This suggests that when tau is 
bound to Hsp70 and CHIP it adopts a unique extended form that is protected from making crosslinks 
with itself. These results suggest a model where tau is bound to the Hsp70:CHIP complex to restrict its 
conformations, making it more rigid and extended to allow space for E2 conjugating enzymes to be 
recruited for productive poly-ubiquitination of tau 
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Figure 1.9 Mass spectrometry identification of DC4 crosslinked peptides for the Hsp70:CHIP and Hsp70:CHIP:tau complexes. 
A) Linkage map of crosslinked peptides in the Hsp70:CHIP complex mapping extensively the N-terminus of CHIP with the C-
terminus of Hsp70, each line represents the identification of doublets in the MS/MS spectra indicating the fragmentation of the 
DC4 between crosslinked peptides [46]. Component peptides were identified using a standard database search. B) Linkage map 
of the Hsp70:CHIP:tau complex revealing the interactions between the microtubule repeats in the center of the tau molecule 
with the Hsp70 SBD, and displacement of some of the contacts in the lid region of Hsp70 with CHIP. C) Histogram tabulating the 
number of crosslinks identified in the ternary complex that had lengths corresponding to distances in the primary amino acid 
sequence between the linked residues. D) Crosslink map of tau on its own exhibiting longer range crosslinks. These experiments 
were performed by Angela Walker Loli Piersimoni. Figures were created by Phil Andrews. 
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• 1.3.5 Hsp70:CHIP cryo-EM structure and proposed arrangement of quaternary structure 
We were also able to use the DC4 crosslinked Hsp70:CHIP samples for cryo-EM. We observed 
homogeneous globular particles in vitrified ice, amenable to single particle reconstruction (Figure 
1.10A). A low resolution 3D reconstruction was obtained from 141,196 particles selected from over 3000 
electron micrographs out of an initial 250,000 raw particles recorded on a K2 camera (Gatan) in a Titan 
Krios microscope (FEI) (Figure 1.10B). An initial model was generated using results from 3D classification 
on negatively stained Hsp70:CHIP complex particles and was similar to the ab initio SGD procedure 
within RELION (see methods). Projections of the 3D model show consistency with the reference-free 
class averages. We docked the known crystal structures of the CHIP dimer (2C2L) as well as the NMR 
RDC refined crystal structure of the DNAK ADP (4KHO) structure into our model, in order to obtain a 
rough estimate if our volume could account for the mass of the components, positioning the CHIP dimer 
in the center and 2 Hsp70 monomers on either flank (Figure 1.10C). In this arrangement, contacts 
between the lid region of Hsp70 and CHIP are maintained supporting our MS crosslinking data. Density is 
present for both NDB and SBDs for the Hsp70 molecules. The TPR and U-box domains of CHIP are 
accounted for, however the helical hairpin dimerization domain seems to be unresolved, which was 
suggested by the crosslink hyperconnectivity of K131 of CHIP (Figure 1.9).  
It has been shown that the Hsp70 binds to model client peptides locking the peptides in extended 
conformations to form a hydrophobic core surrounding the client, closing the substrate binding pocket 
[45]. This suggests that the 2Hsp70:1tau complex can be accounted for when recruiting CHIP and the E2 
enzymes for poly-ubiquitination.  Limitations to the resolution of our cryo-EM structure could be due in 
part to the use of the lysine reactive crosslinker, which performs non-specific lysine crosslinks across the 
protein complex. We have recently begun cryo-EM characterization of the native Hsp70:CHIP complex 
and demonstrate that the reference-free 2D averages for both datasets show very similar features 
(Figure 1.10D). Our goal will be to obtain a high resolution cryo-EM structure of the uncrosslinked 
complex and compare it with the crosslinking profiles obtainable by mass spectrometry to corroborate 
the interactions between Hsp70:CHIP and further extend these comparisons to the client bound 
Hsp70:CHIP:tau complex. 
 
42 
 
 
Figure 1.10 Cryo-EM of the Hsp70:CHIP complex. A) Example electron micrograph (left) of globular particles resulting in the 
reference free class averages that show internal features generated by RELION (right) (scale bar:10nm). B) 3D reconstruction of 
the cryo-EM dataset, limitations in improving the resolution remain an issue, however projections from this model are 
consistent with 2D averages. C) Crystal structures for Hsp70 (4KHO) and CHIP (2C2L) were docked into the volume to explore 
possible arrangements of the proteins in complex. D) 2D class averages of a non-crosslinked native Hsp70:CHIP dataset 
(bottom) show similar features to views seen in the DC4 crosslinked averages.  
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• 1.4 Discussion 
Hsp70 has been implicated in the regulation of tau, preventing aggregation or improving its turnover 
[17, 21, 43]. We have been able to directly demonstrate the ability of Hsp70 to direct tau ubiquitination 
through the CHIP E3 ubiquitin ligase and discover that the nucleotide state of Hsp70 plays a critical role 
in the ubiquitination of tau for proteasomal degradation (see Figure 1.5). ATP is required for the transfer 
of ubiquitin to clients or substrates in the cell and it likely that Hsp70 exists in an equilibrium between 
conformational states. Thus, it may be unclear whether the formation of the stable 210 kDa Hsp70:CHIP 
complex is necessary for Hsp70 driven ubiquitination. However, one important observation from this 
study is that the efficiency of ubiquitination is enhanced in conditions that favor the Hsp70 ADP state 
and the Hsp70:CHIP complex (see Figures 1.1 and 1.5). Pushing the equilibrium of Hsp70 conformations 
to either state would act as the switch regulating client ubiquitination. Both binding and ubiquitination 
of tau were enhanced in conditions that favored the formation of a stable 210 kDa Hsp70:CHIP complex. 
Because ATP is required for ubiquitin transfer we used the Hsp70K71M mutant to demonstrate the 
impact of protein conformation on client ubiquitination. Because the K71M mutant does not hydrolyze 
ATP and is allosterically decoupled from transitioning between conformational states, even in the 
presence of ATP, this mutant can be described as non-cycling, unable to repeatedly bind and release 
client [34, 38]. We supported this notion by designing a peptide inhibition aspect to our ubiquitination 
assay (Figure 1.6).  We observed that when the Hsp70:CHIP:tau complex has pre-formed, the Hsp70 
substrate peptide was unable to compete for the SBD. This suggests that during ubiquitination, Hsp70 is 
not actively going through its conformational cycle. This is interesting because it implies that Hsp70 
molecules that are not actively folding client perhaps make the switch to triage. This has been observed 
before in studies where inhibition of the Hsp70 chaperone cycle promotes tau clearance [18, 21]. In 
addition, mutations of the Hsp70 that have been engineered to resemble the ADP conformation have 
been shown to bind to client and direct tau towards proteasomal degradation [43]. We can propose a 
model where the 210 kDa complex represents the most efficient form of the chaperone that can 
facilitate client ubiquitination, and that the cellular energy levels or factors that cause protein folding to 
slow the cycling of Hsp70 would then open the pathway for client degradation. Further studies will be 
needed to clarify the relationship between the stalling of the Hsp70 client binding and release with the 
formation of the 210kDa complex.  
We were also able to observe evidence of higher molecular weight species based on the Mwavg for the 
formation of Hsp70:tau complex (Figure 1.4). This implies the existence of a bivalent Hsp70 bound tau 
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molecule. In line with our model of client stalling it would be interesting to see if the formation of these 
tau molecules with multi-valent Hsp70 are a sign of stress that push these complexes towards high 
efficiency in ubiquitination. Previous studies on DnaK have shown that under certain conditions, 
multiple simultaneous binding events to a single client can be observed with the presence of the Hsp40 
homologue DnaJ and ATP [49]. For our system, it could be possible that the conditions for multiple 
Hsp70 binding are due to a stalling of Hsp70 cycling, promoting the ADP conformation where tau 
binding and CHIP binding are observed. In the conditions tested that allowed a larger proportion of 
Hsp70 in the ATP form, we saw a decrease in the Mwcalc of these particles, suggesting that the Hsp70:tau 
and Hsp70:CHIP complexes are falling apart and that both CHIP TPRs fail to engage molecules of Hsp70. 
This suggests that the 210 kDa Hsp70:CHIP complex is important and perhaps somehow related with the 
multiple binding of Hsp70s on a single tau client. We saw evidence of this in our MS linkage maps of the 
Hsp70:CHIP:tau complex, where there was a loss of flexibility in tau upon chaperone binding (Figure 
1.9), suggesting that it may be possible for a single tau to be held rigid across two Hsp70 molecules and 
that would enable the recruitment of CHIP.  
Further details in the molecular events or significance of having two TPR domains or two Hsp70 
molecules on a client will require higher resolution structural information. Shorter crosslinks will enable 
us to obtain higher resolution, akin to a shorter FRET probe, to measure short range contacts and map 
areas of relative rigidity [46]. Comparative crosslinking using heavy isotope labelled crosslinkers will also 
be helpful in discerning quantitatively the change of the binding interface when transitioning between 
the client-bound chaperone complexes (work to be done in collaboration with Phil Andrews). This will 
help us determine if there is an order of events that occur between Hsp70, CHIP and tau that allows for 
subsequent ubiquitination. Binding assays for SEC-MALS showed that on the order of bulk solution of 
molecules, order of addition had no effect on the SEC profiles or MALS results (data not shown). 
However on the molecular level there may be a role for certain binding interfaces to form or be 
excluded when Hsp70 performs protein triage. Finally the most direct and turns out most challenging 
pathway is direct structure determination for this chaperone:co-chaperone complex. With high 
resolution cryo-EM the goal is to directly visualize potential tau binding interfaces and whether it could 
exist across two Hsp70 molecules brought together by CHIP. 
All this data leads us to a model where stalling of Hsp70 foldase activity of repeated cycles of binding 
allows for Hsp70 to accumulate on client proteins, where a tau molecule or perhaps any client at risk of 
unfolding or aggregation becomes targeted for proteasomal degradation instead of refolding. Under 
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stress conditions, the need to turnover proteins reducing cellular levels of tau or other aggregation 
prone species could be a form of defense to maintain proteostasis. Structural as well as further 
biochemical studies can be aimed at investigating the significance of multiple Hsp70 binding events on 
clients or the dual Hsp70 binding events that occur on CHIP. 
 
• 1.5 Methods 
• Recombinant Protein Purification 
CHIP was obtained from a pET151 vector containing the human CHIP gene from the Agard lab at UCSF, 
containing a 6x His tag separated from the CHIP by a TEV cleavage site and expressed in BL-21 E. coli 
cells. After growth of several liters of cells in Luria Bertani broth, optical density was checked until about 
0.8 OD relative to uncultured media before adding to a final concentration of 500 μM IPTG for induction 
of protein expression. Following overnight incubation at 18 °C, cells were treated with a protease 
inhibitor cocktail (Roche) and pelleted at 5,000xg on a Sorvall centrifuge and lysed using an Emulsiflex 
high pressure homogenizer (Avestin). After high speed centrifugation of the cell debris at 40,000xg, the 
supernatant was treated with Ni-NTA beads to affinity purify the His-tagged CHIP. Following elution with 
200mM imidazole buffer, the sample was buffer exchanged into SEC buffer (100mM KCl, 40mM HEPES 
pH 7.4, 5mM MgCl2, 7mM BME) overnight and digested with TEV protease. The sample was 
subsequently subjected to size exclusion chromatography on a superdex 200 16/600 column (GE 
healthcare). Fractions containing the protein were confirmed by SDS-PAGE and pooled fractions were 
subjected to buffer exchange into a SEC buffer with 5% glycerol for flash freezing and storage. 
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Hsp70 human isoform HSPA1A was expressed in a baculovirus expression vector system with a TEV 
cleavable His-tagged N-term modified by the Center for Chemical Genomics at the LSI. After induction, 
growth, and recovery of the cells, they were subjected to a purification protocol identical to that of 
CHIP. Generation of the T204A, K71M mutants of Hsp70 and the K30A mutant CHIP was carried out 
using QuikChange site-directed mutagenesis (Agilent) and confirmed by DNA sequencing. The 0N4R tau 
construct was cloned into a pET28 vector by the Gestwicki lab at UCSF, and used to transform BL-21 cells 
for E. coli expression. This construct was also His-tagged and followed the same purification protocol as 
the Hsp70 and CHIP methods, with the addition of a cation exchange chromatography step between 
affinity purification and SEC, using a HiTrap SP (GE healthcare).  
• Size exclusion chromatography in tandem with multi-angle light scattering (SEC-MALS) 
Hsp70:CHIP, Hsp70:tau, Hsp70:CHIP:tau and individual protein components were prepared for analysis 
by SEC-MALS by first incubating the proteins alone or together at equimolar ratios, generally at 10 μM 
protein concentration, in a SEC buffer in the presence of either ADP or ATP at the concentrations listed, 
with 5mM nucleotide considered ‘saturating’ conditions. Hsp40, when used, is present in 
substoichiometric amounts, typically 1/10 of the concentration of Hsp70. After 30 minutes, the samples 
were filtered and injected for SEC-MALS analysis and fractionation. The Mwavg of complexes were 
determined by separation using a WTC-050S5 SEC column (Wyatt Technology Corporation) with an Akta 
micro (GE Healthcare) and analysis with a DAWN HELEOS II MALS detector equipped with a WyattQELS 
DLS, and Optilab rEX differential refractive index detector using ASTRA VI software (Wyatt Technology 
Corporation). The Mwavg was determined from the Raleigh ratio calculated by measuring the static light 
scattering and corresponding protein concentration of a selected peak. Bovine serum albumin served as 
a calibration standard. Light scattering data and calculations were performed using the ASTRA software 
package (Wyatt Technology Corporation). 
• Ubiquitination assays 
Protein concentrations were optimized to produce tau ubiquitination that showed appreciable signal by 
western blot using an Alexa-488 tagged secondary antibody (ThermoFisher). This meant using 1 μM 
concentration of proteins in order to avoid overloading the gel and giving too high of a fluorescent 
signal. E1 and E2 enzyme was generously provided by the Klevit lab at the University of Washington. 
Ubiquitin protein was purchased from Sigma. E1 enzyme from wheat was used at 0.2 μM. To adjust the 
rates of ubiquitination to observe differences between the mutant proteins and conditions, the 
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concentration of E2 enzyme was adjusted, with the final working concentration ending up at 4 μM. 
Excess amount of ubiquitin was used at 40 μM. E1, E2, ubiquitin and ATP were first incubated together 
with the aim of reaching saturating levels of E2-ub to adjust for the variability due to the initial E1, E2 
transfer steps. We also incubated Hsp70, CHIP and tau together for 30 minutes at 10 μM concentration 
to replicate conditions in which binding was observed by SEC-MALS. The ternary complex solution was 
then diluted to a final working concentration of 1 μM along with the concentrations of the E1, E2 and 
ubiquitin as previously described. Reactions were always split with one reaction containing no ubiquitin 
and immediately boiled at 100 °C for 2 minutes to mark the zero time point. Time was recorded 
following dilution and addition of the E1, E2-ub mixture, with 10 minute time points typically being 
when the reaction would be stopped by adding SDS loading dye, reducing agent and heat for 2 minutes. 
Samples were analyzed by SDS-PAGE and transferred to PVDF membranes for western blot analysis, 
using an mouse α tau monoclonal antibody (Santa Cruz) and an Alexa-488 α mouse antibody and 
developed on a Typhoon Tio imager (GE healthcare). Subsequent quantification of intensities were 
obtained using the ImageQuant software.  
For peptide competition assays, we first established that incubating Hsp70, CHIP, tau and NRLLLTG 
peptide together resulted in the interference of tau binding by titration of the peptide, manifested by 
decreased poly-ubiquitination. Hsp70, CHIP and tau were then either preincubated together with the 
NRLLLTG peptide at the indicated concentrations or were first preincubated without peptide for 10 
minutes before its addition.  
• Cryo-EM 
Samples for cryo-EM were prepared on C-FLAT holey carbon grids (EMS) in SEC buffer with a Vitrobot 
(FEI Co.). Data was collected on a Titan Krios microscope (FEI co.) operated at 300 kV on a K2 direct 
electron detector with a 1.0 Å pixel size. 8 second exposures with 0.2s/frame rate and a dose of 50 e/Å2 
were used in electron counting mode. 3583 Micrographs were collected for the dc4 crosslinked 
Hsp70:CHIP dataset and 1518 micrographs were collected for the native Hsp70:CHIP complex, utilizing 
Leginon automated data collection software [50]. Micrograph movie files were output and Motioncor2 
program was used to perform gain normalization and patch-based motion correction [51], after which 
CTFFIND4 was used to estimate CTF parameters for the corrected micrographs [52]. The DoG picker 
program was used for automated particle picking. RELION was used to do multiple rounds of reference-
free 2D averaging to remove images that did not correspond to protein particles to result in a final 
particle count of 141,196 and 145,125 for the DC4 crosslinked Hsp70:CHIP and the native complex 
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respectively. 3D Refinement of the Dc4 crossslinked dataset has been performed using an initial model 
generated from negative stain EM class averages used to bootstrap refinement against a sphere, as well 
as an initial model produced by the stochastic gradient descent algorithms in RELION [53]. Initial models 
were low pass filtered to 60 Å yielded a final structure at 12 Å resolution after B factor sharpening. 
• DC4 crosslinking in preparation for mass spectrometry and cryo-EM 
Complex formation was performed identical to the preparation used for SEC-MALS experiments. The 
Hsp70:CHIP and Hsp70:CHIP:tau complexes were then diluted to a concentration of 1 μM protein to 
avoid high concentrations of high molecular weight complexes due to crowding. We used 1 mM DC4 
concentrations in balancing the amount of crosslinked ~200kDa product while reducing the high 
molecular weight protein smear. At 1 μM concentrations we were able to find distinct bands between 
210 and 250kDa for the Hsp70:CHIP. The Hsp70:CHIP:tau complex produced a higher molecular weight 
band compared to the binary complex. The samples were then concentrated and injected on an S200pc 
column (GE healthcare) for additional purification removing the high molecular weight species. Samples 
were subsequently analyzed by cryo-EM and mass spectrometry. Trypsin digestion, mass spectrometry 
and data analysis for identification of crosslinked peptides were carried out as described in a previous 
publication [46]. 
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Chapter 2 
BAG3 Is a Modular, Scaffolding Protein that physically Links Heat Shock Protein 70 (Hsp70) to the 
Small Heat Shock Proteins 
This chapter is published in: Rauch JN, Tse E, Freilich R, Mok SA, Makley LN, Southworth DR, Gestwicki 
JE., J Mol Biol. 2017 Jan 6;429(1):128-141. 1 
 
• 2.1 Abstract 
Small heat shock proteins (sHsps) are a family of ATP-independent molecular chaperones that are 
important for binding and stabilizing unfolded proteins. In this task, the sHsps have been proposed to 
coordinate with ATP-dependent chaperones, including heat shock protein 70 (Hsp70). However, it is not 
yet clear how these two important components of the chaperone network are linked. In collaboration 
with the lab of Jason Gestwicki at UCSF, we report that the Hsp70 co-chaperone, BAG3, is a modular, 
scaffolding factor to bring together sHsps and Hsp70s. Using domain deletions and point mutations, we 
found that BAG3 uses both of its IPV motifs to interact with sHsps, including Hsp27 (HspB1), αB-crystallin 
(HspB5), Hsp22 (HspB8), and Hsp20 (HspB6). BAG3 does not appear to be a passive scaffolding factor; 
rather, its binding promoted de-oligomerization of Hsp27, likely by competing for the self-interactions 
that normally stabilize large oligomers. BAG3 bound to Hsp70 at the same time as Hsp22, Hsp27, or αB-
crystallin, suggesting that it might physically bring the chaperone families together into a complex. 
Indeed, addition of BAG3 coordinated the ability of Hsp22 and Hsp70 to refold denatured luciferase in 
vitro. Together, these results suggest that BAG3 physically and functionally links Hsp70 and sHsps. 
• 2.2 Introduction 
The mammalian genome contains multiple classes of molecular chaperones that are named according to 
their approximate size, including heat shock protein 90 (Hsp90), heat shock protein 70 (Hsp70), heat 
shock protein 40 (Hsp40), and the small heat shock proteins (sHsps) [1]. Each of the categories of 
chaperones appears to be partly dedicated to individual aspects of protein quality control [2]. For 
example, Hsp70 and Hsp90 are ATPases that use nucleotide hydrolysis to regulate reversible binding to 
unfolded or partially folded proteins, stabilizing many “clients” and favoring their folding and/or 
                                                          
1 My contributions to this chapter were the SEC-MALS and EM analysis. Contributions by the members of the Klevit 
lab are indicated in the figure legends 
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trafficking [3,4]. Other chaperones, such as the Hsp40s, appear to recruit specific clients to the Hsp70 
and Hsp90 systems [5]. The importance of having multiple, non-overlapping categories of chaperones is 
highlighted by their incredible conservation across all kingdoms of life [6–8]. 
Together, the chaperones constitute a network that maintains global protein folding and function [1]. 
Within the chaperone network, many of the major chaperones make physical interactions with each 
other. For example, the prokaryotic orthologs of Hsp70 and Hsp90 directly bind to each other [9,10], as 
do the orthologs of Hsp70 and Hsp110 [11]. In mammals, Hsp70s are physically linked to the Hsp90s, but 
through the scaffolding protein, HOP (Hsc70–Hsp90 organizing factor). HOP is required for the 
Hsp70/Hsp90-mediated activation of steroid hormone receptors [12–15], perhaps by facilitating client 
transfer between the chaperones [16,17]. Thus, the mammalian chaperone network appears to be held 
together, in part, by protein–protein interactions between chaperones and scaffolding proteins. This 
feature might allow unfolded clients to be protected by a closely knit series of physically interacting 
factors, possibly limiting their exposure to bystander proteins. 
Within the chaperone network, sHsps are a large and enigmatic class [18]. In humans, there are 10 
members of the sHsp family, denoted HSPB1 through HSPB10 [19]. Unlike other molecular chaperone 
families, such as Hsp70 or Hsp90, sHsps do not possess enzymatic activity; instead, sHsps function as 
“holdases,” a term that refers to their ability to bind and stabilize denatured or non-native proteins 
against aggregation [20,21]. Individual sHsps range in size from 12 to 43 kDa and they are defined by the 
presence of a conserved α-crystallin domain. In each sHsp, the α-crystallin domain that is flanked by 
variable, disordered N- and C-terminal domains that contain phosphorylation sites and may bind to 
clients [22]. The structure of the α-crystallin domain of Hsp27 has been solved by NMR and it features 
an anti-parallel beta-sheet that mediates stable dimerization [23–25]. In addition, the α-crystallin 
domain contains two highly conserved beta sheets, termed β4–β8, that form a hydrophobic groove. In 
some sHsps, such as Hsp27 and α-crystallin, an IXI motif in the C-terminus binds to this groove and 
stabilizes higher order oligomers [26–29] Specifically, the IXI motif from one unit of the sHsp seems to 
reach back onto the β4–β8 groove of another. This groove can even support hetero-oligomers between 
different sHsp family members [30,31]. The oligomers are typically polydisperse and range in size from ~ 
12 to 40 dimer subunits [30,32,33]. 
The method by which sHsps bind and stabilize clients is still being explored. One model suggests that the 
sHsp oligomers dissociate in the presence of clients, and then re-form into a new oligomeric form 
containing bound client [34,35]. This idea is supported by electron microscopy (EM) [20,36] and mass 
53 
 
spectrometry studies [37–39]. It has also been shown that smaller oligomers of sHsp are more potent 
holdases in vitro[39,40] and that even fragments of sHsps can still bind clients [41]. These observations 
suggest that smaller oligomers might be better able to bind clients. In cells, phosphorylation of some 
sHsps forces larger oligomers into smaller ones, perhaps providing a way for cell stress signaling to 
increase chaperone function [39,42,43]. Similarly, some sHsps can also sense pH [44,45], adjusting their 
structure to protect clients. 
One major gap in our understanding of the chaperone network is how the sHsps link to the other major 
components. This question is important because sHsps lack the enzymatic activity that appears to be 
required for active remodeling or refolding by the other categories of chaperones. Rather, sHsps have 
been proposed to work in conjunction with other chaperone systems, including Hsp70, in cells [46,47]. 
In this model, sHsp oligomers might interact with clients and keep them in a state that is competent for 
re-folding by Hsp70. 
Bcl-2-associated anthanogene-3 (BAG3) is a stress-inducible, 61-kDa protein that is characterized by the 
presence of multiple protein–protein interaction motifs (Figure 2.1A), separated by long regions of 
predicted disorder. BAG3 is a member of the BAG family of co-chaperones (BAG1–5), which are 
characterized by a conserved BAG domain. The BAG domain is well known to bind the nucleotide-
binding domain (NBD) of members of the Hsp70 family [48,49]. This protein–protein interaction helps 
release ADP from the chaperone to facilitate nucleotide cycling. BAG3 binds to Hsp70 tighter than BAG1 
or BAG2 [50], and it is the most potent nucleotide exchange factor, suggesting that it is a functionally 
important partner for Hsp70s. Outside of the BAG domain, the members of the BAG family have a 
variety of other motifs that are not shared. For example, BAG3 contains a WW domain that has been 
shown to be important for binding PPxY motif proteins, such as RAPGEF6 [51] and SYNPO2 [52]. The 
PXXP region of BAG3 has been implicated in interactions with SH3 domain-containing proteins, including 
Src [53] and PLC-γ [54], an interaction that might link BAG3 and Hsp70 to signaling pathways. Finally, 
and most importantly for this study, BAG3 contains two IPV motifs separated by ~ 100 aa in its N-
terminus. BAG3 has been proposed to interact with sHsps through its IPV motifs [55–57], possibly 
mimicking the intra-molecular interactions that normally occur between the IXI motif and the β4–β8 
grooves. 
Based on these interactions, it seemed plausible that BAG3 could be a scaffolding protein that physically 
links sHsps to the Hsp70 system. To test this model in vitro, we generated a suite of BAG3 constructs 
with individual domains mutated or deleted. We found that BAG3 interacts with multiple members of 
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the sHsp family using both of its IPV motifs. Interestingly, we found that BAG3 binding was not passive; 
rather it disrupts the Hsp27 oligomers, as judged by chromatography and EM. This finding suggests that 
BAG3 might actively remodel sHsps, potentially activating them or changing their interactions with 
clients. Indeed, we found that BAG3 could coordinate the ability of Hsp22 and Hsp70 to refold 
denatured luciferase. Finally, we were able to show that BAG3 can bridge the two chaperone families at 
the same time and that this physical interaction is dependent on the IPV and BAG domains of BAG3. 
Based on these data, we propose that BAG3 is the link between these two important components of the 
chaperone network. 
• 2.3 Results 
• 2.3.1 BAG3 binds multiple sHsps 
 
Figure 2.1 BAG3 binds to sHsps. A) Schematic of the domain architecture of BAG3, plus the deletions and point mutations used 
in this study. Deleted domains are indicated by a connecting line. B) ITC results confirm the relative affinities of BAG3 for sHsps. 
Results are representative of experiments performed in triplicate. Error is SEM. These experiments and figures were performed 
and created by Rauch JN (Gestwicki laboratory, UCSF). 
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To study the interactions with BAG3, we selected four members of the sHsp family that are ubiquitously 
expressed in all human tissues [19]: Hsp27 (HSPB1), α-crystallin (HSPB5), Hsp20 (HSPB6), and Hsp22 
(HSPB8). Of these proteins, Hsp20, Hsp22, and α-crystallin have been reported to interact with BAG3 by 
co-immunoprecipitation and pulldown studies [55,57]; however, the affinities of these interactions were 
not known. Therefore, we employed isothermal titration calorimetry (ITC) to better understand them 
(Figure 2.1B). Interestingly, BAG3 bound tightest to Hsp22 (1.2 ± 0.3 μM) and Hsp20 (1.2 ± 0.7 μM), In 
contrast, BAG3 had a relatively weaker affinity for Hsp27 (8.7 ± 2.2 μM) and α-crystallin (5.0 ± 0.6 μM). 
Because of the possibility of competing interactions and the structural heterogeneity of the sHsps, the 
reported Kd values are best used as relative values. Regardless, these results support the idea that BAG3 
uses IPV motifs to interact with sHsps because Hsp22 and Hsp20 lack their own IXI motifs and primarily 
exists as dimers or tetramers in solution [56,58], while Hsp27 and αB-crystallin have IXI motifs and form 
larger oligomers. 
To better understand whether BAG3 might compete with the IXI motifs, we studied the interaction of 
BAG3 with two Hsp27 variants. Hsp27-3D is a triple phospho-mimetic mutant that forms smaller 
oligomers in solution [39], while Hsp27c is a truncated form that contains only the core α-crystallin 
domain and is exclusively a dimer in solution [25]. We found that Hsp27c bound with the tightest affinity 
(Kd ~ 0.49 ± 0.06 μM), followed by Hsp27-3D (3.5 ± 1.7 μM), and then Hsp27 (8.7 ± 2.2 μM). These 
results suggest that larger Hsp27 oligomers may have the weakest affinity for BAG3, while dimers bind 
the tightest. We hypothesize that this difference is because of competition between IXI motifs in the 
sHSPs and IPV motifs in BAG3 (see below). Furthermore, the ITC results suggested that the 
stoichiometry of each of the sHsp:BAG3 interactions is approximately 2:1 (Figure 2.1B). This was an 
intriguing result because BAG3 contains two IPV motifs, so it could potentially interact with both of the 
conserved β4–β8 grooves on either side of a sHsp dimer. 
• 2.3.2 BAG3 uses IPV motifs to interact with the β4–β8 region 
To address this question more definitively, we prepared labeled Hsp27c and examined binding to BAG3 
by 15N–1N heteronuclear single quantum coherence NMR. We observed selective chemical shift 
perturbations (CSPs) in the β4–β8 region (Figure 2.2), consistent with the idea that BAG3 competes with 
the native IXI motifs. Furthermore, mutation of valine to alanine in a short IPV-containing peptide 
weakened its apparent affinity, showing that the IPV was important. Next, we generated BAG3 variants 
in which individual domains were systematically deleted. 
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Figure 2.2 The IPV motif interacts with the expected β4-β8 region of Hsp27c. A) Titration of full length BAG3 into labeled 
Hsp27c revealed chemical shift perturbations (CSPs) in the β4-β8 region. CSPs greater than two standard deviations were 
colored blue on PDB 2N3J. Concentrations: Hsp27c (200 µM), Bag3 (100 µM). B) Titration of an IPV peptide confirms the 
interaction site. IPV peptide: EITIPVTFE (250 µM), 5% DMSO. IPA peptide: EITIPATHE (300 µM) 3% DMSO, 1mM EDTA. Due to 
solubility limits for the BAG3-derived peptides, sequences from Hsp27 were used. C) Comparison of the peak intensities from 
addition of the IPV and IPA peptides. Methods: HSQC spectra were acquired at 30 °C on a 600 MHz Bruker Avance III 
spectrometer equipped with cryoprobe, running Topspin version 2.1. Spectra were acquired on samples containing 200 μM 
Hsp27c in 50 mM sodium phosphate, pH 7.5, 100 mM NaCl and the results were compared to solvent controls. 256 scans were 
acquired per t1 value and spectral widths of 1500 Hz and 9615 Hz were used in the 1H and 15N dimensions, respectively. 
Processing and spectral visualization were performed using rNMR and Sparky. These experiments and figures were performed 
and created by Rauch JN (Gestwicki laboratory, UCSF). 
These deletions included the BAG3 variants: ΔWW, Δ87–101, Δ200–213, Δ87–101, and Δ200–213, 
ΔPXXP, ΔBAG, and BAG3C (Figure 2.1A). The truncations Δ87–101, Δ200–213, Δ87–101, and Δ200–213 
removed the first IPV motif, the second IPV motif or both, respectively, while the other truncations 
removed known domains involved in other protein–protein interactions. Finally, BAG3C was composed 
of only the BAG domain, so we could use it to understand the role of this region. We assayed the 
truncated proteins for binding to Hsp27c using ITC (Figure 2.3) and found that the ΔWW, ΔPXXP, or 
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ΔBAG proteins bound with approximately the same affinity as full length (~ 0.5 to 0.7 μM). BAG3C 
construct did not bind to Hsp27c, as expected. These results are consistent with the role of IPV motifs in 
binding to sHsps, and they suggest that other domains are not involved. More interestingly, we found 
that deletion of individual IPV motifs (Δ87–101, Δ200–213) or mutation of the first IPV motif to GPG 
(named as IPV1) weakened affinity by at least 2-fold (~ 1 to 2 μM). The mutation or deletion of 
individual IPV motifs also reduced the stoichiometry (N) of the interaction from 2:1 to approximately 1:1 
(Figure 2.3B). When both IPV motifs were deleted (Δ87–101 and Δ200–213) or mutated (IPV1 and IPV2 
to GPG), binding was abolished. The simplest explanation for these results is that BAG3 uses both of its 
IPV motifs to engage the Hsp27c dimer.  
To explore whether this bi-dentate binding mode might be conserved in the interaction with other 
sHsps, we measured binding of each of the BAG3 mutants to Hsp27, αB-crystallin, Hsp22, and Hsp20 
using a flow cytometry protein interaction assay (FCPIA). Consistent with the results obtained using 
Hsp27c, deletion or mutation of one IPV motif weakened the apparent binding affinity (typically by 
about 2-fold) for each of the full-length sHsps. Removing both IPV motifs prevented measurable binding 
to Hsp27, HSP27-3D, Hsp20, and αB-crystallin (Kd > 50 μM) and weakened the affinity for Hsp27c and 
Hsp22 by more than 25-fold (Kd ~ 10 to 20 μM). Replacing both IPV motifs with GPG had a similar effect; 
binding to Hsp27, HSP27-3D, and αB-crystallin was unmeasurable (Kd > 50 μM) and the affinity for 
Hsp27c, Hsp20, and Hsp22 was weakened (Kd ~ 3 μM). Together, these results suggest that BAG3 uses 
both of its IPV motifs to interact with sHsps. These interactions do not necessarily have to involve two 
IPV motifs binding to a single dimer, especially in the context of the more complex, polydisperse sHsp 
oligomers. 
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Figure 2.3 BAG3 uses both IPV motifs to bind sHsps. Deletions and point mutations in BAG3 reveal that the IPV motifs are 
important for binding to Hsp27c, using ITC. Experiments were performed in duplicate and the error bars are SEM. These 
experiments and figures were performed and created by Rauch JN (Gestwicki laboratory, UCSF). 
• 2.3.3 BAG3 reduces the size of Hsp27 oligomers 
Knowing that BAG3 uses its IPV motifs to interact with sHsps and that sHsps also use their IXI motifs to 
regulate their oligomer size, we wondered if BAG3 could disrupt sHsp oligomers. To test this hypothesis, 
we first used size exclusion chromatography with multi-angle light scattering (SEC-MALS). This technique 
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allows molecular weight determination of a sample based on the intensity of light scattering as a 
function of angle. In these experiments, we focused on Hsp27 because it is known to form large 
oligomers that can be visualized by EM (see below) [44]. Injection of Hsp27 (30 μM) alone yielded an 
SEC-MALS trace with an average mass of 425 kDa (Figure 2.4A). This mass corresponds to ~ 18 
monomeric subunits, which is consistent with literature values [59]. In addition, the Hsp27 peak was 
broad (mass range 390–470 kDa), suggesting a polydisperse ensemble of oligomers that has been 
observed previously [60]. Adding BAG3 to this sample effectively reduced the apparent oligomer size 
from 425 kDa to 330 kDa (Figure 2.4A). This change represents a predicted drop in average subunit size 
from approximately 18 monomers to ~ 14 monomers, supporting the hypothesis that BAG3 can 
disassemble oligomers of Hsp27. Importantly, this estimate is a conservative upper bound because 
 
Figure 2.4 BAG3 binding reduces the size of Hsp27 oligomers. A) Hsp27 (30 μM) was incubated with increasing concentrations 
of BAG3 and the mixtures were analyzed by SEC-MALS. BAG3 reduced the average molecular weight of the Hsp27 peak and 
increased the polydispersity of the samples. Experiments were repeated in duplicate and average MW is reported with SEM. 
Importantly, the estimate of the number of Hsp27 subunits within the complex does not include the contributed mass of bound 
BAG3 because the stoichiometry is not yet clear, so it should be considered a conservative upper bound. B) 2D class averages of 
oligomer particles show a modest decrease in the average particle size. Scale bar is 10 nm. C) BAG3 decreases the number of 
Hsp27 oligomers, as measured by negative stain EM. Scale bar is 20 nm. 
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BAG3 is also likely to contribute to the apparent molecular mass. If, based on the ITC results, we assume 
a 2:1 stoichiometry, then the oligomers would be composed of ~ 6 monomers. Although a definitive 
conclusion is difficult, owing to the heterogeneity of the samples, the qualitative conclusion is that BAG3 
disrupts the Hsp27 oligomers. 
To test this idea in a different way, we used EM. We found that oligomers of Hsp27 are visible using 
negative stain EM, with an average size of 115 × 140 Å (Figure 2.4B). Importantly, we expect that smaller 
oligomers, such as dimers, are “invisible” by this method because they do not readily accumulate stain. 
In fact, this feature allowed us to ask whether BAG3 could convert samples of Hsp27 into a smaller 
oligomer size by two approaches. In the first, we examined all of the visible particles and measured their 
dimensions to see if BAG3 could favor smaller structures. Indeed, we found that the Hsp27 particle size 
decreased to 105 × 125 Å when treated with 30 μM BAG3 (Figure 2.4B). Next, we counted the total 
number of visible Hsp27 particles in the grids to estimate whether BAG3 was lowering the number of 
oligomers. Small oligomers and dimers of Hsp27 would not be expected to retain stain and, therefore, 
would not be visible by this method. Strikingly, we found that the total number of visible particles was 
strongly reduced by BAG3 in a dose-dependent manner (Figure 2.4C). Specifically, the average number 
of oligomers observed in micrographs of Hsp27 alone was 505 particles/field. With increasing amounts 
of BAG3 at a constant concentration of Hsp27 (30 μM), the number of large particles was drastically 
decreased: 203 in the presence of 7.5 μM BAG3, 119 in the presence of 15 μM BAG3, and only 53 
oligomer particles in the presence of 30 μM BAG3. At this time, the exact stoichiometry of the Hsp27–
BAG3 complexes and the size distribution of treated samples are not clear. However, these results point 
to a model in which competition for IXI motifs during binding to BAG3 is not static—it results in a 
decrease in average Hsp27 oligomer size. 
• 2.3.4 BAG domain is essential for Hsp70 nucleotide exchange factor function 
BAG3 forms a tight interaction with the NBD of Hsp70 (Kd ~ 10 nM) to stimulate ADP release [50]. While 
it is known that this process requires the BAG domain, it was not yet clear if other regions of BAG3, 
especially the IPV motifs, might contribute to Hsp70 binding. To explore this idea, we measured binding 
of the BAG3 deletion mutants to Hsp70. Using FCPIA, we first confirmed that ΔBAG can no longer bind to 
Hsp70 (Figure 2.5A), consistent with the literature. This result was also confirmed by ITC (Figure 2.5B). 
The other deletions or mutations had a less dramatic effect on the BAG3–Hsp70 affinity (typically less 
than 2-fold reduction), suggesting that the majority of the binding energy originates from the BAG 
domain. 
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To verify this finding in a different platform, we turned to a nucleotide release assay. In this assay, Hsp70 
is loaded with a fluorescent ATP analog and then the ability of BAG3 to release the tracer is measured by 
fluorescence polarization [50]. We found that all of the domain deletion constructs were approximately 
equivalent in their ability to promote nucleotide release from Hsp70 (Figure 2.5), with the exception of 
the ΔBAG construct. Together, these results point to a model in which the BAG domain interaction with 
Hsp70's NBD is largely “insulated” from other parts of BAG3, including the IPV motifs. 
 
 
Figure 2.5 BAG3 binds Hsp70 through its BAG domain and stimulates client release. Binding of labeled BAG3 to immobilized 
Hsp70 by A) FCPIA and B) ITC. Results are the average of experiments performed in triplicate. Error bars represent EM. C) BAG3 
releases fluorescent nucleotide from Hsp70 NBD. Deletion of the BAG domain blocks this activity. Results are the average of 
experiments performed in triplicate. Error is SEM. These experiments and figures were performed and created by Rauch JN 
(Gestwicki laboratory, UCSF). 
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• 2.3.5 Hsp70–BAG3–sHsp form a ternary complex 
After characterizing the individual, binary interactions between BAG3–sHsp and BAG3–Hsp70, we set 
out to determine if a ternary Hsp70–BAG3–sHsp complex could be formed. The results of the binding 
studies thus far suggested that BAG3 could be a modular scaffolding protein, leading to the prediction 
that binding to Hsp70 would not impact binding to sHsps and vice versa. To ask this question, we 
immobilized Hsp22, α-crystallin or Hsp27 on streptavidin beads, incubated them with a constant 
concentration of Alexa 647-labeled BAG3 (50 nM), and then added increasing amounts of Alexa 488-
labeled Hsp70NBD (Figure 2.6A). Unfortunately, we were not able to immobilize sufficient levels of 
Hsp20 for this study. If Hsp70NBD could compete with sHsp for binding to BAG3, we would expect to see 
a decrease in Alexa 647 signal upon titration. However, we observed no decrease in fluorescence in the 
presence of Hsp70NBD (Figure 2.6A, top). Moreover, since we labeled BAG3 and Hsp70NBD with 
fluorophores that have distinct spectral properties, we were also able to confirm that both proteins 
were bound at the same time by monitoring the increase in Alexa 488 signal (Figure 2.6A, bottom). 
Lending further support to the idea of a modular interaction, the apparent affinity of the Hsp70NBD–
BAG3 interaction (~ 15 nM) was unchanged in the presence of Hsp22, α-crystallin, or Hsp27, when 
compared to the binary interaction. These findings suggest that sHsps and Hsp70 do not interfere with 
(or promote) binding to the other partner. In important control studies, we found that Hsp70NBD did 
not bind Hsp22, α-crystallin, or Hsp27 in the absence of BAG3 (Figure 2.6A). Thus, Bag3 appears to be a 
modular scaffolding protein for the two chaperone families.  
To confirm this idea, we analyzed solutions of Hsp70, BAG3, Hsp22, or a mixture of the three by SEC. 
Hsp22 was chosen for this experiment because of its tight affinity (see Figure 2.1B) and its relatively 
homogeneous oligomer size distribution on SEC (Figure 2.6B). Also, ATP (1 mM) was added to favor tight 
binding of Hsc70NBD to BAG3. Other sHsps were too heterogeneous in this platform to allow 
conclusions. However, we found that Hsp70, BAG3, and Hsp22 were clearly distinguished from each 
other on the SEC traces when injected individually (Figure 2.6B). Moreover, pre-incubation of these 
components showed a conversion to a higher-order complex (Figure 2.6B). All three proteins were part 
of this complex, as judged by collecting fractions and subjecting them to SDS-PAGE. Thus, BAG3 appears 
to be an adapter protein that links Hsp22, and likely other sHSPs, to Hsp70. 
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Figure 2.6 BAG3 stabilizes a ternary complex with Hsp70. (a) Alexa Fluor 488-labeled Hsp70 NBD was titrated against a solution 
of Alexa Fluor 647-labeled BAG3 in the presence of sHsp- (α-crystallin, Hsp27, or Hsp22) coated beads. Binding was detected 
using a flow cytometer. Experiments were performed in triplicate and error is SEM. A schematic of binding experiment is 
shown. Note that the sHsp oligomer size is heterogeneous. (b) SEC and SDS-PAGE analysis of a solution of Hsp22 (6 μM), BAG3 
(12 μM), and Hsp70 (6 μM) or solutions of individual components. In all experiments, ATP was added (1 mM) to favor tight 
binding of Hsp70 to BAG3. These experiments and figures were performed and created by Rauch JN (Gestwicki laboratory, 
UCSF). 
• 2.3.6 Hsp22 promotes the co-chaperone activity of BAG3 in vitro 
To explore possible functional implications of the ternary complex, we measured two chaperone 
activities of Hsp70: ATP turnover and firefly luciferase refolding. ATPase activity is typically measured 
using a colorimetric, malachite green assay, while refolding activity is measured by treating denatured 
firefly luciferase with chaperones and monitoring the recovery of luminescence. It is known that 
substoichiometric concentrations of BAG3 promote Hsp70's nucleotide turnover because it overcomes 
the rate-limiting step in cycling. Likewise, low levels of BAG3 are thought to balance the binding-and-
release of luciferase in the refolding assay, increasing the yield of re-folded enzyme. However, in both 
assays, higher concentrations of BAG3 seem to stall Hsp70, such that it converts from being a stimulator 
into an apparent inhibitor [50]. 
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Using these assays, we varied the concentration of both BAG3 and Hsp22, holding the levels of Hsc70 (1 
μM) constant. Importantly, we found that Hsp22 had no significant effect on either ATPase activity or 
luciferase refolding in the absence of BAG3 (Figure 2.7A and B), so this sHsp was ideal for these 
experiments. In the ATPase assay, we observed a striking ability of Hsp22 to promote the activity of 
BAG3 (Figure 2.7A). For example, at 0.5 μM of Hsp22, BAG3 became a potent suppressor of cycling. At 2 
μM, this effect was even more pronounced, allowing BAG3 to be a strong inhibitor at concentrations at 
which it was normally inactive (e.g., 0.125 μM; Figure 2.7A). We noted a trend of Hsp22 to modestly 
promote the ability of low levels of BAG3 to activate turnover when the Hsp22 was also present at low 
concentrations (0.125 and 0.0625 μM of Hsp22; Figure 2.7A); however, this trend was not statistically 
significant (p value > 0.01). 
 
Figure 2.7 Hsp22 affects the chaperone functions of Hsp70 through BAG3. (a) The ATPase activity of Hsp70 was measured by 
malachite green assays. Addition of BAG3 suppresses ATPase activity, consistent with previous reports. Hsp22 promotes this 
activity and makes BAG3 more effective at lower concentrations. Results are the average of at least three independent 
experiments performed in triplicate. Error bars represent SD. Importantly, Hsp22 has no effect on Hsp70's ATPase activity in the 
absence of BAG3. (b) Hsp22 coordinates with Hsp70–BAG3 to refold denatured luciferase. Titration of BAG3 into Hsp70 initially 
promotes luciferase refolding, but it then becomes inhibitory at higher concentrations. Addition of Hsp22 promotes luciferase 
refolding. Results are the average of at least three independent experiments performed in triplicate. The error bars represent 
SD. In both A and B, the results are shown as a two- and three-dimensional display of the same data. These experiments and 
figures were performed and created by Rauch JN (Gestwicki laboratory, UCSF). 
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The possible effects of BAG3 and Hsp22 on luciferase refolding were measured using a similar approach. 
Chaperone-mediated refolding of firefly luciferase requires a careful balance of client binding and 
release, which eventually favors the folded, enzymatically active state. We observed that titration of 
Hsp22 into the Hsc70–BAG3 system strongly promoted the refolding of luciferase, with luminescence 
increased by 2- to 3-fold when Hsp22 was above 1 μM (Figure 2.7B). Again, this activation was highly 
dependent on coordination with BAG3, because Hsp22 was unable to promote refolding in the absence 
of BAG3 or at high concentrations of BAG3. These results suggest that BAG3 regulates the chaperone 
functions of Hsc70 and Hsp22 in the context of refolding damaged luciferase. 
• 2.4 Discussion 
Using pulldowns, BAG3 had been reported to interact with some sHsps through its IPV motifs [56,57]. 
Using NMR, we first confirmed that BAG3 binds the conserved β4–β8 region of the core crystallin 
domain, where the IXI motifs normally reside (see Figure 2.2). Furthermore, deleting or mutating either 
of the IPV motifs of BAG3 weakened binding to Hsp27, Hsp20, Hsp22, and αB-crystallin and deleting or 
mutating them both largely abolished binding (see Figure 2.1). These results suggest that BAG3 uses 
both of its IPV motifs to engage the two β4–β8 grooves. In the simplest case (such as Hsp27c), such an 
interaction could occur through a “clamp-like” mechanism, with both of the IPV motifs making contact 
within a single dimer. There is a sufficient distance between the IPV motifs (~ 100 aa; see Figure 2.1A) to 
allow for such an interaction and the 2:1 stoichiometry, calculated from ITC, is supportive. However, the 
sHsps that form larger oligomers, such as those formed by full-length Hsp27 or αB-crystallin, may 
interact with BAG3 in a more complex way. Indeed, it seems likely that a single BAG3 might use both IPV 
motifs to bind β4–β8 regions in nearby protomers within the oligomer, which are not necessarily part of 
a single homodimer. 
One important implication of this model is that BAG3 might be expected to inhibit oligomerization of 
some sHsps. Specifically, it is known that the IXI motifs of some sHsps are important in linking dimers 
together into higher order oligomers. This idea is supported by the fact that Hsp20 and Hsp22 both lack 
their own IXI motifs and have reported to form relatively smaller oligomers in solution [56,58]. Indeed, 
we found that incubation of full-length Hsp27 with BAG3 leads to an overall decrease in both oligomer 
size and frequency, as judged by SEC-MALS and EM. Thus, BAG3 does not appear to be a “passive” 
scaffolding protein. Rather, its interactions with sHsps compete for IXI binding and partially disrupt 
quaternary structure. As we observed in the luciferase refolding experiments (see Figure 2.7), this 
structural change may have functional implications. It is important to note that interactions outside the 
66 
 
IXI motifs also contribute to the formation of higher-order oligomers, so it seems unlikely that BAG3 
could convert oligomers to an entirely dimeric state. 
Hsp70 and the sHsps constitute an ancient system for protecting proteins under conditions of 
proteotoxic stress. sHsps are capable of binding and stabilizing unfolded/denatured proteins and 
keeping them in a refolding-competent form [21]. Due to their lack of intrinsic refolding ability, sHsps 
must then collaborate with ATP-powered refolding systems, such as the Hsp70 system [61]. Indeed, it 
has been shown both in vitro and in vivo that sHsp substrates can be refolded by the Hsp70 chaperone 
system [62–65]. However, a mechanistic understanding of how sHsps might communicate with the 
Hsp70 system has been elusive, especially for the mammalian systems. 
Using FCPIA and SEC, we found that BAG3 could bind to Hsp70 at the same time as Hsp27, Hsp22, and 
αB-crystallin. Multiple pieces of evidence suggest that the strength of the two protein–protein 
interactions within this ternary complex (e.g., BAG3–Hsp70, BAG3–sHsp) is not influenced by the other. 
For example, the apparent affinity of the BAG3 interaction with Hsp27, Hsp22, and αB-crystallin was not 
significantly different in the presence of Hsp70 (see Figure 2.4). Moreover, deletion of the BAG domain 
or the IPV motifs from BAG3 did not impact binding to the other partner (see Figs. 2 and 4). Thus, it 
appears that BAG3 is a modular scaffolding protein that physically links sHsps to Hsp70. In this way, 
BAG3 may act like the scaffolding protein, HOP, which coordinates the Hsp70–Hsp90 axis [66]. In that 
system, HOP is thought to organizing “hand-off” of partially folded clients, such as nuclear hormone 
receptors, between the chaperones. We speculate that the mammalian chaperone network may contain 
additional examples of such scaffolding proteins. 
Because smaller oligomers of Hsp27 and α-crystallin had been shown to be more potent chaperones 
[39,40] and we found that BAG3 could compete for the IXI motifs that help hold together oligomers (see 
Figure 2.4), we wondered whether BAG3 might promote sHsp chaperone activity. Furthermore, BAG3 is 
well known to regulate Hsp70's chaperone function through its BAG domain interactions, so it might be 
expected to coordinate the activities of both sHsps and Hsp70s. Indeed, we found that the combination 
of BAG3, Hsp22, and Hsp70 (at the proper ratio) was a potent refolding machine (see Figure 2.7). The 
mechanistic details of this process are not yet known and it remains to be seen whether this ternary 
complex could be functionally important in cells and animals. Yet, these results suggest that BAG3 is 
both a physical and functional link between the sHsps and Hsp70s. In this way, BAG3 is not a “passive” 
scaffolding protein, but one that remodels the activity of its chaperone partners. 
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BAG3 binds to Hsp70 with an affinity of ~ 13 nM (see Figure 2.5) in the ATP state, while its affinity for 
sHsps is between ~ 8700 and 350 nM (see Figure 2.1). Although there is much to learn about how 
“client” proteins, expression level and post-translational modifications might impact these apparent 
affinity constants in the cell, it is interesting that BAG3 has a tighter affinity for Hsp70 than sHsps. This 
observation suggests that BAG3 and Hsp70 form a relatively more stable pair, which might only 
transiently coordinate with sHsps. 
BAG3 is the only stress-inducible member of the BAG family, so we propose that its unique scaffolding 
function may be especially important during conditions that favor protein unfolding and aggregation. In 
this scenario, the stress-inducible expression of BAG3 might bring together sHsps with Hsp70s, while 
simultaneously “activating” both systems. It is clear that other stress-inducible mechanisms, such as 
phosphorylation of sHsps [42,43], also contribute to adaptive proteostasis. However, the expression of 
BAG3 may also play a role in this process through its ability to coordinate two major components of the 
chaperone network. 
• 2.5 Methods 
• Cloning and recombinant protein production 
All domain deletion constructs were subcloned from the BAG3 pMCSG7 parent vector and confirmed 
with DNA sequencing. Mutations were constructed using standard mutagenesis protocols. Constructs 
for Hsp27, Hsp27c, Hsp27-3D, and α-crystallin were all received from the Klevit laboratory. Hsp22 was a 
kind gift from Jean-Marc Fontaine, and Hsp20 was received from the Conklin laboratory and 
subsequently cloned into the pMCSG7 vector. All constructs were transformed into BL21(DE3) cells and 
single colonies were used to inoculate TB medium containing ampicillin (50 μg/mL). Cultures were 
grown at 37 °C for 5 h, cooled to 20 °C and induced overnight with 200 μM IPTG. BAG3 full length and 
IPV mutants were purified as previously described [50]. BAG3 deletion constructs were pelleted and re-
suspended in His-binding buffer (50 mM Tris, 300 mM NaCl, 10 mM imidazole [pH 8.0]) + 3 M Urea. 
Samples were sonicated and then applied to the Ni-NTA resin. After Ni-NTA columns, all proteins were 
subjected to TEV cleavage overnight, concentrated and applied to a Superdex S200 (GE Healthcare) size 
exclusion column in BAG buffer (25 mM Hepes, 5 mM MgCl2, 150 mM KCl [pH 7.5]). Hsp72 and 
Hsp72NBD were purified as described elsewhere [67]. sHsp in plasmids containing an N-terminal His tag 
(Hsp27-3D, α-crystallin, Hsp22, and Hsp20) were all purified using a His column and subsequent SEC on a 
Superdex S200 in BAG buffer or phosphate-buffered saline, as previously reported [33]. Hsp27 and 
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Hsp27c were in tagless vectors, so they were purified using a two-step ammonium sulfate precipitation 
followed by MonoQ and SEC. Briefly, ammonium sulfate was added to a final concentration of 16.9% 
(w/v), centrifuged, pellet discarded, and then an additional 16.9% (w/v) ammonium sulfate was added 
to the supernatant to precipitate the protein from solution. Precipitated protein was brought up and 
dialyzed into MonoQ Buffer A (20 mM Tris, pH 8.0) overnight, followed by a MonoQ column (0–1 M NaCl 
gradient), and finally an SEC on a Superdex S75 (Hsp27c) or Superdex S200 (GE Healthcare) equilibrated 
in 50 mM sodium phosphate and 100 mM NaCl (pH 7.5) buffer. Throughout the manuscript, the 
concentration of sHSPs is reported based on effective monomer concentration and not oligomer 
concentration. 
• ITC 
BAG3 constructs, Hsp72NBD, and sHsps were dialyzed overnight against ITC buffer (25 mM Hepes, 5 mM 
MgCl2, 100 mM KCl [pH 7.5]). Concentrations were determined using a BCA Assay (Thermo Scientific), 
and the experiment was performed with a MicroCal VP-ITC (GE Healthcare) at 25 °C. Hsp72NBD (100 
μM) or indicated sHsp (200 μM) in the syringe was titrated into a 10-μM cell solution of BAG3 protein. 
Calorimetric parameters were calculated using Origin® 7.0 software and fit with a one-site binding 
model. 
• FCPIA 
The assay procedure was adopted from previous reports [50]. Briefly, biotinylated Hsp70 was 
immobilized (1 h at room temperature) on streptavidin-coated polystyrene beads (Spherotech). After 
immobilization, beads were washed to remove any unbound protein and then incubated with labeled 
BAG3 proteins at the indicated concentrations. Binding was detected using an Accuri™ C6 flow 
cytometer to measure median bead-associated fluorescence. Beads capped with biocytin were used as a 
negative control, and non-specific binding to beads was subtracted from signal. 
For ternary complex formation experiments, Hsp27 or α-crystallin was immobilized on beads with 
constant concentration (50 nM) of Alexa 647-labeled BAG3 present. Increasing concentrations of Alexa 
488-labeled Hsp72 NBD were titrated against the sHsp–BAG3 solution and fluorescence was measured 
using an Accuri™ C6 flow cytometer. Again, beads capped with biocytin were used as a negative control, 
and non-specific binding to beads was subtracted from signal. 
• Nucleotide release assay 
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A fluorescent ATP analog, N6-(6-Amino)hexyl-ATP-5-FAM (Jena Bioscience) was used to measure BAG3-
induced nucleotide dissociation from Hsp72, as previously described [50]. In black, round-bottom, low-
volume 384-well plates (Corning), 1 μM Hsp72 and 20 nM N6-(6-Amino)hexyl-ATP-5-FAM were 
incubated with varying concentrations of BAG3 protein for 10 min at room temperature in assay buffer 
(100 mM Tris, 20 mM KCl, 6 mM MgCl2 [pH 7.4]). After incubation, fluorescence polarization was 
measured (excitation: 485 nm emission: 535 nm) using a SpectraMax M5 plate reader. 
• SEC-MALS 
Solutions of Hsp27 (15 μM) and BAG3 (either 15 or 30 μM) were pre-mixed and resolved by analytical 
SEC on a Shodex 804 column on an Ettan LC (GE Healthcare). Molecular weights were determined by 
multi-angle laser light scattering using an in-line DAWN HELEOS detector and an Optilab rEX differential 
refractive index detector (Wyatt Technology Corporation). The column was equilibrated overnight in 
BAG buffer prior to analysis. Samples were run at the indicated concentrations. Calculation of molecular 
weights was performed using the ASTRA software package (Wyatt Technology Corporation). 
• SEC 
Solutions of BAG3 (6 μM), Hsp72 (6 μM), Hsp22 (12 μM), or BAG3–Hsp72–Hsp22 (6 μM:6 μM:12 μM) 
were examined using a Superdex S200 (GE Healthcare) size exclusion column. Indicated fractions were 
collected and analyzed using SDS-PAGE analysis. Samples were separated using 4%–15% Tris–Tricine gels 
(Bio-Rad) and stained with Coomassie Blue. Image color was changed to grayscale for clarity. 
• EM 
Solutions of Hsp27 (30 μM) and BAG3 (7.5, 15, or 30 μM) were pre-incubated, diluted, and applied to a 
thin carbon-coated copper grid for negative staining using uranyl formate at pH ~ 6.0. Electron 
micrographs were collected on a Tecnai T12 Microscope (FEI) equipped with a LaB6 filament operated at 
120 kV. Images were collected at 50,000 × magnification with a 2.2 Å/pixel spacing and 1.0–1.3 A 
defocus range on a 4k × 4k CCD camera (Gatan). Particle images were selected and extracted from 
micrographs, subsequently phase-corrected from the estimated CTF parameters using EMAN2 software. 
2D reference free alignment and classification was then performed using the SPIDER software package. 
A set of 15 class averages representing ~ 1500 particles for each BAG3 concentration were used to 
measure the longest dimension observed as well as the distance perpendicular to obtain an average size 
of the particles. 
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• Chaperone assays 
The steady-state ATPase activity of Hsc70 was measured by malachite green and the refolding of 
chemically denatured firefly luciferase was measured by recovered luminescence, as previously reported 
[50]. Hsc70 was used at 1 μM. DnaJA2 was used at 0.5 μM and ATP at 1 mM. In the ATPase experiments, 
results were normalized to the signal from Hsc70 and DnaJA2 with 30 nM BAG3 (100%). In the luciferase 
refolding experiments, results were normalized to the luminescence signal produced by addition of 
Hsc70 and DnaJA2 alone (100%). At these concentrations and incubation times, this value represents 
only ~ 40% of the total luminescence signal that can be recovered. We selected these conditions to 
allow for BAG3 and Hsp22 to have the possibility of further improving the refolding activity. 
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Chapter 3 
A conserved histidine modulates HSPB5 structure to trigger chaperone activity in response to stress-
related acidosis 
This chapter is published in: Rajagopal, P. Tse, E. Borst, A. J. Delbecq, S. P. Shi, L. Southworth, D. R. 
Klevit, R. E., Elife, 2015. 4.2 
 
• 3.1 Abstract 
Small heat shock proteins (sHSPs) are essential ‘holdase’ chaperones that form large assemblies and 
respond dynamically to pH and temperature stresses to protect client proteins from aggregation. While 
the alpha-crystallin domain (ACD) dimer of sHSPs is the universal building block, how the ACD transmits 
structural changes in response to stress to promote holdase activity is unknown. In collaboration with 
the lab of Rachel Klevit at the University of Washington, we found that the dimer interface of HSPB5 is 
destabilized over physiological pHs and a conserved histidine (His-104) controls interface stability and 
oligomer structure in response to acidosis. Destabilization by pH or His-104 mutation shifts the ACD 
from dimer to monomer but also results in a large expansion of HSPB5 oligomer states. Remarkably, His-
104 mutant-destabilized oligomers are efficient holdases that reorganize into structurally distinct client–
bound complexes. Our data support a model for sHSP function wherein cell stress triggers small 
perturbations that alter the ACD building blocks to unleash a cryptic mode of chaperone action. 
• 3.2 Introduction 
Cells have numerous strategies to cope with the consequences of stress conditions that lead to protein 
misfolding and aggregation. Ineffective resolution of protein misfolding and unmitigated protein 
aggregation can lead to formation of plaques, fibrils, and other aggregated species encountered in 
neurodegenerative diseases. Generally, ATP-dependent chaperones such as Hsp70 and Hsp90 assist with 
protein refolding, while ATP-independent chaperones known as small heat shock proteins (sHSPs) act as 
first responders by maintaining proteins in soluble forms to inhibit misfolding and to delay aggregation. 
Under transcriptional regulation of the heat shock factor, Hsf1, levels of sHSPs can rise to 1% of total 
                                                          
2 My contributions to this chapter were the SEC-MALS and negative stain EM analysis of the global architecture of 
HSPB5 and client binding. Contributions by members of the Klevit lab (University of Washington) are indicated in 
the figure legends 
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cellular protein when conditions deviate from the norm, e.g. ischemia, hypoxia, oncogene activation, 
and chemotherapy [1]. sHSPs are found throughout prokaryotes and eukaryotes. There are ten sHSPs 
encoded in the human genome (HSPB1, HSPB2, etc), ranging in size from 15 to 25 kDa. Most, including 
the ubiquitously expressed human sHSP HSPB5, form large assemblies that exist as dynamic 
distributions of polydisperse oligomers whose properties are both temperature and pH dependent [2]. 
Which form or forms of an sHSP are active and how they function are central unanswered questions. In 
addition, how sHSPs interact with partly unfolded or aggregate-prone proteins (‘clients’) to prevent 
formation of aggregates remains enigmatic. 
Some acute cellular stresses are associated with acidosis. For example, measurements in mouse brain 
following ischemic stroke showed a pH of 6.4 in ischemic tissue compared to a pH of 7.0 in normal tissue 
[3]. A decrease in cellular pH may give rise to destabilization of some proteins and/or a decrease in 
solubility for proteins with pI values between pH 6 and 7. Furthermore, the pH in normal eye lens fiber 
cells, which contain extremely high concentrations of the sHSPs HSPB4 and HSPB5 is ∼6.5 [4, 5]. Such 
observations raise the question as to the nature and determinants of pH-dependent properties of sHSPs 
in general and HSPB5 in particular. 
Here, we report how pH affects structural, biochemical, and functional properties of HSPB5 (also known 
as αB-crystallin). Like all sHSPs, HSPB5 has a conserved central α-crystallin domain (ACD) flanked by 
variable N- and C-terminal regions. We carried out investigations both on the HSPB5-ACD, which forms 
the dimeric building block found in all sHSPs, and on full-length oligomeric HSPB5. We find that ACD 
dimer stability decreases over a narrow physiologically relevant pH range and we have identified a 
conserved histidine residue that is largely responsible for the observed destabilization. Surprisingly, the 
histidine is not on the dimer interface but its mutation to glutamine or lysine partly or fully recapitulates 
low pH behavior both in the context of the ACD dimer and in oligomers. The mutant proteins allowed us 
to probe the consequences of dimer interface destabilization without additional complicating factors 
that arise when comparing experiments performed at differing pH. Mutations that destabilize the dimer 
interface produce extremely large oligomers that can rearrange to form long-lived complexes with a 
model client protein. Our studies unmask a cryptic mode of HSPB5/client interaction not previously 
detected using the wild-type protein under non-stress conditions. The results highlight mechanistic 
differences in the ways in which holdases work and suggest that HSPB5 has a repertoire of ways in 
which it can carry out its function. 
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• 3.3 Results 
• 3.3.1 NMR solution structure and 15N relaxation reveal conformational plasticity in HSPB5-ACD 
As ACD dimers are the fundamental, stably folded building blocks of sHSP oligomers, we first sought to 
define their response to changes in pH over a physiologically relevant range. Although multiple 
structures have been solved for HSPB5-ACD, there are differences among them as well as differences in 
the conditions under which the structures were obtained (i.e., pH 4.6, 6.0, 7.5, 8.5, 9.0) [6]. We felt this 
situation necessitated structure determination under solution conditions relevant to our studies. The 
solution structure of HSPB5-ACD at pH 7.5, 22°C (Figure 3.1 A,B) was calculated from NMR data that 
included backbone and side chain chemical shifts, NOEs, and RDCs. As in all previously determined 
HSPB5-ACD dimer structures (PDB 2WJ7, 3L1G, 2KLR, 2Y22, 4M5S, and 4M5T), each subunit adopts a six-
stranded β-sandwich structure and two ACDs form a dimer through anti-parallel alignment of their long 
β6+7 strands (Figure 3.1 A,B,C). A notable difference among solved sHSP ACD structures is that dimers 
appear in different alignments of the two β6+7 strands [6, 7]. In the solution structure reported here, 
the dimer interface places Glu117 across from Glu117’ (Figure 3.1D). This register is observed in all but 
two of the available HSPB5-ACD structures and is also the predominant alignment observed in other 
metazoan sHSP ACD structures. 
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Figure 3.1 Solution structure ensemble of HSPB5-ACD at pH 7.5 is an anti-parallel dimer. A) Backbone traces of ten ACD 
structures determined by RosettaOligomer are aligned over all residues (RMSD of 1.4 Å). Subunits of the dimer are shown in 
blue and gray. B) Cartoon representation of one member of the HSPB5-ACD ensemble is shown. The six strands of the β-
sandwich structure are labeled using previously defined nomenclature for ACD structures. The dimer is formed by antiparallel 
arrangement of the β6+7 strands at the interface. Loop 5/6 is highlighted in the blue subunit. (C) The sequence of the ACD 
construct for which the solution structure was solved is shown with elements of secondary structure highlighted. (D) The 
alignment of the β6+7 strands at the dimer interface, shown schematically, places Glu-117 across from Glu-117′. This alignment 
is called ‘APII’ in previous reports (Clark et al., 2011). (E) Overlay of protomers from all available HSPB5-ACD structures. All 
members of the solution NMR structure (this paper; PDB 2N0K) and the solid-state NMR structure (2KLR; Jehle et al., 2010) are 
shown in dark gray and light gray, respectively. Five crystal structures are shown: (1) 2WJ7 (yellow), (2) 3L1G (orange), (3) 4M5S 
(green), (4) 4M5T (red), and (5) 2Y22 (blue). These experiments and figures were performed and created by Rajagopal P (Klevit 
laboratory, University of Washington). 
At the level of the protomers, the HSPB5-ACD structures are remarkably similar despite having been 
solved under significantly different conditions and by different techniques (Figure 3.1E). Two NMR 
ensembles (solution-state reported here and solid-state PDB 2KLR) and five crystal structures all overlay 
well with the exception of the loop that connects β5 and β6+7 (called Loop 5/6; residues His-104–Gly-
112). Loop 5/6 curves upwards in our solution ensemble (pH 7.5) and in three crystal structures (2WJ7 
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[pH 9.0], 3L1G [pH 4.6], and 2Y22 [pH 8.6]). In the ‘loop up’ conformation, Loop 5/6 residues make 
contacts across the dimer interface to the other subunit. In contrast, Loop 5/6 curves slightly 
downwards in the solid-state NMR ensemble (2KLR; pH 7.5) and in two crystal structures (4M5S [pH 
6.0]; 4M5T [pH 6.5]). Thus, among structures solved between pH 6.5 and 7.5, both loop conformations 
have been observed, suggesting that the loop is dynamic in the physiological pH range. 
To investigate dynamic processes in the HSPB5-ACD, we performed 15N relaxation measurements. A 
majority of backbone amide nitrogens have 15N T2 values between 30 and 40 ms, but resonances in 
Loop 5/6 and the dimer interface have T2 < 30 ms, indicating they undergo a change in their 
environment in the millisecond timescale (data not shown). To better probe this time regime, we 
performed NMR 15N relaxation-compensated CPMG relaxation dispersion measurements under the 
solution structure conditions (700 μM ACD at pH 7.5, 22°C). Examples of relaxation curves obtained 
from spectra collected at two magnetic field strengths (600 and 800 MHz) are shown in Figure 3.2A. 
Twenty resonances gave curves that could be analyzed; of these, half are well fit by a two-state model 
(χred2; reduced chi-square < 10; Figure 3.2). This indicates that the ACD dimer is exchanging between a 
major species (i.e., the one revealed in the solution structure ensemble) and one or more minor species. 
The nature of the minor species will be discussed below. Values for kex, the rate of exchange, for 
individual resonances ranged between 760 s−1 and 1119 s−1. The less than two-fold difference for the 
range of values obtained from fitting data for individual resonances suggests that the residues that 
exhibit exchange could be involved in the same dynamic phenomenon. The residues that undergo 
exchange are along the dimer interface and in Loop 5/6 (Figure 3.2B). These findings are consistent with 
the apparent plasticity of the dimer interface and Loop 5/6 inferred from crystal structures of the ACD 
dimer. Analysis of available HSPB5-ACD structures and NMR relaxation data combined indicate that (1) 
the HSPB5 protomer structure is retained over a wide pH range and (2) there are two regions of 
plasticity, namely the dimer interface and Loop 5/6. 
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Figure 3.2 15N-CPMG relaxation dispersion experiments detect dimer-to-monomer exchange. A) Relaxation dispersion 
measurements reveal a two-state transition. Representative relaxation dispersion curves of 15N transverse relaxation rate 
(R2,eff) plotted as a function of field strength, (νCPMG) are shown (see Materials and methods for details). Data were recorded at 
static field strengths of 800 MHz (red) and 600 MHz (black) at pH 7.5 and 22°C. Values of kex, δω, and pb were extracted using 
the program, GUARDD. B) Backbone representation of HSPB5-ACD dimer is shown with the Cα atoms of exchanging residues 
that are well fit by a two-state model shown as spheres. Resonances showing relaxation rates in the range 760 s−1 to 1119 s−1 
occur mainly at the dimer interface and in Loop 5/6. These experiments and figures were performed and created by Rajagopal 
P (Klevit laboratory, University of Washington). 
• 3.3.2 HSPB5-ACD undergoes pH-dependent dimer dissociation 
To assess thermodynamic stability of the ACD dimer, dimer–monomer dissociation constants were 
determined from isothermal titration calorimetry dilution measurements in which highly concentrated 
ACD was titrated into buffer. The resulting isotherms fit a simple dimer-monomer equilibrium model. 
We made measurements at two physiological pH values, pH 7.5 and pH 6.5 (25°C), and obtained 
dissociation constants of 2 ± 2 μM and 30 ± 16 μM, respectively. The value at pH 7.5 is in excellent 
agreement with the value of 2 μM inferred from tandem MS/MS measurements performed at the same 
pH [8]. The dimer is also destabilized by an increase in temperature, with a KD of 36 ± 2 μM at pH 7.5, 
37°C. Thus, the HSPB5-ACD dimer is destabilized by either a decrease in pH from 7.5 to 6.5 or an 
increase in temperature from 25°C to 37°C. 
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Figure 3.3 HSPB5-ACD undergoes a conformational transition between pH 7.5 and 6.5. A) 1H-15N HSQC spectra acquired on a 
200 µM sample of HSPB5-ACD at pH 7.5 and 6.5 (22°C) reveal two states. Full spectra collected at pH 7.5 (black) and 6.5 (red) 
are overlaid (left). At pH 7.5, 82/85 non-proline residues are observed (residues G64, L65, and S139 are not detected due to fast 
exchange with H2O). At pH 6.5, approximately ∼65 additional peaks appear, indicating the presence of two conformations. 
Boxed regions shown on the right provide clear examples of peak doubling. Some resonances (labeled in the panel on the left) 
disappear from their original positions at pH 7.5 and their new positions could not be determined by inspection of the spectrum 
at pH 6.5. B) Example of a full pH titration series (spectra collected at pH 8.4 [blue], 7.5 [black], 7.0 [cyan], 6.7 [green], and 6.5 
[red]). The behavior of the resonance of H119 as a function of pH illustrates two pH-dependent processes (see text). Its 
chemical shift is in fast exchange from pH 8.4 to 7.5 (solid arrow) and changes direction and is in slow exchange from pH 7.0 to 
6.5 (dashed arrow). The region shown contains several other resonances that undergo slow-exchange transitions over the same 
pH range. C) Residues that undergo the slow exchange transition are highlighted in color on a surface representation of the ACD 
dimer. Residues with perturbations > 0.2 ppm are red; those with perturbations between 0.1 - 0.2 ppm are orange. D) Analysis 
of relaxation dispersion data yields the difference in 15N chemical shift between the major and minor species (ΔδNcalc). The 
values of ΔδNcalc (blue) are compared to the experimental values obtained from the difference of 15N chemical shifts at pH 7.5 
and 6.5, i.e., ΔδN(7.5−6.5) (red), in the histogram. Concordance between these two parameters supports the notion that the minor 
form detected by relaxation dispersion experiments is the monomeric form of ACD that is populated at lower pH. These 
experiments and figures were performed and created by Rajagopal P (Klevit laboratory, University of Washington). 
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1H, 15N-HSQC spectra of HSPB5-ACD collected at pH 7.5 and 6.5 show extensive changes (Figure 3.3A). 
Furthermore, spectra collected between pH 7.0 and pH 6.0 had significant peak doubling which is mostly 
resolved at pH 6.0, making analysis of the pH-induced spectral changes based solely on existing 
resonance assignments at pH 7.5 [9] challenging. Therefore, we assigned the HSPB5-ACD spectum at pH 
6.5 using standard triple resonance spectra collected at both pH 6.5 and pH 6.0 so that we could follow 
individual resonances through a pH titration series. An expanded region of the 1H, 15N HSQC pH series is 
shown in Figure 3.3B. In the absence of another pH-dependent process, resonances arising from 
residues that undergo a protonation/deprotonation event as a function of pH will shift in a continuous 
manner. Resonances from residues that are proximal to titrating residues will also show similar 
behavior. Such processes will appear in the so-called ‘fast-exchange’ NMR regime due to the rapid 
on/off rate of acidic protons. At pH values above 6.7, some resonances in the HSPB5-ACD spectrum 
exhibit fast-exchange pH behavior, consistent with protonation/deprotonation of ionizable groups. This 
behavior is illustrated by the resonance for His-119 in spectra collected at pH 6.7 and above (Figure 
3.3B). At pH < 6.7, some resonances double and appear in a new position (for example, resonances 
labeled 87, 119, and 135 in Figure 3.3B). Such behavior exemplifies intermediate-to-slow exchange and 
is indicative of the existence of two states that interconvert slowly on the NMR timescale. The relative 
intensities of the peaks reflect the relative population of the two states, so a new species of HSPB5-ACD 
is increasingly populated as the pH decreases. 
Spectral assignments at pH 7.5 and 6.5 allowed identification of residues most affected by the pH-
dependent transition. The chemical shift difference between the ‘high’ pH form (pH 7.5) and the ‘low’ 
pH form (pH 6.5), Δδ(pH7.5–pH6.5) was calculated for each NH resonance (see ‘Materials and 
methods’). Resonances that exhibit large chemical shift perturbations (>0.2 ppm) and/or change 
trajectory during the titration mainly arise from two structural regions (colored red in Figure 3.3C): the 
dimer interface (residues F113–I124) and Loop 5/6. In light of the pH-dependent KD values obtained by 
ITC, the dissociation of dimers to monomers is a likely source of the slow exchange process observed in 
NMR spectra below pH 7. 
The above findings raised the possibility that the minor species detected by relaxation dispersion at pH 
7.5 is an ACD monomer. In addition to the exchange rate, the fractional population of the minor species 
(pb = 1 − pa), and the chemical shift difference between the major and minor species for a given 
resonance (δω) can be extracted from analysis of relaxation dispersion data [10]. Seven resonances 
provided an estimate for the fractional population of the minor species, pb, as ∼5%, in good agreement 
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with the value of 4% calculated from the KD measured by ITC. We compared the predicted difference in 
15N chemical shift (δω) to the experimentally determined difference in chemical shifts between the ACD 
at pH 7.5 and at pH 6.5, ΔδN(pH7.5- pH6.5). As seen in Figure 3.3D, there is remarkably close 
correspondence for dimer interface residues, supporting the notion that the minor species detected by 
relaxation dispersion at pH 7.5 is the same as the monomeric form populated as the pH decreases below 
7. 
Finally, we performed relaxation dispersion measurements at 37°C (pH 7.5) to determine the rates of 
association/dissociation at physiological temperature. For a dimer-to-monomer transition, the 
measured exchange rate will be concentration dependent: 
• kex=kmd[monomer]+kdm, 
where kmd is the rate constant for monomer–dimer association and kdm is the constant for dimer 
dissociation. We collected relaxation dispersion data at two protein concentrations (700 and 200 µM; 
pH 7.5, 37°C). Global fitting of relaxation dispersion data for residues in the dimer interface gave kex 
values of ∼1500 s−1 and 460 s−1 at 700 and 200 µM HSPB5-ACD, respectively. The concentration 
dependence confirms that the observed exchange is due to dimer-monomer dissociation/association. 
Based on a KD (=kdm/kmd) of 36 μM, the concentration of ACD monomers at 700 μM ACD subunits is 
∼100 μM. This gives kmd = 1.1 × 107 M−1 s−1 (in the range for diffusion-controlled bimolecular 
association; [11]) and kdm = 400 s−1. Thus, several NMR parameters plus ITC measurements provide a 
picture in which the long dimer interface dissociates at a rate of 400 s−1 at pH 7.5, 37°C and is 
destabilized as pH decreases below 7. Under the same conditions, full-length HSPB5 subunits in 
oligomers exchange much more slowly, at a rate of 10−3 s−1 [12]. Therefore, the rate at which subunits 
leave an oligomer is not determined by disruption of the ACD dimer and the results suggest that dimer 
interfaces within oligomers may break and reform many times during the residency of subunits within 
HSPB5 oligomers. 
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Figure 3.4 His-104 plays a key role in the dimer-monomer transition. A) The electrostatic surface of HSPB5-ACD at pH 7.5 
(calculated using experimentally determined histidine pKR values) reveals patches of positive (blue) and negative (red) charges 
that cross the dimer interface. B) The five histidines of HSPB5-ACD (blue and cyan sticks) occur as pairs and are located in 
proximity to the dimer interface. C) Mutation of His-104 shifts the dimer-monomer equilibrium as observed by NMR. Overlays 
of 1H-15N HSQC spectra at pH 7.5 (black) and pH 6.5 (red) are shown for H104K-ACD (left panel) and WT-ACD (right panel). A 
single set of peaks is observed in WT-ACD at pH 7.5, and peaks due to the monomer conformation appear as the pH is lowered. 
Peaks belonging to the dimer interface, e.g., R120 and R116 disappear from their original positions in WT-ACD at pH 6.5 and in 
H104K-ACD at both pH conditions (dotted circles). D, E) Expanded regions of 1H-15N HSQC spectra of WT-, H104K-, and H104Q-
ACD. The same color scheme is used for WT- and H104K-ACD as in panel C; H104Q-ACD overlay is in blue (pH 7.5) and red (pH 
6.5). D) Comparison of H104K-ACD (left panel) and WT-ACD (right panel). Dotted lines connect resonances in similar positions in 
H104K-ACD and WT-ACD. The example shows that the peaks for residues 87, 95, 119, and 136 have similar positions in H104K-
ACD (at both pH values) as in WT-ACD at pH 6.5. E) Comparison of identical regions of spectra of H104K-ACD (top left panel), 
WT-ACD (top right panel), and H104Q-ACD (lower panel). Both forms (dimer and monomer) are observed in the H104Q-ACD 
spectrum at both pH values, whereas only peaks corresponding to the monomer are observed in H104K-ACD at both pH values. 
These experiments and figures were performed and created by Rajagopal P (Klevit laboratory, University of Washington). 
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• 3.3.3 A conserved histidine is responsible for destabilization of the HSPB5-ACD dimer 
The arrangement of the ACD dimer creates patches of positively and negatively charged surface that 
cross the dimer interface on both faces of the structure (Figure 3.4A). At pH 7.5 and 22°C where the 
dimer is more stable, the electrostatic forces are presumably in balance, but the high densities of like 
charges suggest the stability is tenuous. A protonation event or other rearrangement at or near the 
dimer interface may tip the balance and trigger dimer dissociation. HSPB5-ACD has a high histidine 
content, with five His residues out of 89 total residues, (5.6%, which is more than double the average His 
frequency across all proteomes). In the dimer structure, eight of ten histidine residues (five in each 
protomer) are located in pairs (two His-83/His-104 pairs and two His-101/His-119 pairs) and are 
concentrated towards the center of the dimer (Figure 3.4B). Overall, the organization and surface 
electrostatics suggested a possible role for histidine residues in triggering the pH-dependent dimer 
dissociation. 
To identify candidate histidines, pKR values and tautomeric states were determined from NMR chemical 
shifts of imidazole ring nuclei (Nδ1, Nε2, Hδ2, and Hε1) measured as a function of pH. pKR values were 
obtained for four of five His residues: His-101 and His-111 have low values of <6 and His-83 and His-119 
have values of 6.6 and 7.7, respectively (Figure 3.4). A pKR could not be determined for His-104 because 
its side chain resonances broaden and disappear at pH values below 7.5. Though His 104 is not 
positioned on the dimer interface, the behavior of its backbone NH resonance is similar to backbone NH 
resonances on the dimer interface undergoing exchange between dimer and monomer, indicating that it 
undergoes a change in environment as a result of the dimer-to-monomer transition. At pH 7.5 where its 
imidazole resonances are detectable, His-104 exists as the less common Nδ1H tautomer, while the other 
four His residues are in the more common Nε2H tautomer. A resonance is observed at a chemical shift 
of 12.4 ppm for the Nδ1H of His-104, indicating that it is hydrogen bonded. Among members of the 
solution ensemble, there are several potential H-bonding partners in proximity to His-104: the backbone 
carbonyls of His-83, Glu-105, and Glu-106 and side chain groups of Arg-107 and Arg-116 (Figure 3.4). 
Together, the data reveal that His-104 is in a specific conformation in the ACD dimer at pH 7.5 that is 
stabilized through an H-bond. 
The sensitivity of His-104 resonances to the dimer-to-monomer transition suggested it as a prime 
candidate for the pH trigger. His-104 was substituted with either Gln or Lys and the mutant ACDs were 
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compared to WT-HSPB5-ACD. As discussed above (Figure 3.3A,B), peak doubling is observed in the 
spectrum of WT ACD below pH 7, with new peaks appearing at lower pH corresponding to ACD 
monomers. The 1H-15N HSQC spectrum of H104Q-ACD has peak doubling even at pH 7.5 and the two 
sets of peaks correspond to dimer and monomer peaks already assigned in the WT spectrum (Figure 
3.4E, lower panel). The H104K-ACD HSQC spectrum has a single set of resonances under both pH 
conditions, but the peaks correspond to the monomer, even at pH 7.5 (Figure 3.4C–E). Thus, substitution 
of His-104 with glutamine destabilizes the dimer so that approximately equal populations are observed 
at pH 7.5 and NMR concentrations. Glutamine at position 104 would have difficulty mimicking the 
Nδ1H-bond formed by His-104. Substitution of His-104 with a positively charged lysine yields an ACD 
that is predominantly monomeric at pH 7.5. We did not determine KD values for the mutants by dilution 
ITC experiments because the starting ACD concentration must be ten-fold above KD. Based on the 
relative populations of dimer and monomer peaks in the NMR spectra, we can estimate that the KD for 
H104Q-ACD is ∼100–500 μM (approximately equal populations of dimer and monomer at [ACD] = 200 
μM) and the KD for H104K-ACD is >1 mM (based on our inability to detect dimer resonances in samples 
containing 200 μM protein). Although only order-of-magnitude, these estimates reveal that substitution 
of His-104 with Gln or Lys destabilizes the dimer more than 100-fold. To ascertain whether the effect of 
mutating His-104 is specific, the other four His residues were each mutated to Gln. The mutant ACDs 
retained the pH-dependent spectral behavior of the WT-ACD (data not shown). Altogether, the data 
implicate His-104, which sits at the base of Loop 5/6 (Figure 3.4B), as a hotspot whose conformation, H-
bonding capacity, and protonation state strongly affect the stability of the HSPB5-ACD dimer interface. 
• 3.3.4 A destabilized dimer interface triggers a large expansion in HSPB5 oligomers 
To uncover consequences of dimer interface stability in HSPB5 oligomer structure, we compared 
properties of full-length H104Q- and H104K-HSPB5 with WT-HSPB5. Size exclusion chromatography 
combined with multi-angle light scattering (SEC-MALS) provided information on oligomer size and 
polydispersity and negative-stain electron microscopy (EM) allowed observation of single oligomeric 
particles (Figure 3.5). SEC-MALS data of WT-HSPB5 oligomers confirmed previously reported pH 
dependent changes in oligomeric dimension [2, 13]. At pH 7.5, the molecular weight (Mw) determined 
at intervals across the elution peak ranged from 440 kDa to 500 kDa. The average Mw of 465 kDa 
corresponds to the mass of ∼24 subunits, consistent with previous reports [14, 15]. At pH 6.5, WT-
HSPB5 oligomers elute earlier, with an average Mw of 720 kDa, corresponding to ∼36 subunits per 
oligomer—an increase of 12 subunits on average per oligomer (Figure 3.5A).  
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Figure 3.5 Destabilizing the ACD dimer interface via low pH or His-104 mutation triggers large expansion of HSPB5 oligomers. 
A) SEC-MALS analysis showing protein elution profile (refractive index, right Y-axis) with average Mw (horizontal trace under 
peak corresponds to left Y-axis) for WT-HSPB5 at pH 7.5 (blue) and pH 6.5 (green), and H104Q-HSPB5 (orange) and H104K-
HSPB5 (red) at pH 7.5. B) 2D projection class averages showing representative ensemble of oligomer sizes. C) SEC-MALS analysis 
showing elution profile and average Mw of mixed oligomers of WT and H104K-HSPB5 incubated together at ratios of 1:0 
(green), 2:1 (light green), 1:1 (yellow), 1:2 (orange), and 0:1 (dark red), respectively. D) Histogram of oligomer diameters 
showing fraction of oligomer particles vs average diameter (nm) for WT at pH 7.5 (blue) and pH 6.5 (green), and H104K at pH 
7.5 determined by negative-stain EM 2D classification. Representative 2D class averages corresponding to measured diameter 
are shown. Experiments were performed in triplicate. Scale bar (lower left image) equals 10 nm. 
 
Negative-stain EM micrographs and single particle images collected on WT-HSPB5 oligomers at pH 7.5 
and 6.5 reveal large globular structures at both pHs (Figure 3.6). In 2D projection averages (generated by 
reference-free alignment of single particle data sets), WT-HSPB5 oligomers are generally spherical and 
have varied diameters that are on average greater at pH 6.5 than at pH 7.5 (Figure 3.5B, Figure 3.6B). 
Thus, SEC-MALS and EM measurements reveal an expansion in the hydrodynamic radius, particle 
dimensions, and number of subunits in WT-HSPB5 oligomers as a function of decreasing pH. 
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Figure 3.6 EM micrograph images, 2D classification, and particle diameter estimation for WT and H104K HSPB5. A) 
Representative micrograph images of WT-HSPB5 at pH 7.5 and 6.5 and H104K-HSPB5 at pH 7.5 negatively stained with 0.75% 
uranyl formate (scale bar equals 20 nm). Example individual particle projections are shown below with scale bar equal to 10 
nm. B) 2D reference free class averages for WT-HSPB5 pH 7.5, WT-HSPB5 pH 6.5 and H104K-HSPB5 pH 7.5 from data sets of 
5,321, 5713, and 5145 single particles for respectively. Scale bar equals 10 nm. C) Example class averages, corresponding 
rotational averages and estimated diameter (nm) for HSPB5 oligomers. 
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To ask if the change in oligomer size observed with pH is a consequence of dimer interface 
destabilization, the His-104 mutants were analyzed by SEC-MALS and EM at pH 7.5. H104K-HSPB5 forms 
very large, polydispersed oligomers ranging from 785 to 840 kDa (Figure 3.5A), with an average Mw of 
810 kDa (∼41 subunits). H104Q-HSPB5 oligomers elute at an intermediate position relative to WT- and 
H104K-HSPB5. Thus, more subunits are recruited when oligomers are assembled from destabilized 
dimers. We propose that oligomers composed of H104K-HSPB5 are made predominantly of monomeric 
units while oligomers composed of H104Q-HSPB5 contain both dimeric and monomeric units. If this 
model is accurate, we should be able to recapitulate intermediate-sized H104Q-containing oligomers by 
mixing together WT- and H104K-containing subunits. As shown in Figure 3.5C, the elution position and 
oligomer mass in mixtures of WT-HSPB5 and H104K-HSPB5 titrate as a function of added H104K-HSPB5 
subunits, consistent with a model in which oligomers are formed from both dimeric and monomeric 
units. WT-HSPB5 oligomers at pH 6.5 have a mass range that corresponds to a 1:2 ratio of WT:H104K 
subunits, indicating that the pH-dependent oligomeric assemblies likely arise from a combination of 
monomeric and dimeric subunits. 
The results above suggest that H104K-HSPB5 oligomers represent an endpoint in a continuum of 
oligomer composition and that H104Q- and (pH 6.5) WT-HSPB5 are reflective of species that are favored 
under differing conditions including stress-induced acidosis. To ask if oligomers composed uniquely or 
partly of monomeric units have distinct structural features, negative-stain EM images of H104K-HSPB5 
at pH 7.5 and WT-HSPB5 at pH 6.5 were collected and analyzed. In a majority of images, defined 
features, identified as light and dark regions of density, are apparent within the structures, indicating an 
organized arrangement of subunits. The particles are generally spherical, with some oblong-shaped 
structures also observed. Quantitative information on the size and distribution of oligomers was 
obtained by measuring the diameter of circular averages generated for each 2D projection average 
(Figure 3.6C). Single particles were then binned based on diameter of their corresponding average to 
generate a distribution (Figure 3.5D). The size distribution derived in this way is consistent with the SEC-
MALS analysis: WT-HSPB5 at pH 7.5 has the smallest average diameter, 15 nm, (a range of 13–17 nm), 
H104K-HSPB5 has the largest, with an average of 17 nm, and WT-HSPB5 at pH 6.5 is intermediate, at 16 
nm. Oligomers of WT-HSPB5 at pH 6.5 cover the entire range of diameters measured, between 14 and 
>18 nm, while the distribution of H104K-HSPB5 is skewed to the largest dimensions, with a majority of 
particles (>70%) greater than 16 nm. For comparison, the diameter of the WT-HSPB5 cryo-EM model 
[16] determined similarly from the circular average measures 15 nm, in good agreement with our 
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measurements. Altogether the results reveal that conditions and/or mutations that affect the stability of 
the antiparallel dimer interface have substantial impact on HSPB5 oligomer size and structure. 
• 3.3.5 Oligomers with destabilized dimer interfaces are effective holdases that reorganize to 
bind client proteins 
To ascertain the functional and mechanistic consequences of the expanded oligomer structures 
described above, standard holdase assays in which aggregation of a model client protein is monitored as 
a function of time in the absence and presence of sHSP were performed. At pH 7.5, H104Q- and H104K 
HSPB5 are more effective than WT-HSPB5 at delaying formation of large aggregates by two model 
clients, αLactalbumin (αLac) destabilized by addition of DTT, and alcohol dehydrogenase (ADH) 
destabilized by addition of DTT and EDTA (Figure 3.7). The results indicate that enhanced holdase 
activity is associated with destabilization of the dimer interface. 
 
Figure 3.7 His-104 mutants of HSPB5 are effective at delaying the onset of aggregation of a model client protein. 
(Top panel) Aggregation of DTT-denatured bovine αLactalbumin at 42°C in the absence (green) and presence of WT-HSPB5 
(blue) or HSPB5 mutants H104K (red) and H104Q (orange). Light scattering at 360 nm was used to monitor the DTT-induced 
aggregation of αLac (600 µM) in the presence and absence of HSPB5 (40 µM). Assays were performed in duplicate and the 
average scattering curves are shown. (Bottom panel) Aggregation of Yeast Alcohol Dehydrogenase in the presence of EDTA and 
DTT, at 37°C in the absence (green) and presence of WT-HSPB5 (blue) or HSPB5 mutants H104K (red) and H104Q (orange). Light 
scattering with 360 nm light was used to monitor ADH (100 µM) aggregation in the presence and absence of HSPB5 (20 µM). 
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Assays were performed in duplicate and the average scattering curves are shown. These experiments and figures were 
performed and created by Borst, A (Klevit laboratory, University of Washington). 
To understand how destabilization of the dimer interface yields more effective holdases, we compared 
how HSPB5 and the mutants interact with clients. We took advantage of the long delay in αLac 
aggregation afforded by both the WT and mutant HSPB5 species to attempt to detect sHSP-client 
interactions. Mixtures of αLac and one of the HSPB5 species were analyzed by SEC-MALS following 
addition of DTT and before the onset of aggregation (Figure 3.8). Although WT-HSPB5 maintains αLac in 
a soluble form during the time frame of the experiment, no interaction between the two proteins was 
detected by SEC or SDS-PAGE, indicating that its holdase function is achieved through highly transient 
interactions (Figure 3.8A). In contrast, a mixture of αLac and H104K-HSPB5 elutes with a dramatically 
different profile. SDS-PAGE analysis across the broad peak that elutes between 7.5 and 9.2 ml shows 
that it contains both proteins (Figure 3.8B). There is a broad range of molecular weights across this peak, 
from >550 kDa to ∼250 kDa. A similar but less dramatic change in the elution profile was obtained for a 
mixture of αLac and H104Q-HSPB5 (Figure 3.8C). Thus, long-lived complexes are formed between αLac 
and the H104 mutant HSPB5s, and these are markedly smaller than the oligomers that are populated in 
the absence of client protein. 
 
Figure 3.8 H104K- and H104Q-HSPB5 oligomers reorganize into small, long-lived client-bound complexes in the presence of 
αLac model client protein. A–C) SEC-MALS analysis and corresponding Mw of WT A), H104K B) and H104Q C), HSPB5 oligomers 
(40 μM in subunit concentration) incubated with αLac (120 μM) in the absence (blue) and presence (red) of 50 mM DTT to 
destabilize αLac. SDS-PAGE analysis of peak fractions for corresponding HSPB5-αLac incubations with DTT (red trace) is shown 
(inset). Dashed lines correspond to WT elution at 8 ml and H104K elution at 7.4 ml. D) 2D projection class averages of H104K- 
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and H104Q-HSPB5-αLac peak fractions corresponding to peaks I, II, and III (gray bars) in B and C are shown with representative 
averages of WT, H104K-, and H104Q-HSPB5 incubated without αLac substrate for comparison. Scale bar (lower left panel) 
equals 10 nm. 
Negative-stain EM was performed on fractions collected across the peak containing both H104K-HSPB5 
(or H104Q-HSPB5) and α-Lac (Figure 3.8D). In micrograph and single particle images, the particles 
appear intact and there is little background from unbound protein, indicating the mutant HSPB5/αLac 
complexes remain stable following dilution for EM (Figure 3.9). The particles are much smaller and are 
structurally distinct from the spherical oligomers observed for WT-, H104Q-, or H104K-HSPB5 on their 
own. A large single particle data set of fractionated H104K-HSPB5/αLac complex was collected, and 2D 
projection averages were determined as above. The 2D averages (Figure 3.8D) show clear structural 
features and reveal that a major structural reorganization occurs in the mutant sHSP upon binding of a 
model client protein. Among the 2D averages, some smaller spherical oligomers similar to WT-HSPB5 
are observed, but the ultra-large (>16 nm) oligomers that predominate in H104K HSPB5 alone are no 
longer detected. The sizes are highly variable, likely depending on the orientation, stoichiometry, and/or 
oligomeric state of the complex.  
To see if similar HSPB5/αLac complexes form with WT-HSPB5 but do not survive the SEC-MALS 
experiment, unfractionated samples of mixtures of WT-HSPB5 and α-Lac were analyzed by negative 
stain EM (data not shown). No smaller species were detected and the spherical oligomers remain 
unchanged for WT-HSPB5. Overall the results demonstrate that HSPB5 oligomers with destabilized 
dimer interfaces disassemble and undergo a dramatic reorganization to form stable complexes with a 
model client protein while the wild-type protein at pH 7.5 does not do so and performs its holdase 
function via highly transient interactions with client. 
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Figure 3.9 EM micrograph images and 2D classification of HSPB5 incubated with αLac. A) Representative micrograph images 
and single particles of WT-HSPB5 and H104K-HSPB5 incubated with or without αLac substrate and DTT prior to fractionation by 
SEC-MALS showing the shift in oligomer size only occurs with H104K-HSPB5 and α-Lac. Scale bars equal 20 nm and 10 nm for 
the micrographs and single particles, respectively. B) Complete set of 2D projection class averages of H104K-HSPB5-αLac 
isolated in Peak 1 and Peak II following SEC-MALS fractionation. Class averages were obtained from 11,727 particles in fraction I 
and 9257 particles in fraction II are shown and the scale bars equal 10 nm. 
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• 3.4 Discussion 
Despite their key roles in maintaining cellular protein solubility under and following stress conditions, 
the determinants of sHSP structure and function remain ill defined. Stresses such as ischemia and 
hypoxia are associated with acidosis in which cellular pH can decrease to as low as pH 6.4 [3]. As HSPB5 
must function under stress conditions, we sought to investigate effects of pH on its structure and 
function. sHSPs have three structural regions, each of which plays a role in oligomer assembly. The 
highly conserved ACD is necessary and sufficient for dimer formation and dimers are thought to be the 
fundamental building blocks for oligomers. The N- and C-terminal regions appear to drive oligomer 
assembly, although the details of these interactions are not yet elucidated. We find that HSPB5-ACD 
dimers dissociate into folded monomers that are favored as the pH decreases. ITC and NMR 
measurements revealed a modest affinity for the ACD dimer (KD of 36 μM at pH 7.5, 37°C), with dimers 
dissociating at a rate of 400 s−1. The long β6+7 strands of two subunits align in an antiparallel fashion to 
form the dimer interface. This structure with its associated H-bonds might be expected to afford higher 
affinity. The juxtaposition of Glu-117 and Glu-117′ in the middle of the interface and the positively and 
negatively charged patches that cross the interface may contribute to the modest affinity and to the 
dynamics and plasticity we observed in the interface. Dimer affinity decreases 15-fold over 1 pH unit (pH 
7.5 to pH 6.5) and this likely corresponds to a similar fold increase in the rate of dissociation at the dimer 
interface. A pH-dependent destabilization of the HSPB5-ACD dimer interface was inferred from native 
MS studies performed on oligomers as a function of pH; our results offer a direct confirmation and 
quantification of this hypothesis [17]. 
We identified a histidine residue that plays a key role in ACD dimer interface stability. Substitution of 
His-104 with Gln or Lys decreases dimer stability substantially. NMR spectra reveal that the His-104 ring 
is in the more unusual of the two possible tautomeric forms, stabilized by serving as an H-bond donor. 
Analysis of members of the solution structure ensemble and crystal structures with the Loop 5/6-up 
conformation identifies several backbone carbonyls as potential H-bond acceptors for His-104: His-83, 
Glu-105, and Glu-106. Alteration of the H-bonding potential or geometry (as in the H104Q mutant) or 
charge (as in the H104K mutant and low pH) destabilizes the dimer. Among the ten human sHSPs, His-
104 is the most conserved His residue, appearing in eight of ten proteins, with the non-H104-containing 
sHSPs having a Gln (HSPB9) or a Lys (HSPB7) (Figure 1—source data 2). Consistent with a conserved role 
for His-104, the unusual tautomeric state adopted by His-104 in HSPB5 is also observed for the 
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analogous histidines in HSPB1 (His-124) and HSPB6 (His-103) (Rajagopal and Klevit, unpublished 
observation). 
Identification of the role of His-104 in dimer stability was unexpected because while there are histidines 
on the dimer interface, His-104 is not one. His-104 is located at the beginning of Loop 5/6, the loop 
connecting strands β5 and the dimer interface strand, β6+7 (Figure 4B). NMR relaxation dispersion 
analysis of the ACD dimer revealed that residues in the dimer interface (116–123) exist in two states 
consistent with a dimer-monomer equilibrium (Figure 2B). Residues in Loop 5/6 have similar exchange 
rates suggesting that loop movements and the structural transition may be coupled. However, a 
rigorous demonstration that the dynamics of the two regions are coupled requires a robust 
determination of kex values as a function of [ACD] for loop residues as well as interface residues and the 
data collected did not allow for this determination with sufficiently high confidence. Nevertheless, 
consistent with this notion, inter-subunit contacts are observed that involve Loop 5/6 residues: His-111 
at the apex of Loop 5/6 makes contacts to Arg-120’ and Tyr-122’ across the dimer interface. These inter-
subunit contacts help to position Loop 5/6 in a ‘loop up’ conformation in the solution structure at pH 7.5 
(Figure 1E, Figure 4—figure supplement 1). A majority of residues in Loop 5/6 are charged (H104-E-E-R-
Q-D-E-H111) so a possible consequence of His-104 protonation, which sits at the base of the loop, is to 
alter the conformation or position of Loop 5/6, disrupting inter-subunit contacts involving the loop and 
shifting the dimer–monomer equilibrium of the HSPB5-ACD. In structures with the ‘loop up’ 
conformation, side chains of Arg-107 and Arg-116 are in proximity to His-104; the ‘loop down’ 
conformation moves Arg-107 away from His-104 and Glu-106 closer to His-104 (Figure 4—figure 
supplement 1). In sum, we propose that in both loop conformations His-104 sits at the center of a 
dynamic network of electrostatic and H-bonding interactions that is responsible for modulating the 
stability of the dimer interface. 
A survey of all 17 available mammalian sHSP-ACD structures (9 HSPB5 [WT and mutants], 3 HSPB1, and 3 
HSPB6) reveals that Loop 5/6 is found in two conformations; a ‘loop up’ conformation as seen in the 
HSPB5-ACD solution structure and a ‘loop down’ conformation. In the ‘loop up’ structures, the details of 
the interactions between Loop 5/6 residues across the dimer interface vary, again pointing to the 
plasticity of this region. Nevertheless, the residues corresponding to His-111, Asp-109, and Arg-120 are 
involved in all cases. Furthermore, although Loop 5/6 contains predominantly polar and/or charged 
residues, it is remarkably well conserved among the human sHSPs (Figure 1—source data 2). There are 
several reported examples where Loop 5/6 residues affect the dimer-monomer equilibrium. In HSPB5, 
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residues His-104, Asp-109, and His-111 have recently been implicated in Cu2+ and Zn2+ binding and the 
binding of divalent cation appears to destabilize the dimer interface [18]. In HSPB1, which has an almost 
identical Loop 5/6 sequence to HSPB5, substitution of the two glutamate residues that correspond to 
HSPB5 Glu-105 and Glu-106 to Ala resulted in monomeric HSPB1-ACD [19]. Also, a Loop 5/6 mutation in 
HSPB1, R127W (corresponding to Arg107 in HSPB5 numbering) is reported to promote monomer over 
dimer [20]. In each case, a change in the net charge of Loop 5/6 leads to monomer being more favored. 
Altogether the observations suggest a model in which properties of Loop 5/6 are coupled to the stability 
of the dimer interface. It is notable that inheritance of single alleles of D109H-HSPB5 or R127W-HSPB1 is 
associated with cataract, myofibrillar myopathy, and distal hereditary motor neuropathy [21]. Both 
mutations alter the net charge of Loop 5/6, implying a critical role for structural and/or dynamic 
properties of Loop 5/6 in sHSP function. 
Moving into the context of full-length HSPB5, we found that decreasing pH or substituting His-104 has 
dramatic effects on oligomer dimensions and subunit stoichiometry. A continuum of oligomer sizes is 
observed that trends reciprocally with ACD dimer interface stability. H104K-HSPB5, whose ACD will be 
predominantly monomeric, assembles into the largest oligomers containing over 40 subunits. While the 
notion that dimers are the fundamental building blocks of sHSP oligomers may describe the situation 
under certain conditions, our results indicate that oligomers can also be built from monomeric subunits 
and from combinations of dimeric and monomeric units and that more monomeric subunits can be 
incorporated into a given oligomer. This revelation will be important in any future attempts to 
determine HSPB5 oligomer structures for oligomers larger than the 24-mer previously determined [2, 
16]. 
The His-104 mutants allowed us to ask if and how the dimer interface contributes to holdase function 
without the confounding complications of comparing aggregation of model denatured client proteins at 
differing pHs. Both dimer-destabilizing mutations yield an HSPB5 that can delay aggregation of model 
clients longer than the wild-type protein at pH 7.5. Unexpectedly, the His-104 mutant proteins, which 
form much larger oligomers than WT-HSPB5, reorganize to form long-lived complexes with a client 
protein. EM images reveal particles that are markedly smaller and distinct from the mostly spherical 
sHSP-alone structures. During the time period in which WT-HSPB5 inhibits client protein aggregation, we 
were unable to detect a complex with the client, either by SEC or by EM. Thus, the mutant sHSPB5 
species perform holdase function via a different mechanism from the wild-type protein at pH 7.5. WT 
HSPB5 acts via weak-and-transient interactions while the mutants act via stronger-and-longer 
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interactions. Notably, two inherited missense mutations in HSPB1 associated with Charcot-Marie-Tooth 
syndrome, R127W-HPSB1 (in Loop 5/6) and S135F-HSPB1 (on the dimer interface), engage in stronger, 
longer-lived interactions with client proteins than the WT-HSPB1, as evidenced from tandem affinity 
purification [20]. Two client binding modes have been observed in studies of the highly related HSPB4 
(αA-crystallin), dubbed ‘high capacity’ and ‘low capacity’ based on differing client:sHSP stoichiometries 
[22]. It remains for future studies to ascertain whether these reflect the species observed and reported 
here. 
Solid-state NMR studies of WT-HSPB5 oligomers at pH 7.5 revealed three types of inter-subunit 
interactions: (1) ACD-to-ACD (i.e., the dimer interface), (2) C-terminal region-to-ACD, and (3) N-terminal 
region to either ACD or other N-terminal regions [2]. The findings in the current study indicate that the 
relative strength and, perhaps, abundance of these interactions can affect not only the size and 
structure of oligomers but also the way in which client proteins are recognized. Subunit exchange in WT-
HSPB5 is orders of magnitude slower than the exchange rate we measured for the dimer-to-monomer 
transition (10−3 s−1 vs ca. 103 s−1, respectively, at pH 7.5, 37°C; [12]). So, while breaking the dimer 
interface is not the rate-limiting step in subunit exchange, destabilizing the ACD dimer yields oligomers 
that can more readily disassemble to form smaller species with clients and these complexes must be 
more stable than the mutant sHSP oligomers themselves. Long-lived sHSP-client complexes have been 
detected by SEC for Hsp18.1 from peas, but the complexes formed are larger than those of Hsp18.1 in 
the absence of client [23, 24]. Hsp26 from yeast also forms larger complexes with client than in the 
absence [25]. These examples contrast with our findings, which imply that HSPB5 has evolved to 
perform its holdase function via weak-and-transient interactions and that small perturbations can 
unleash a second, cryptic mode of client interaction (long-and-strong). The highly charged ACD dimer 
interface and the proximal Loop 5/6 provide exquisite sensitivity to small changes in electrostatic 
environment that can be effected by slight changes in pH, temperature, divalent cations, other cellular 
conditions, and mutations. Of the approximately twenty inherited disease-related missense mutations 
documented in ACD regions of human sHSPs, more than half are in residues on the dimer interface or in 
Loop 5/6 and all these involve substitutions of charged residues. 
Our original intent was to define how HSPB5 functions under pH conditions associated with stress-
induced acidosis. Our results show unequivocally that the dimer interface stability decreases over a 
physiologically relevant pH range and that mutation (or protonation) of a single histidine residue is 
sufficient to destabilize the dimer. The His-104 mutants provide several general insights regarding the 
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modulation of structure and function of sHSPs. First, the stability of an ACD dimer interface relative to 
other interactions involved in oligomer formation can modulate holdase function. In our study, 
destabilization of the dimer interface leads to enhanced holdase activity. It remains to be seen if the 
converse will be true. Second, dimer stability can be modulated by residues other than the dimer 
interface itself. Such effects are likely achieved through a network of conserved charged residues that 
ultimately favor or disfavor the dimer over monomer. Third, relatively small changes in pH or single 
missense mutations are capable of shifting HSPB5 from a weak, transient mode of client interaction to 
one that involves long-lived co-complexes. We propose that the continuum of oligomeric structures we 
observe for HSPB5 under differing pH (or mutation) may lead to a continuum of client-binding modes 
that allow the sHSP to ramp its holdase activity up or down as conditions require. A thorough 
understanding of the ways in which sHSP structure and activity can be modulated under differing 
cellular conditions will ultimately provide much needed insights into the cellular functions of this 
important, but previously intractable class of protein chaperones. 
• 3.5 Methods 
• Protein purification and Cloning 
HSPB5 and HSPB5-ACD (residues 64-152) were expressed and purified as described previously [9]. Site-
directed mutagenesis was performed with Quik-Change mutagenesis kit from Sigma. The growth and 
purification protocols of mutant proteins were similar to that of wild-type proteins. 
• Structure determination of WT-ACD by solution state NMR 
Resonances in the NMR spectrum of WT-ACD were previously assigned [9]. To obtain distance restraints 
from NOES, 15N-edited NOESY and 13C-edited NOESY spectra on aliphatic and aromatic groups were 
acquired on a 1 mM, 13C, 15N-WT-ACD sample in NMR buffer (50 mM sodium phosphate, pH 7.5100 mM 
NaCl, 0.1 mM EDTA, and 1 mM PMSF). The spectra were acquired on a Bruker 950 MHz US2 (ultra-
shield, ultra-stabilized) spectrometer equipped with Avance III console and a z-gradient, triple resonance 
cryoprobe (David H Murdock Research Institute in Kannapolis, North Carolina). 15N-edited NOESY 
and 13C-edited spectra were acquired with a mixing time of 120 ms in 90%H2O/10%D2O solution at 22°C 
and 100% D2O solution at 37°C, respectively. Data were processed with NMRPipe [26] and analyzed with 
NMRViewJ [27] and CcpNmr [28]. NOEs were binned into short (3 Å), medium (4 Å), and long-range 
constraints (5 Å) and input as distance restraints into RosettaOligomer [29]. Intermolecular NOEs in 
homodimeric proteins are usually obtained from edited/filtered-type NOESY experiments on a mixed 
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sample containing labeled and unlabeled protein. This method failed in the case of WT-ACD due to 
signal-to-noise issues. A preliminary structure of the dimer was determined with CS-Rosetta [30] and 
RosettaDock [31] (see below). The β-sandwich fold was determined from CS-Rosetta using backbone 
chemical shifts. RosettaDock gave a model of the dimer in the APIII register (where residue R116 from 
each subunit is across from each other). Using this preliminary model, intra- and inter-molecular NOEs 
could be parsed out from 15N-edited and 13C-edited NOESY spectra. The Hα-Hα NOEs observed in the 13C-
edited NOESY spectra unambiguously confirmed the APII register as the dimer interface (Glu-117-Glu-
117′ across from each other). Intra- and inter-molecular NOE restraints, 1H-15N RDCs, and all chemical 
shifts including the backbone and side-chain were input into RosettaOligomer for the final 
determination of the WT-ACD dimer structure. 
1H-15N residual dipolar couplings (RDCs) were measured on a 500-µM protein sample dissolved in 500 µl 
of NMR buffer containing 10% Pf1 phage obtained from ASLA biotech. IPAP (In-Phase/Anti-Phase) 1H-15N 
HSQC spectra were acquired in-house on a Bruker Avance III 800 MHz spectrometer equipped with a z-
gradient, triple resonance cryoprobe. Spectra were analyzed in NMRView to obtain the values of RDCs. 
The program PALES [32] was used to calculate RDCs for the different structures published in literature. 
• RosettaOligomer 
The Rosetta symmetric fold-and-dock protocol can be used to determine the structure of symmetric 
homodimers. Starting from an extended chain, this protocol simultaneously explores the folding and 
docking degrees of freedom. It consists of four low-resolution stages of increasing complexity in the 
energy function, in which symmetric fragment insertions are interleaved with symmetric rigid-body 
trials. During the low-resolution step, side chains are represented using a single, residue-specific 
pseudo-atom, positioned at the Cα carbon. Finally, symmetric repacking of the side chains and gradient 
based minimization of the side chain, rigid body, and backbone degrees of freedom are applied. In this 
high-resolution step, Rosetta's full-atom energy function is used. The conformational search is largely 
guided by experimental data, including intra- and inter-molecular NOE distance constraints and RDCs. A 
penalty term that is proportional to the rmsd between experimental and calculated data was used in 
Rosetta during the Monte Carlo trials and gradient-based minimization. NOE distances are modeled as 
atom pair constraints in Rosetta. For a structural model, RDCs are fitted using Levenberg–Marquardt 
non-linear square fitting algorithm. The orientations of alignment tensor are optimized, while keeping 
the axial component (Dα) and Rhombic component (R) of the alignment tensor fixed. The values of Dα 
and R of 21.5 and 0.35, respectively, were estimated from a powder pattern distribution of the RDC 
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data. A total of 10,000 models are generated, of which 1000 lowest ones are selected for cluster 
analysis. Ten models with the lowest Rosetta full-atom energy in the best-ranked cluster were selected 
as the final structural ensemble and deposited in the Protein Databank as PDB 2N0K. 
• pH titration and determination of pKR by NMR 
1H-15N HSQC-TROSY spectra were acquired on WT-ACD (200 µM) in NMR buffer at pH values 9.3, 8.56, 
7.86, 7.44, 7.0, 6.83, 6.7, 6.52, and 6.0 at 22°C on an in-house Avance III 500 MHz spectrometer 
equipped with a z-gradient, triple resonance probe. The pH of the solution was adjusted by adding small 
aliquots of 1N HCl or NaOH. The long-range correlations between the ring carbon-bound hydrogens 
(Hε1 and Hδ2) and the ring nitrogens (Nε2 and Nδ1) give information on the tautomeric states of the 
histidines [33]. These correlations were observed in 1H-15N HSQC spectra using WATERGATE for water 
suppression and by setting the INEPT delay to an integral multiple of 1/JNH where JNH is the value of the 
single bond N-H coupling constant. pKR values of histidine residues were determined by following the 
chemical shifts of Hε1, Nε2, and Nδ1 atoms as a function of pH. Non-linear regression fitting of chemical 
shifts vs pH was performed with Prism (GraphPad) using a modified version of the Henderson–
Haselbach equation: 
                                        
δobs is the observed chemical shift at a specific pH value, and δHA and δA are the chemical shifts in the 
fully protonated and deprotonated state, respectively. 
• Chemical shift perturbations (CSP) due to pH 
CSPs (Δδ(pH7.5–pH6.5)) were computed as follows: 
                                        
where Δδ is the chemical shift difference of an amide group at pH 7.5 and 6.5, ΔHN and ΔN are the 
amide proton and 15N backbone amide chemical shift differences, respectively. 
• 15N-CPMG relaxation dispersion experiments 
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To probe conformational fluctuations in the ms timescale, 15N effective relaxation rates (R2,eff which is the 
sum of the intrinsic relaxation rate, R02R20 and the chemical exchange rate, Rex) were measured for 
WT-ACD using pulse sequences described in literature [34]. Experiments were performed on 200 and 
700 µM samples at 22°C and 37°C at two field strengths, 800 and 600 MHz. The values of νcpmg used were 
25, 50, 75, 100, 150, 175, 200, 300, 600, and 1000 Hz. A recycle delay of 2.2 s between scans and a total 
CPMG delay (T) of 20 ms was used. Spectra were processed and analyzed with NMRPipe, and the fits of 
intensities vs νcpmg were analyzed with the program, GUARDD [35]. 32 out of 85 observable residues in 
WT-ACD exhibit values of R2,eff(∞)–R2,eff(0) > 8 s−1 at 22°C, where R2,eff(∞) and R2,eff(0) are the effective 
relaxation rates at νcpmg values of 25 Hz and 1000 Hz, respectively. Of those, 16 residues could be fit to a 
two-site exchange model with a reduced χ2 < 10 and these exhibit two exchange regimes (a) fast 
exchange (model-2, kex >> δω) and (b) slow exchange (model-3, kex << δω). kex and δω are the exchange 
rate and the chemical shift difference between the major and minor state, respectively. In the slow 
exchange regime, the parameters, pb (the population of the minor state) and δω can be extracted from 
the fits in addition to kex. In the fast exchange regime, only the value of kex can be extracted from the fits. 
For estimation of goodness of fits, the target function, χ2 is determined as follows: 
                                           
where RCalc2,eff is the calculated value of the effective relaxation rate, and σ is the experimental 
uncertainty in observed R2,eff which is estimated from two data sets that are repeat values of νcpmg. In this 
case, repeat data sets were collected at 25 and 200 Hz. The errors reported in kex, pb, and δω values are 
estimated from 100 Monte Carlo simulations and are reported as the standard deviation of the 
optimized fit parameter from its 100-element distribution. 
• Determination of KD 
The value of the dimer–monomer dissociation equilibrium constant, KD, was determined with isothermal 
titration calorimetry (ITC). ITC was performed on a MicroCal iTC200TM Calorimeter at the Analytical 
Biopharmacy Core, Univ of Washington. WT-ACD samples were dialyzed into 50 mM sodium phosphate, 
100 mM NaCl at either pH 7.5 or pH 6.5. 200 µl of 1 mM WT-ACD and 300 µl buffer were placed in the 
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sample and reference cells, respectively. Forty 1 µl injections were performed and the exothermic heat 
was measured. Data were fitted using MicroCal Origin software to obtain values of KD and change in 
enthalpic heat (ΔH). 
• Holdase assays 
All holdase assays were performed in duplicate using a 96-well plate reader (BioTek) with PBS solutions 
at pH 7.5 and 250 μL well volumes. DTT-denatured bovine αLactalbumin (Sigma L6010) was used as a 
model substrate and light scattering at 360 nm was used to monitor protein aggregation in the presence 
and absence of WT- and mutant HSPB5 at 42°C. 40 µM sHSP (subunit concentration) was added to 600 
µM αLac. Aggregation of αLac was induced by the addition of DTT to final concentrations of 50 mM. 
Aggregation of the model substrate Yeast Alcohol Dehydrogenase (Sigma A8656) was achieved with the 
addition of EDTA and DTT to final concentrations of 5 mM at 37°C. Light scattering by aggregates was 
monitored in the presence and absence of WT- and mutant HSPB5. 20 µM sHSP (subunit concentration) 
was added to 100 µM Alcohol Dehydrogenase. 
• Molecular weight (Mw) determination by SEC-MALS 
The Mw of HSPB5 oligomers was determined by separation using a WTC-050S5 SEC column (Wyatt 
Technology Corporation) with an Akta micro (GE Healthcare) and analysis with a DAWN HELEOS II MALS 
detector equipped with a WyattQELS DLS, and Optilab rEX differential refractive index detector using 
ASTRA VI software (Wyatt Technology Corporation). The Mw was determined from the Raleigh ratio 
calculated by measuring the static light scattering and corresponding protein concentration of a selected 
peak. Bovine serum albumin served as a calibration standard. Prior to SEC-MALS HSPB5 samples were 
pre-incubated at 37°C for 30 min at 40 μM monomer concentration in 50 mM sodium phosphate, pH 
7.5, 100 mM NaCl, and 1 mM DTT. To examine HSPB5 behavior at pH 6.5, 40 μM of protein was allowed 
to equilibrate in phosphate buffer (50 mM sodium phosphate, pH 6.5, 100 mM NaCl, and 1 mM DTT) at 
37°C for at least 60 min. Substrate binding assays were performed under similar conditions established 
from αLac holdase assays: HSPB5 (40 μM) was pre-incubated with αLac (240 μM) at 37°C in pH 7.5 
buffer for 10 min. DTT was subsequently added to a final concentration of 50 mM to trigger αLac 
aggregation. After 50 min, the sample was filtered and injected for SEC-MALS analysis and fractionation. 
Light scattering data and calculations were performed using the ASTRA software package (Wyatt 
Technology Corporation). 
• Negative-stain EM analysis 
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HSPB5 and HSPB5-αLac samples were diluted to approximately 100–200 nM, applied to a thin carbon-
coated copper grid and negatively stained using uranyl formate, pH ∼6.0, essentially as described [36]. 
Micrograph images were collected on a Tecnai T12 transmission electron microscope (FEI) equipped 
with a LaB6 filament operated at 120 kV. Images were recorded at 50,000X magnification with 2.2 
Å/pixel spacing and a 1.0–1.5 μM defocus on a 4k × 4k CCD camera (Gatan). Micrograph images were 
phase-corrected following CTF estimation and HSPB5 particle projections were selected and excised 
from micrographs using EMAN2 [37]. 2D reference-free alignment and classification was performed 
using SPIDER [38] to generate projection averages. For size estimation, rotational averages were 
generated from class averages using SPIDER. The contrast was normalized for all images and the 
diameter was measured across the rotational average. The averages were grouped according to size, 
and the total number of single particles for each group was used to obtain the size distribution. 
Independent data collection and analysis were performed in triplicate to obtain error bars. 
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Chapter 4 
Identification of the chaperone binding site in a 2-Cys peroxiredoxin3 
• 4.1 Abstract 
Two-Cys-peroxiredoxins (2-Cys-Prxs) are ubiquitous and highly abundant proteins endowed with two 
functions, that of peroxidase and of chaperone. While the peroxidase activity has been extensively 
studied and characterized, the mechanisms underlying the chaperone function of 2-Cys-Prxs are not so 
well defined. In this study we used the mitochondrial Prx (mTXNPx) from Leishmania, whose chaperone 
function is crucial for parasite infectivity, to dissect the regions involved in client binding. In 
collaboration with the Jakob lab, our approach involved the genetic incorporation of a photo-
crosslinkable amino acid at various positions of the mTXNPx sequence, followed by in vivo crosslinking 
with client proteins. In this chapter I present the work by the Jakob lab the biochemistry detailing 
residues that make up the chaperone binding interface as well as describe preliminary data on a high 
resolution cryo-EM structure of the client bound mTXNPx, where the ordering of the N-terminus is 
found specifically with client binding. Our preliminary results indicate that temperature-dependent 
structural rearrangements of the reduced mTXNPx decamer are required for exposure of the client 
binding site. 
• 4.2 Introduction 
Peroxiredoxins (Prxs) are ubiquitous, highly abundant proteins found in every biological kingdom [1]. 
Best known for their ability to detoxify a variety of different peroxides, peroxidases act as general 
antioxidant devices, sophisticated regulators of peroxide-dependent cell signaling pathways and thiol 
oxidases [2]. The catalytic activity of Prx is mediated by an active site cysteine, which reacts with 
peroxides and undergoes reversible thiol oxidation [3]. Importantly, during peroxide catalysis, 2-Cys-Prxs 
(from here on abbreviated as Prx) undergo major structural rearrangements and transition between 
obligate homodimers and higher oligomeric species [4]. Generally, five reduced Prx dimers associate 
into decamers with ring-like structure [5]. Oxidation and disulfide bond formation results in the 
dissociation of the decamer into the individual oxidized dimers, while overoxidation of the active site 
cysteine can lead to the formation of even higher oligomeric structures [6]. These higher oligomeric 
                                                          
3 My contributions to this chapter include the preparation of luciferase bound mTXNPx for negative stain and cryo-
EM structure determination. This chapter is currently a work in progress with the goal of publishing a manuscript 
on both the in vivo crosslinking data and cryo-EM structure. Contributions by Ursula Jakob and members of her lab 
(University of Michigan) are indicated in figure legends.  
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structures were found to adopt a peroxidase-independent second function as molecular chaperones, 
which protect cells against stress-induced protein unfolding [7].  
In agreement with previous studies, we reported that the mitochondrial 2-Cys Prx of Leishmania 
(mTXNPx) also adopts two functions, as peroxidase and as molecular chaperone [8, 9]. Reduced, 
decameric mTXNPx functions as an effective chaperone holdase that protects a wide range of proteins 
from heat-induced aggregation in vitro. Upon return to non-stress conditions, mTXNPx interacts with 
other chaperones and transfers its client proteins for proper refolding [8]. Activation of the chaperone 
function of mTXNPx appears to be mediated by heat-induced structural rearrangements of the reduced 
protein that lead to the exposure of hydrophobic surfaces, which are likely the binding sites for 
unfolding client proteins. Importantly, expression of this chaperone-inactive mutant variant in mtxnpx-/- 
deletion strains of leishmania revealed that the lack of Prx’s chaperone function causes extensive 
protein aggregation in parasites at temperatures that reflect the body temperature of mammals, and 
decreases the survival of the parasites in mammalian hosts [8, 10] 
The present study aimed at gaining further insight into the mechanism of chaperone activity of mTXNPx 
by defining which residues of the protein are involved in client binding. To accomplish this, we 
constructed several mTXNPx variants harboring the unnatural photo-crosslinkable amino acid p-benzoyl-
L-phenylalanine (Bpa) at different positions in the mTXNPx sequence. We then analyzed the mTXNPx 
muteins which crosslinked with client proteins under protein unfolding heat-shock conditions. Following 
this approach we could identify five residues with probability of being directly implicated in interaction 
with client proteins. Furthermore, we were able to obtain a cryo-EM structure of mTXNPx in complex 
with client, revealing the ordering of N-terminal residues that have not been previously resolved by x-
ray crystallography or cryo-EM. The results presented here pinpoint the importance of the heat-induced 
structural rearrangements necessary for the exposure of the client binding site of mTXNPx as many of 
the residues found to crosslink with client proteins under heat-stress conditions are found buried in the 
structure of the resting protein and the quaternary structure of mTXNPx also appears to change under 
such stress conditions. 
• 4.3 Results 
• 4.3.1 Genetic Incorporation of p-benzoyl-L-phenylalanine (Bpa) into mTXNPx 
To identify regions in mTXNPx potentially involved in client binding, we employed an in vivo crosslinking 
technique originally developed by Schultz et al. [11]. We engineered 19 different mTXNPx variants, each 
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of which harboring one unnatural, UV-crosslinkable amino acid p-benzoyl-L-phenylalanine (Bpa) at 
defined positions in the protein. Upon exposure to UV light, Bpa acts as zero-length cross-linker. 
Irreversible crosslinks with client proteins are therefore only expected when the clients come in very 
close proximity to one of the engineered Bpa residue in mTXNPx. By applying site-specific mutagenesis 
to mTXNPx, we individually substituted each phenylalanine or tyrosine codon with a TAG amber stop 
codon (Figure 4.1). We reasoned that mTXNPx would likely tolerate these substitutions since Bpa is a 
structural analogue of Phe/Tyr.  
 
Figure 4.1 Primary structure of mTXNPx showing the residues tested in the crosslinking studies. Highlighted in red are all 
phenylalanine and tyrosine residues that were genetically substituted by an amber stop codon which allows for the 
incorporation of Bpa during protein synthesis. Underlined is the mitochondrial import sequence of mTXNPx which is not 
present in the constructs utilized in this study. This figure was generated by Jakob U (University of Michigan).  
Importantly, the 19 substitutions were fairly randomly distributed throughout the amino acid sequence 
of mTXNPx, potentially increasing our chances to detect residues involved in client binding. We then co-
transformed the mutant plasmids together with the aminoacyl-tRNA synthetase/suppressor tRNA pair 
into E. coli and tested them for in vivo Bpa incorporation by growing them in the presence or absence of 
exogenously added Bpa at 30°C for 3 hours. Subsequently, we determined the expression level of full-
length mTXNPx, indicative of successful Bpa incorporation, by western blot analysis using anti-mTXNPx 
antibodies. We found that the majority of our E. coli strains expressed some amount of the full-length 
mTXNPx in the presence of Bpa but not in its absence. The expression levels of Y63Bpa, F192Bpa and 
F194Bpa were reproducibly low, and required prolonged exposure times for detection (Figure 4.2). The 
F221Bpa and F222Bpa variants, which contain Bpa substitutions only 5 or 4 aa from the C-terminus of 
mTXNPx, respectively were also detectable in the absence of Bpa making it impossible to determine 
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whether they contained Bpa. We therefore decided to primarily focus our studies on the remaining 17 
mTXNPx mutant variants. 
 
 
Figure 4.2 Expression levels of mTXNPx in the presence and absence of BPA by western blot. These experiments were 
performed by Teixeira F (University of Michigan). This figure was generated by Jakob U (University of Michigan). 
• 4.3.2 Determination of mTXNPx residues putatively involved in vivo in client binding 
Previous in vitro studies revealed that reduced, decameric mTXNPx becomes rapidly activated upon 
exposure to heat shock temperatures, and forms apparently stable complexes with thermally unfolding 
client proteins [8]. We therefore reasoned that exposure of our mTXNPx-Bpa expressing E. coli strains to 
45°C should fulfill the two requirements; activate reduced mTXNPx and, at the same time, provide a 
pool of thermally unfolding client proteins that could interact with active mTXNPx.  
To test for in vivo crosslinking, we then cultivated all of our mTXNPx-Bpa expressing strains as before in 
Bpa, and either left them at 30°C or shifted them to 45°C for 30 min. After the incubation, we moved the 
samples onto ice knowing that in vitro complexes between mTXNPx and client proteins are stable at low 
temperature for extended periods of time [8]. To crosslink any potential clients with mTXNPx, we then 
subjected the samples to a 10 min exposure to UV light, applied the samples on SDS Page and detected 
mTXNPx by western blot, using at least two exposure times (short and long) for optimal detection 
(Figure 4.3). The most prominent band that we detected upon crosslinking in all but one mutant Bpa 
variant (i.e., Y63Bpa) migrated with twice the molecular weight of mTXNPx, suggesting that it 
corresponds to a Bpa-linked mTXNPx dimer. In addition, however, a subset of our mTXNPx-Bpa mutant 
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also showed UV-specific higher molecular weight bands, which became particularly obvious upon 
exposure to 45°C. These higher migrating bands are likely due to crosslinked complexes between 
mTXNPx and client proteins (mTXNPx-X) and not due to inter-mTXNPx crosslinks. Given that mTXNPx 
monomers are arranged in head-to-tail orientation in the dimer, only crosslinks between two monomers 
within one dimer or between the monomers of neighboring dimers would be expected.  
 
Figure 4.3 Bpa crosslinking of mTXNPx in vivo. Escherichia coli expressing mTXNPx variants, in which specific amino acids were 
substituted by Bpa, were treated either at 30°C or 45°C for 30 min. Upon temperature treatment, cells were transferred to ice 
and either exposed (+) or not (-) to UV light for 10 min to induce crosslinking. Subsequently, bacteria were lysed and cell 
extracts analyzed by western blot with an anti-mTXNPx antibody. The two most prominent bands correspond to monomeric 
(mTXNPx) and dimeric mTXNPx-mTXNPx). Additional bands, seen as a smear, correspond to mTXNPx crosslinked to E. coli 
proteins (mTXNPx-X). Western blot signals detected at different intervals (short and long exposures) are shown. Wild-type 
mTXNPx, in which no amino acid was substituted, was used as negative control, and so were Bpa variants not irradiated with 
UV (-). Here shown is a representative experiment 
As can be seen in one representative experiment, by comparing the crosslinking pattern and efficiency 
of the different mTXNPx mutant variants at 30°C and 45°C, we identified at least three different 
categories of crosslinks: Group I) Bpa variants, which reveal reproducibly higher migrating bands at 45°C 
as compared to 30°C (e.g., Y67Bpa); Group II) Bpa mutants, which crosslink similarly to other proteins at 
both 45°C and 30°C (e.g., Y30Bpa) and Group III) Bpa variants, which do not show any detectable higher 
migrating smear, suggesting that they do not crosslink with clients (e.g., Y63Bpa) (Figure 4.3, 4.4). While 
the results with group I) Bpa variants were highly reproducible, some variability in crosslinking efficiency 
and pattern were observed for group 2 and group 3 Bpa-variants. We therefore decided to score the 
respective crosslinks in each of the conducted experiments according to their classification, giving a 
score of ”1” to group 1 crosslinks, “0.5” to group 2 crosslinks and “0” to group 3 crosslinks. We classified 
those amino acids (F67, F71, Y73, F77, F79, F88) with an average score of “1” to be most relevant for 
temperature-dependent client binding (Figure 4.4, red). We considered all those amino acids (F45, F95, 
F160, F192, Y194) with an average score of 0.5 < 1 as potential interactors since they revealed 
temperature-induced increase in crosslinking in at least one or more of our experiments (Figure 4.4, 
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magenta). Amino acids with a score of < 0.5 were considered as non-binders (Y30, Y33, Y63, Y111, Y145) 
(Figure 4.4, blue).   
 
Figure 4.4 Classification of residues involved with mTXNPx client binding. Several independent experiments were conducted 
as described in A. Here shown are the categorization of each amino acid into binder (red), likely binder (pink), and non-binder 
(blue), as detailed in the main text, for the several experiments conducted. The normalized final categorization of each amino 
acid into the 3 classes described above was achieved by attributing to each experiment the following arbitrary numbers: (1) to 
binders, (0.5) to likely binders and (0) to non-binders and dividing the sum by the number of experiments performed. Based on 
this, each amino acid that had a score i) > 0.5 was categorized as binder, ii) ≤0.5 and >0.25 were categorized into likely binders 
and iii) ≤ 0.25 categorized into non-binders.  
Crosslinking of group 1 Bpa variants, such as Y73-Bpa or F77-Bpa upon exposure to protein unfolding 
conditions in vivo revealed extensive crosslinking, whereas no higher migrating smear was observed 
with group 3 Bpa variants, such as the Y111-Bpa mutant. To ascertain that the higher migrating bands 
observed upon shift to 45°C and crosslinking in group 1 mutants are indeed crosslinks with in vivo client 
proteins and that the lack of crosslinks in group 3 mutants is not due to loss of chaperone function, we 
purified three representative mTXNPx-Bpa variants (i.e., Y73-Bpa, Y77-Bpa and Y111-Bpa). We then 
measured their in vitro chaperone function (Figure 4.5A) and their in vitro crosslinking behavior (Figure 
4.5B). All three purified proteins showed wild-type like chaperone-activity when reduced, excluding that 
the inability of Y111-Bpa to crosslink with clients is due to lack of chaperone function. Moreover, 
crosslinking of the three proteins only yielded in the expected monomeric and dimeric mTXNPx species. 
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These results suggested that the higher migrating species that we observed upon in vivo exposure of 
Y73-Bpa, Y77-Bpa and most likely all other group 1 and 2 mutant variants to 45°C and subsequent UV-
crosslinking, are indeed mTXNPx-client complexes. 
 
Figure 4.5 Chaperone activity and Oligomeric status of mTXNPxred and mTXNPxox as assessed by gluteraldeyde mediated 
cross-linking. A) Chaperone activity was assessed for each Bpa variant, where the presence of luciferase in the soluble fraction 
indicating protection from heat induced aggregation is identified by SDS-PAGE, B) Increasing concentration of mTXNPxred or 
mTXNPxox were incubated in the presence (+) or absence (-) of 40 mM glutaraldehyde at 30 °C for 10 min. The oligomeric status 
of mTXNPx was assessed by running the samples on reducing SDS-PAGE followed by silver staining.  
• 4.3.3 Localization of client- mTXNPx interaction sites 
To visualize which region(s) of mTXNPx might be involved in client binding, we mapped the three groups 
of amino acids onto the solved crystal structure of the reduced mTXNPx decamer from Leishmania 
brasiliensis (pdb: 4KB3)(Figure 4.6). For simplification, we focused only on one dimeric unit of the 
decamer and applied the same color scheme established in our previous figure. We found that some of 
the amino acids that when substituted to Bpa reproducibly crosslinked with client proteins upon 
exposure to heat shock conditions (i.e., group 1 amino acids) are in very close proximity to the active site 
cysteine Cys80 (Figure 4.6). These results made us wonder whether some of the crosslinking products 
that we observed might involve proteins that form transient disulfide bonds with mTXNPx’s active site 
cysteines before and/or during the process of UV-crosslinking. Formation of an intermolecular disulfide 
bond would bring the proteins into close contact with Bpa-substituted amino acids close to the active 
site residue, and hence could cause crosslinking. Indeed, analysis of protein samples prepared from cells 
expressing the non-crosslinkable wild-type mTXNPx on non-reducing SDS-PAGE revealed a large number 
of proteins that form reversible disulfide bonds with the protein. However, the pattern and amount of 
co-migrating proteins appeared to be completely independent of temperature or UV exposure. 
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Figure 4.6 Mapping of Bpa-substituted residues in the quaternary structure of mTXNPx. Representation of the quaternary structure of ring-like decameric 
mTXNPxred. For simplicity, in this structure one of the composing dimers of the decamer is highlighted while the others are shown in grey. Different views 
of the selected mTXNPx dimer are presented. Amino acids are colored differentially into binders (red), likely binders (pink) and non-binders (blue), as 
detailed before, according to their ability to crosslink E. coli proteins. The structure of the mTXNPx homologue from L. brasiliensis was used to highlight the 
residues involved in binding (4KB3) using pymol software. This figure was generated by Jakob U (University of Michigan). 
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While these results might explain the behavior of Bpa-mutants that revealed similar crosslinking pattern 
at both 30°C and 45°C (Figure 4.7A), they did not explain our results with Group 1 variants, which were 
found to crosslink with a specific subset of proteins only upon in vivo exposure to 45°C (Figure 4.6, 4.7B). 
These findings corroborate our conclusion that the interactions that we observe with Group 1 and, most 
likely also Group 2 residues are not the result of thiol-disulfide exchange reactions but specifically due to 
interactions between chaperone-activated mTXNPx and thermally unfolding in vivo client proteins.  
 
Figure 4.7 Bpa crosslinking of Group 1 variants are specific for client interactions, A) extracts using cells expressing wildtype 
mTXNPx was run on non-reducing SDS-PAGE showing that disulfide bond formation was not dependent on temperature or UV 
exposure. B) in vivo crosslinking with the Y79-Bpa mTXNPx variant after UV exposure reveals that heat shock under reducing 
conditions causes specific subsets of unfolding client proteins. These experiments were performed by Teixeira F and the figure 
was generated by Jakob U (University of Michigan). 
Most group 2 crosslinking residues (i.e., F45; F72; F159) were found facing the interior of the decameric 
structure. This result made sense given that our previous EM studies on mTXNPx:luciferase complexes 
revealed the presence of electron dense material in the center of mTXNPx’s decameric ring structure [8]. 
However, we were surprised to notice that in the crystal structure of leishmania mTXNPx, which was 
modeled according to existing structures [12], was highly charged and the crosslinking residues were 
only partially accessible (Figure 4.6). Closer inspection of the structure revealed that the crosslinking 
residues were masked by several N-terminal amino acids as well as a short flexible alpha-helix (H4), 
which appears to interact with and is stabilized by the N-terminus (Figure 4.6, bottom panels, circled). 
Both regions contribute to the highly charged nature of this surface. Moreover, we determined that H4 
also contains one of our few clearly non-binding Group 3 residues (F145), which put this residue in 
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immediate vicinity to three crosslinking amino acids. Based on these and previous results, which showed 
that i) tmTXNPx undergoes significant conformational rearrangements upon activation that increase 
surface hydrophobicity; ii) upon client binding, the N-termini of mTXNPx form spoke-like structures that 
extend into the interior of the ring structure; and iii) manipulation of the N-termini abolishes chaperone 
function, we propose that activation and/or client binding likely changes the position of mTXNPx’s N-
terminus. This rearrangement would affect the stability of the nearby alpha-helix, which, when 
removed, causes the exposure of an almost contiguous, highly hydrophobic surface, which could serve 
as the binding site for unfolding proteins in mTXNPx (Figure 4.6). 
• 4.3.4 Cryo-EM structure of reduced mTXNPx and mTXNPx:client complexes reveal ordering of 
the N-terminus in response to client binding 
We further analyzed the mTXNPx-client complex using cryo-EM to analyze the inner ring binding 
interface and the role of the N-termini. Two samples were prepared with the mTXNPxred decamer 
treated with heat shock in the presence or absence of luciferase as described previously [8] for the 
collection of cryo-EM data. 57,683 and 234,808 particles were selected for the mTXNPxred alone and 
mTXNPxred with luciferase respectively after initial 2D classification using the RELION software package 
[13]. The remaining selection of particles classified into clear ring structures similar to those observed in 
negative stain with high resolution features within the decamer ring (Figure 4.8A). Through much 
optimization of sample purification and preparation, we were able to obtain a cryo-EM dataset of the 
mTXNPxred:luciferase complex with enough substrate occupancy to show that a majority of the top-
down views had density in the center of the ring. Both mTXNPx datasets were then refined to yield 3D 
models estimated at resolutions of 4 Å (Figure 4.8B). Clear densities for the carbon backbone of mTXNPx 
were resolved and interestingly fits well with the crystal structure of the Leishmania braziliensis mTXNPx 
[12].  
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Figure 4.8. Cryo-EM structure of the mTXNPx:luciferase complex compared to the mTXNPx alone. A) reference-free class 
averages generated by RELION software, comparing heat treated mTXNPx by itself (left) or upon protecting clients from 
aggregation (right) showing clear protrusions of density into the lumen in the presence of client. Scale bar: 10 nm. B) 3D 
reconstruction of the mTXNPx and mTXNPx:luciferase complex resolved to 4 Å resolution, a crystal structure of the Leishmania 
braziliensis mTXNPx dimer was used to generate a homology model for the Leishmania infantum variant and docked into the 
EM density (bottom left). Coot and Rosetta software was used to refine the homology model into the mTXNPx:luciferase 
structure and build the N-terminal residues (bottom right). 
One of the most striking features of the 3D map of mTXNPxred:luciferase was the resolved density within 
the center of the ring. At higher contour levels, the density in this region becomes weak, most likely due 
to the disordered nature of the unfolded substrate. Nonetheless, density is present in the lumen of the 
mTXNPx:luciferase map compared to mTXNPx alone, and we attribute the ordering of these central 
densities due to client binding since heat shock of the mTXNPx alone did not effectively resolve these 
residues. Because the crystal structure was solved for the Leishmania braziliensis mTXNPx decamer [12], 
which has 89% sequence identity with Leishmania infantum mTXNPx, we generated a homology model 
based on the previously solved structure for pseudo-atomic modelling into the EM map. Refinement by 
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Rosetta and Coot shifted the carbon backbone compared with the positions of the Leish crystal structure 
(Figure 4.9A, top panel). Density present in the center of the mTXNPx:luciferase map allowed us to build 
additional residues of the N-terminus, previously unresolved in the Leishmania braziliensis mTXNPx 
crystal structure (PDB:4KB3) which begins with alanine 36. We were able to extend the carbon backbone 
about 6 amino acids (Figure 4.9A), fitting side chain densities for R34, Y33 and Y30, (data not shown). 
We identify these two tyrosines in the N-terminus as group 3 non-binding residues, making non-specific 
contacts with non-clients at both high and low temperatures (Figure 4.3). This may be due to how these 
N-terminal residues are positioned in the central pore where initial contacts with substrates can be 
made. Because the ordering of these residues is seen only after exposure with client (Figure 4.8), we 
propose a model where these initial contacts may be important for chaperone activity. Refinement of 
side chains into the EM density is currently ongoing. 
The Prx1 family of 2-cys peroxiredoxins are conserved in the regions of the protein commonly resolved 
by x-ray crystallography and cryo-EM (Figure 4.9B, 4.9C). Crystal structures from diverse organisms and 
Prx families, show that the lumen of these Prx structures lack any protruding residues compared to our 
structure [14-18]. Because of the intrinsic flexibility of the N-terminal regions, it has been difficult to 
characterize the binding events in the lumen of decameric mTXNPx. A protein BLAST and alignment of 
various mTXNPx from different species give further aspects for additional study [19].  A comparison 
between Leishmania mTXNPx with other mitochondrial peroxiredoxins show a divergence in the N-
terminal region which contains the mitochondrial import sequence [20] (Figure 4.9C). Organisms of a 
different class of the euglenozoa phylum to which Leishmania belong already show divergence in 
Euglena gracilis, a unicellular algae that does not deal with the stressors of a digenic life cycle. Examining 
the next closest homologues, PrxII family 2-cys peroxiredoxins, we observe the loss of an N-terminal 
region after the putative mitochondrial import sequence. In higher eukaryotic phylum including the 
bovine, mouse and human PrxIII (Figure 4.9C) an extended N-terminus is present for mitochondrial 
import. Interestingly, the mTXNPx among different Euglenozoa phylum parasites show sequence 
conservation at the N-terminus (Figure 4.9D). The N-terminus may be important for client binding and 
holdase activity, as it was observed that the extension of the N-termini with a large His-thrombin tag 
interferes with its chaperone activity [8]. Thus we propose a model where the N-terminal region is 
responsible for a mechanism unique to trypanosome parasites of mTXNPx chaperone activity in 
response to heat stress. Further studies into the N-terminus of these parasitic mTXNPx chaperones are 
necessary to further understand the mechanism of activation, as well as Prx classes of other species to 
test whether the loss of N-termini coincides with loss of chaperone activity. 
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Figure 4.9 mTXNPx activation leads to ordering of its N-terminus upon client binding. A) Zoomed in view of dimer in the 
mTXNPx:luciferase map with the Leishmania infantum homology model before (left panel) and after building in the N-terminus 
and refinement (right). The A36 residue where the 4KB3 structure starts is positioned perfectly at the protruding densities into 
the lumen, allowing us to use coot to append 6 a.a. into the densities of the N-terminus subsequent refinement in Rosetta as 
described in the methods. B) Comparison of our mTXNPx:luciferase structure with various Prx class enzymes solved by cryo-EM 
and x-ray crystallography demonstrating the lack of center density; top left: our current model, top center: human Prx3 (EMDB: 
3233), top right: human Prx3 filament (EMDB: 6309), bottom left: Crithidia fasciculata mTNPx (PDB: 1E2Y), bottom middle 
Schistosoma masoni Prx1 (PDB: 3ZL5), bottom right bovine Prx3 (PDB: 1ZYE). C) Protein BLAST search of mitochondrial 
peroxiredoxins  reveal sequence conservation in the thioredoxin domains and the majority of the protein. D) Protein BLAST of 
mTXNPx from different genus of trypanosomatidae show that Leishmania infantum relatives possess similar N-termini [19]  
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• 4.4 Discussion 
Overall, the results shown here represent the first step towards the characterization of the client-
binding site in mTXNPx. This study implicated residues belonging to Group I (Y48Bpa, F54Bpa, F63Bpa, 
F70Bpa, F135Bpa) and to Group II (F20Bpa, Y42Bpa, F46Bpa, F47Bpa, F52Bpa) in mTXNPx client binding. 
Importantly, since the spacing between the substituted residues (Figure 4.1) is, in some regions, larger 
than 30 residues, it will be worth conducting additional experiments focusing on residues around the 
potential client binding site(s). Although preliminary, these results support the idea that residues facing 
the lumen of mTXNPx ring-like structure might be involved in client binding.  
Given how well the Leishmania braziliensis mTXNPx decamer crystal structure fits into our Leishmania 
infantum mTXNPxred:luciferase map, one possibility is that the client bound structure reflects a state 
distinct from the 42°C heat stressed decamer (Figure 4.8). The exact nature of the N-terminus 
interactions with substrate requires further investigation; refinement of residues into the electron 
density of the cryo-EM map is still in the preliminary stages and further validation is required in order to 
discern how much of the mTXNPx protein can be resolved from the substrate in the center of the ring 
(Figure 4.9). The high resolution achieved in this map makes exploring previously uncharacterized 
regions of both the N- and C- terminus possible. It is at least clear that changes in the N-terminus has 
occurred due to heat stress. Density is present in the center of these rings when mTXNPx is exposed to 
conditions where it must protect client, this is especially apparent in the 2D averages (Figure 4.8). 
Though we were unable to trap the client bound mTXNPx structure in a heat activated conformation 
exposing the Group I and Group II residues, the N-terminus may still be important for initiating holdase 
activity, and that further structural arrangements that occur upon heat shock must be made in order to 
protect clients.  
Based on the in vivo crosslinking data, the presence of additional client binding sites cannot be 
disregarded. More importantly, this study highlights the significance of the structural rearrangements 
that mTXNPx undergoes at high temperatures which likely contribute to the exposure of the client 
binding site. Interestingly, these rearrangements may even involve the reorganization of the decameric 
structure of mTXNPx, a model that needs to be further explored. Uncovering the exact nature of such 
structural rearrangements as well as solving the structure of a chaperone-active form of mTXNPx will be 
crucial to define the client binding site and therefore constitute the next step of this project.  
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In a long term perspective, we expect that, by shedding light into the mechanistic aspects of mTXNPx 
chaperone activity, these findings aid in the development of inhibitors of mTXNPx-client interactions. 
Inhibition of the chaperone function of mTXNPx is expected to negatively impact on Leishmania survival 
in their mammalian hosts, and might thus constitute a novel strategy to treat the devastating diseases 
elicited by these parasites. It will also be interesting to investigate whether this mechanism of sensing 
heat shock is dependent on the elusive N-terminus and is missing in higher eukaryotes.  
• 4.5 Methods 
• Plasmid construction 
To express mTXNPx without the mitochondrial import sequence or any additional tags, pET28c6His-THR-
TmTXNPx was PCR-amplified using Pfu polymerase and primers  
5’-ccgcgcacatatgAATCTGGACTATCAGATGTAC-3’ and  
5’-gcacatatgTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCT-3’. The PCR product was digested with NdeI 
(restriction site underlined in the primer) and subsequently re-ligated to originate a plasmid encoding 
mTXNPx devoid of any tag – pET28cTmTXNPx. The plasmid was further sequenced to ensure that no 
mutations on mTXNPx ORF had occurred and that the N-terminal 6His-Thr tag had been successfully 
removed. 
• Production of the mTXNPx - p-benzoyl-L-phenylalanine (bpa) variants 
For the construction of mTXNPx-Bpa variants, we used a site-directed mutagenesis approach and 
substituted each phenylalanine or tyrosine codon in the sequence with an amber stop codon (TAG). 
Following DpnI digest of the parental DNA for 1h at 37 °C and desalting, the PCR product was 
transformed into E. coli (XL1-Blue strain). Mutant colonies were sequenced and confirmed to carry the 
desired mutation. 
• In vivo Bpa-mediated photo-crosslinking 
Bpa-mediated crosslinking was performed as previously described [11].  Briefly, E. coli cells (BL21 strain) 
were co-transformed with a plasmid encoding the respective mTXNPx-Bpa variant (pET28cTmTXNPx-
Bpa) and a plasmid encoding the orthogonal aminoacyl-tRNA synthetase/tRNA pair (pEVOL) necessary 
for Bpa incorporation. Cells were then plated in the presence of appropriate selective drugs and 
incubated overnight at 30°C. Colonies were scraped off the plates and resuspended in LB medium 
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(OD600=0.4) containing the adequate combination of antibiotics with or without 1 mM Bpa (Bachem 
AG, Bubendorf, Switzerland). Cells were then grown at 37 °C for 1h.  Afterwards, cells were cooled down 
to 30 °C and expression of mTXNPx-Bpa variants and the tRNA synthetase/tRNA pair was induced with 
10 µM IPTG and 0.1% L-arabinose, respectively. Cells were grown for 3 h at 30ºC, after which they were 
harvested and resuspended in … buffer using a volume of 100 µl per OD600 of 1.0. Each sample was 
then subjected to a 30 min incubation at either 30ºC (control) or 45ºC (heat shock), transferred onto ice 
and exposed to a 10 min UV irradiation (366 nm) using a lamp distance of 2.5 cm. Cells were 
subsequently lysed using three cycles of sonication and two cycles of freeze-thaw. Total cell extracts 
were then supplemented with 5x SDS sample loading buffer before analysis by SDS-PAGE. 
Immunoblotting using polyclonal anti-mTXNPx antibodies was used to visualize mTXNPx and its 
crosslinking products. 
• Differential in vivo thiol trapping with NEM 
Cells expressing either wild-type mTXNPx or the Bpa-mutants were cultivated in LB as described above. 
Afterwards, the in vivo redox status of mTXNPx was assessed as previously described [8]. Briefly, cells 
were acidified with trichloroacetic acid (10%) for 30 min on ice. Subsequently, samples were centrifuged 
(20,000xg 20 min, 4°C) and the precipitated proteins were resuspended in DAB buffer (6 M Urea, 200 
mM Tris-HCl pH 8.5, 10 mM EDTA, and 0.5% w/v SDS) +/- 100 mM N-ethylmaleimide (NEM). Upon 
incubation for 30 min at 25°C, the samples were again precipitated with TCA and separated on SDS-
PAGE under reducing or non-reducing conditions and visualized by western blot analysis using a 
polyclonal anti-mTXNPx antibody 
• Preparation of mTXNPxred - client complexes and electron microscopy (EM) 
Reduction of mTXNPx was done as previously described [8]. To allow complex formation between 
chaperone active mTXNPxred (10 µM) and thermally unfolding luciferase (1 µM), the two proteins were 
incubated for 2 min at room temperature before they were slowly heated from 30°C to 42°C for 10 min 
[REF]. Samples for negative staining electron microscopy were collected either before or immediately 
after treatment at 42°C, and centrifuged at 16,100 xg for 30 min at 4°C to remove large aggregates. The 
supernatant was removed and negatively stained with 0.75% (w/v) uranyl formate (pH 5.5-6.0) on 400-
mesh as previously described [21]. 
Samples for cryo-EM were prepared on C-FLAT holey carbon grids (EMS) in 100mM HEPES buffer pH 7.0 
with a Vitrobot (FEI Co.). Data was collected on a Titan Krios microscope (FEI co.) operated at 300 kV on 
122 
 
a K2 direct electron detector with a 1.0 Å pixel size. 8 second exposures with 0.2s/frame rate and a dose 
of 50 e/Å2 were used in electron counting mode. 5419 Micrographs were collected for the 
mTXNPx:luciferase dataset and 1406 micrographs were collected for mTXNPxred alone, utilizing Leginon 
automated data collection software [22]. Micrograph movie files were output and Motioncor2 program 
was used to perform gain normalization and patch-based motion correction [23], after which Ctffind3 
was used to estimate CTF parameters for the corrected micrographs [24]. The DoG picker program was 
used for automated particle picking generating an initial 394,201 particles for the mTXNPx alone dataset 
and 653,294 particles for the mTXNPx:luciferase complex [25]. RELION was used to do multiple rounds 
of reference-free 2D averaging to remove images that did not correspond to mTXNPx particles to result 
in a final particle count of 57,683 and 234,808 for mTXNPx alone and in complex respectively [13]. 
Refinement of these particles using the 4KB3 crystal structure converted to mrc format and low pass 
filtered to 60 Å yielded final structures at 4 Å resolution after B factor sharpening. The Leishmania 
infantum homology model was obtained using SWISS-MODEL [26] and further refinement and modelling 
makes use of features in coot [27], used to build the N-terminal residues into the structure, as well as 
EM tools developed in Rosetta by the DiMaio lab for refinement of the carbon backbone [28].  
• 4.6 Notes 
I was involved in the work leading up to the data of this chapter, initially characterizing the structure of 
the mTXNPx:luciferase complex, which has been published in Teixeira, F. Castro, H. Cruz, T. Tse, E. 
Koldewey, P. Southworth, D. R. Tomas, A. M. Jakob, U., Proc Natl Acad Sci U S A, 2015. 112(7): p. E616-
24. Refinement of the cryo-EM data is ongoing and the data presented in this chapter is currently being 
formatted into a manuscript. 
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Chapter 5 
Conclusions and Future directions 
• 5.1 Conclusions  
The biochemical decision for client degradation by molecular chaperones is a central question in 
understanding protein quality control. Because of the implications linking together Hsp70, CHIP and tau, 
this process is critical to understanding tau homeostasis and neurodegeneration. The repertoire of 
Hsp70 is vast, in terms of its clientele as well as the co-chaperones diversifying its function, thus studies 
aiming to characterize structure of these various protein complexes can help us understand how the 
various Hsp70 conformational states are affected by CHIP and client ubiquitination. Given how 
structurally different the ADP and ATP states of Hsp70 are and the sparse structural information 
available on Hsp70:co-chaperone binding, I performed a systematic study on CHIP binding and 
nucleotide state in context of the full-length proteins, establishing that the ADP conformation of Hsp70 
is essential for association for further structural characterization. Studies have shown that increasing 
affinity of Hsp70 for tau has a direct effect on its turnover, however direct evidence of how Hsp70 
directs ubiquitination of client is lacking. Thus, in chapter 1, I characterized CHIP catalyzed ubiquitination 
events on tau. With assistance from the lab of Rachel Klevit in designing a ubiquitination assay and 
purification of the E1 and E2 enzymes, I was able to identify the Hsp70 dependent ubiquitination of tau 
and observed that the ADP conformation of Hsp70 was also important for the efficiency of poly-
ubiquitination of tau. We were able to observe evidence of multiple Hsp70 binding events to tau, and 
how it might be significant in relating the structure of CHIP to the function of chaperone triage of clients. 
We supported our biochemical observations with help from our collaborators in the lab of Phil Andrews, 
to obtain MS linkage maps that identify conserved contacts that occur within the Hsp70:CHIP and 
Hsp70:CHIP tau complexes of our study. Additional support will be provided in the use of cryo-EM as 
well to corroborate the contacts made in the Hsp70:CHIP complex with the ternary Hsp70:CHIP:tau 
complex.  
Pro-folding decisions balance the other end of proteostasis, and through collaborations I have been 
fortunate to explore various mechanisms promoting the chaperone activities of Hsp70, sHSPs and Prx. 
The distribution of oligomeric species makes structural studies on the mechanism of sHsp holdase 
activity difficult. One global question on sHsp structure lies in how oligomeric holdase chaperones bind 
to client proteins. Thus, in collaboration with the labs of Jason Gestwicki and Rachel Klevit, two sHsp 
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family members were used to characterize chaperone activation. We were able to define sHsp activation 
and use EM to define global changes to sHsp oligomer distribution. We also looked at the distinct 
rearrangements that occur with client binding.  
In chapter 2, in collaboration with the lab of Jason Gestwicki, we characterized the NEF BAG3, a co-
chaperone with limited structural information, that has multiple protein binding domains linking it to 
both Hsp70 and sHsp systems. We found that the structure of Hsp27 oligomers was modulated by the 
presence of BAG3, disassembling the oligomer by competing with sHsp interactions with IXI motif 
binding. We further established a direct link between the Hsp70 and sHsp systems and correlate these 
structural changes to the ability to refold luciferase. In chapter 3, in collaboration with the lab of Rachel 
Klevit, we analyzed a specific modification to the histidine 104 residue at the interface of the HSPB5 
dimer critical for sensing changes in pH. This caused activation of HSPB5 modifying its oligomeric 
distribution to form larger species when analyzed by electron microscopy and increasing its ability to 
protect client from aggregation. When we looked at the forms of HSPB5 that engaged with client we 
saw a surprising result where the sHsp oligomers rearranged into smaller form, another mechanism of a 
sHsp family member where global rearrangements in its quaternary structure are triggered by some 
cellular factor such as a BAG3 co-chaperone or pH, and allow for proteostasis to be maintained in the 
cell. 
Another protein chaperone of interest is the peroxiredoxin class of enzymes, discovered as enzymes that 
protect against oxidative stress it has been discovered that these proteins can also act as molecular 
chaperones. Aside from the general ability to delay protein aggregation, the mechanism by which Prx 
switches its function is not understood. Given the abundance of different families of Prx and the 
homologues that exist among different species, different mechanisms for activation are expected. In 
chapter 4, in collaboration with the lab of Ursula Jakob, we further characterized the structural role of 
the mTXNPx ring lumen as a client binding site, whose chaperone activity we previously elucidated as a 
response to heat stress [1]. Given our initial work in characterizing a novel binding site within the ring of 
the Prx, we mapped residues facing the lumen of the mTXNPx ring through an in vivo crosslinking assay 
to be close proximity to clients upon heat stress. Furthermore we were able to obtain a high resolution 
cryo-EM map of the mTXNPx:luciferase complex. Specific for the heat activation and client binding we 
find an ordering of the N-terminal residues protruding into the ring structure and are working on 
refining the structure to model more definitively the structure of this region to discern what parts of this 
density correspond to the N-terminus and what could be interpreted as substrate. We propose a model 
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where the N-terminus acts to initiate contacts with potential clients which allows for subsequent 
conformational changes to occur to expose the binding sites identified by in vivo crosslinking. 
The protein systems I have studied are diverse, but revolve around a central theme of protein quality 
control. Given the flexible nature of the protein complexes or oligomeric states involved, and the vast 
dynamics that define the action of chaperone proteins, electron microscopy seems particularly 
amenable to exploration of these mechanisms of protein quality control. Each case of client:chaperone 
interaction may prove to have unique structural implications, thus we must exhaust the study of these 
interactions essential for proteostasis. In so doing we may find generalities of chaperone mechanisms 
that can help us bridge our studies to an increasing breadth of important client proteins.  
• 5.2 Future Directions 
• 5.2.1 Hsp70 and CHIP- the degradation pathways 
Although our biochemical characterization of Hsp70 and CHIP binding give insight towards the 
conditions required for client ubiquitination to occur, our model still needs more validation and 
clarification. We proposed that he stalling of Hsp70 folding activity results in or from conditions that 
push Hsp70 towards its ADP state, allowing the engagement of both TPR domains of CHIP resulting in a 
210 kDa complex. Questions remain as to how these conditions originate that would facilitate favoring 
the ADP state. We can utilize conditions from in vivo experiments where Hsp70 can facilitate tau 
turnover in order to describe tau turnover mechanisms that would explain the in vivo phenotype [2, 3]. 
Chemical modulators that inhibit or Hsp70 ATPase activity may be a key in enhancing the client ‘dwell-
time’ which may promote this ADP specific Hsp70:CHIP complex and tau ubiquitination [4]. Although we 
used the K71M and T204A Hsp70 mutants to explore the roles of Hsp70 conformation on client 
ubiquitination, exploring how ATP levels directly affect Hsp70 mediated tau ubiquitinaion would be 
closer to conditions found in vivo, whether there is a balance of ATP and ADP that needs to be made and 
if there’s an inflection point at which Hsp70 is no longer able to efficiently direct client ubiquitination. 
The question of the nature of client is also just beginning to be explored. Questions of how pathological 
post-translational modification of tau [5-7] impact this Hsp70 driven ubiquitination could point to new 
examples of Hsp70 substrate binding and model how tauopathies develop. Using the ubiquitination and 
binding assay platforms, a wide array of different clients could be tested for Hsp70’s role in their triage. 
To further analyze the question of whether Hsp70 engagement at both TPR domains is necessary, a CHIP 
heterodimer mutant would be very informative. It has proven extremely difficult to generate this 
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heterodimer since the homodimer affinity is so high that even guanadinium chloride or urea treatment 
of this complex was unable to separate the dimer. Various efforts have been made from affinity 
purifications mixing homodimers of mutant and wildtype proteins, but the most promising is the dual 
expression of the two constructs, which must be carefully adjusted in terms of expression levels in order 
to obtain appreciable levels of heterodimer protein. Efforts are currently needed to validate the 
formation of a heterodimer aside from the observation that the protein managed to pass the tandem 
affinity purification scheme. 
Another elusive topic is the possibility of multiple Hsp70 binding events on a tau molecule. Observations 
have been made for multiple DnaK binding events to substrate [8], which required the role of the 
bacterial Hsp40 homologue DnaJ. One report used σ32 heat shock transcription factor as a substrate 
which is rapidly degraded during bacterial steady state growth, giving one example of the possible role 
of multiple chaperone binding events facilitating protein turnover [9]. In order to validate this part of 
our model for Hsp70, efforts must be made to establish conditions that could favor multi-valent Hsp70 
binding. Conditions that could result in increased high molecular weight crosslinked species for instance 
can be explored. Currently we have generated tau deletion mutants that target putative Hsp70 binding 
sites [3]. Though binding of the complex is diminished in these mutants, it is still difficult to ascertain the 
stoichiometry of the species contained in our SEC peaks by MALS and Mwavg calculations. Another 
ambitious project relies on FRET between Hsp70 molecules. With the controls to prove that tau binding 
with Hsp70 would be stronger than Hsp70 dimer formation, the formation of a FRET pair in the presence 
of tau would be indicative of multiple binding of Hsp70.  
Hsc70 which has had several structural characterizations are conflicted in the dominant structure of the 
Hsp70:CHIP complex in solution. Whether or not the two proteins are tethered in loose flexible 
conformations or if there are important contacts that are made between Hsp70 and CHIP are still 
unclear without a high resolution structural model of the complex. Resolving the DC4 crosslinked 
structure will be helpful since the MS crosslink identification will provide much additional information 
about the complex formation [10]. However, because the crosslinks are made at random there is a 
fundamental limit on the resolution achievable. To aid in the development of linkage maps, work in the 
lab of Phil Andrews aim to develop shorter DC4 variant crosslinkers, as well as the development of heavy 
and light isotope crosslinked complexes which can be mixed and then used to generate a quantitiative 
comparison of crosslinks. The resolution of the non-crosslinked Hsp70:CHIP complex as well as 
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additional biochemistry on the binding interface of Hsp70 and CHIP must be made to validate our 
proposed model.  
• 5.2.2 sHsp systems – HSPB5 and Hsp27  
Efforts to elucidate the structural arrangement of the oligomeric sHsp proteins are ongoing and [11, 12]. 
Previous attempts to obtain a 3D structure of HSPB5 utilized a symmetric 24-mer model, with the 
rationale that symmetry with 24 subunits would assemble with a small subset of variations in the 
building blocks [13]. Although extensive efforts were made to sort the heterogeneous dataset, and 
crosslinking and various structural approaches were utilized to generate this model, we still do not have 
atomic resolution to really understand the behavior of the variable N-terminii or C-terminal IXI/V motifs. 
I have been trying to sort out a cryo-EM dataset of a similar size to the previous study mentioned, but 
collected on a microscope operated at a higher voltage and utilizing a direct detector camera. We have 
noticed that while it is possible to sort out highly symmetric particles with features similar to the 
previous tetrahedral 24-mer model, the resolution shows no improvement. When we try to sort the 
particles into smaller subsets we have had some success at improving the resolution with fewer 
particles, illustrating that part of the issue is in the classification process (data not shown). Nonetheless 
a larger dataset will be combined with more extensive 3D classification of the particles until we can find 
subsets of particles that are truly of the same conformation. Work on resolving the structures of HSPB5 
oligomers will be carried out in collaboration with the Rachel Klevit lab. 
With advancements in microscope and detector technology as well as automation of data collection, 
other examples of activation and client binding of sHsp seem lucrative targets. In the case of HSPB5, our 
studies in the activation by pH and structural rearrangements that arise from client binding show unique 
structural characteristics for important chemistry in sHsp activity [14]. The oligomeric structures seen in 
our negative stain EM analysis, with a high throughput setup for cryo-EM, couldn’t be more difficult to 
process than trying to sort the heterogeneity of the HSPB5. Recently other groups have also reported 
structural rearrangements into smaller oligomers in response to client binding and holdase activity [15]. 
The rearrangements we observed for Hsp27 are also of interest, recently in collaboration with Rebecca 
Freilich from the Gestwicki lab at UCSF we observed that the presence of tau was enough to cause 
oligomer rearrangements causing Hsp27 particles to become smaller, similar to our study with BAG3, 
only now with the involvement of a client protein. Other interesting structural forms of sHsps are also 
emerging, for instance deletions of certain domains in Hsp27 causing unique the formation of long 
filamentous structures. Exploring the enormous variety of structure in the sHsp family may have been a 
130 
 
daunting question as heterogeneity would be a serious limitation for any structural determination 
technique. However, with the ability to screen for these unique morphologies as was done in chapters 2 
and 3 for sHsps and the continuing development of cryo-EM technology we may be entering a phase 
where the throughput of cryo-EM makes it worth at least trying to see if we can classify any interesting 
structures from these sHsp molecules to further investigate their chaperone function. 
• 5.2.3 mTXNPx and Prx chaperones  
The Leishmania infantum mTXNPx structure remains an ongoing project on the refinement of the 3D 
structure of the mTXNPx:luciferase complex. The high resolution of the structure is rare to be solved by 
EM, and we are able to resolve features that indicate client binding and chaperone activity. We are 
investigating the role of the N-terminal sequence in the binding of client proteins, this region is already 
shown to be crucial as modifications to make it too long have blocked clients from entering and the 
protein fails to protect clients from aggregation [1, 16]. We have noticed that the sequence conservation 
is limited in this region, however it is high among other parasites of the same phylum, suggesting a role 
unique to these organisms and their life cycles [16]. Understanding how these chaperone functions work 
in these parasites will allow us to specifically target them to impair their survival, to develop inhibitors 
for mTXNPx that will treat devastating diseases. 
Other Prx proteins also are interesting since they also adopt decameric ring structures, their chaperone 
functions have been characterized in a variety of contexts, including pH and over-oxidizing conditions 
and have resulted in the formation of high molecular weight species [17, 18]. Focus has been placed on 
the C-termini of Prx proteins, on the outside of the ring or filament. It will be interesting to examine the 
chaperone activities of other classes of Prx to see if the chaperone mechanism is preserved among 2-
cys-peroxiredoxins. Regardless of the type of chaperone mechanism, identifying and understanding the 
structural rearrangements that occur for chaperone activation remains paramount. With the unique 
functional shift of these peroxidases to chaperone activity it is very interesting that cells have evolved 
multiple functions in various protein systems, such as Hsp70 dual functions as a foldase and also in 
facilitating client degradation, and Prx proteins which handle oxidative stress until other stressors kick in 
their chaperone holdase functions all within the same protein. 
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• 5.2.4 Use of EM for structure determination 
Various efforts are being made to push the capabilities of cryo-EM, the ability to freeze almost any 
protein particle for visualization makes it powerful tool in accessing structural information contained in 
a vast variety of protein complexes. EM is becoming a higher throughput technique, with advancements 
in automated data collection and speed up of computational processing is being pushed constantly [19-
21]. This will allow for tackling any chaperone chemistry despite the possible issue of flexibility and 
heterogeneity, one needs only embrace the technology to push past these issues. Though there are 
many exciting developments in EM, two examples are presented for their potential application to 
chaperone protein chemistry especially for the study of smaller or more dynamic protein complexes: the 
phase plate and the stochastic gradient descent algorithm for generating initial models ab initio. 
The phase plate is a technology that promises improvement of contrast for small molecules, improving 
the ability to align particles by improving signal and thus hopefully not have to sacrifice high resolution 
information [22]. Alignment of particles, or determining the pose, relies on low resolution information, 
which we can obtain by taking a heavily defocused image. But in so doing we lose higher spatial 
frequency information and lower the resolution of our map. If we try to take an image too close to focus 
we lose the low resolution frequencies and our particles become very difficult to see, with low signal we 
have high resolution information and noise, none of which can aid us in assignment of the projection’s 
actual pose [23]. 
Despite advances in sample preparation and detectors, electron scattering events from proteins is still 
limited by radiation damage, which result in poor contrast between protein and vitreous ice [19]. Thus, 
classical approaches to obtaining contrast have been to take advantage of the physics of electron image 
formation in the imperfect contrast transfer, or ‘contrast transfer function’ (CTF) due to aberrations 
characteristic of every electron microscope [24]. This causes phase contrast in the scattered electron 
wave from the proteins to generate variations in amplitudes, or intensities at the detector level. It is 
common practice to therefore obtain images out of focus and correct for the microscope aberrations in 
order to correct or translate the phase contrast (CTF correction) [23]. A phase plate, situated in the 
diffraction plane, can cause a shift in the electron wave such that after the wave is diffracted from the 
sample, containing the weak phase contrast from the proteins of interest, the phase shifts basically 
become amplitude shifts producing detectable contrast near focus instead of relying on microscope 
aberrations. Greatly boosting the contrast of particles allow alignment of smaller particles, where before 
there was too little signal [22, 25]. In practice there are still limitations to the resolution achievable but 
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recently a hybrid approach where images are acquired closer to focus rather than at focus and CTF 
correction is still carried out resulted in reconstructions with resolutions better than 3 Å. [26]  
The initial model problem is another issue that In order to assign a pose to a given 2D projection one 
must have an initial 3D model from which to produce projections at various poses to compare the 
correlations, referred to as the initial model problem [27]. Various methods have been developed to 
solve this issue, such as using random blob models to compare with 2D reference-free class averages to 
bootstrap refinement of pose [28]. More recently algorithms utilizing the raw data and stochastic 
gradient descent (SGD) to obtain models for a cryo-EM dataset ab initio [21]. SGD basically utilizes an 
iterative method to approximate gradient descent optimization to minimize an objective function, used 
in a wide variety of computing applications such as machine learning. SGD optimization is a fast process 
where each iteration takes random subsets of the EM dataset to calculate the gradient of the objective 
function, eventually converging to a local optima, for instance minimizing the error in cross correlations 
between the particles and projections to assign their pose. What this ultimately allows is a robust 
method of generating an ab initio model that is consistent with the experimental data, without any prior 
knowledge of the structure. This promises to be a valuable tool in both discovery and validation of 
structure. 
Finally, an issue that plagues many endeavors in structural biology lies in the inherent structural 
heterogeneity that is required for proteins to fulfill their biochemical functions, a major hurdle to many 
of the cryo-EM projects in this thesis. For example, the flexibility of the Hsp70 C-terminus allows for a 
wide range of conformational states of the Hsp70:CHIP complex, making it difficult to determine 
whether a given 2D projection represents a particular orientation or a different conformation altogether 
[29]. One method used to deal with sample heterogeneity is the use of chemical crosslinking to limit the 
number of conformations a protein complex can adapt in solution. The development of compounds that 
can be used for crosslinking as well as the identification of crosslinks via mass spectrometry is a rapidly 
developing field where more efficient as well as shorter crosslinkers are becoming available [30]. There 
are challenges with using these crosslinkers in the determination of high resolution structures by cryo-
EM, namely that lysine or cysteine reactive compounds will non-specifically crosslink to different amino 
acids in different particles, thus when trying to reach beyond the 10 Å resolution regime these crosslink 
moieties will provide an additional level of heterogeneity. However, in the case where the flexibility of 
the protein conformations are apparent at the level of quaternary structure, as was the case with the 
Hsp70:CHIP complex, chemical crosslinking provides a valuable tool in stabilizing low energy states of 
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the complex reducing the overall number of conformations allowing determination of a number of 3D 
structures in solution. Using these low-resolution EM maps, one can obtain information about protein 
component orientation or relative positioning of the component proteins. Future work involves pushing 
the achievable resolution on crosslinked complexes to allow increased confidence in quaternary 
structure determination. Some efforts have already been carried out on chaperone complexes [31, 32]. 
The use of shorter length or amino acid specific crosslinking may provide ways to allow stabilization of 
both quaternary/tertiary structure as well as higher resolution secondary structure [30, 33]. 
The problem of sample preparation for cryo-EM remains one of the slowest progressing aspects limiting 
the achievable resolution of the protein structure. In the case of HSPB5, which exists as a distribution of 
oligomers where crosslinking does not isolate any specific oligomer, it has proven very challenging to 
obtain high resolution information [34]. One hopes for serendipity in discovering mutations or post-
translational modifications at the level of protein engineering to cause stabilization of certain states of 
the protein sample. In one of our experiments with HSPB5, mixing WT and H104K molecules shifts the 
oligomer distribution depending on their ratio (Chapter 4) [35]. Unfortunately, the problem of the 
overall heterogeneity and distribution remains. Thus, other methods must be considered to change the 
properties of the protein to obtain a smaller subset of conformations. The process of protein purification 
under different buffer conditions and analysis of changes by SEC has been classically used to optimize 
the same protein for cryo-EM [36, 37]. In addition, use of different detergent or amphipol molecule 
additives have allowed improvement of sample preparation, but success has mainly lied in the case of 
membrane proteins where these molecules in solution bind to the transmembrane domains of these 
proteins [36]. The use of these additives in solution would also cause changes in the solution and surface 
properties as the sample undergoes vitrification, which may protect the protein from denaturing or 
unfolding at the air-water interface [38]. In my hands, I have observed the effects of these additives to 
allow us to resolve particles where previously there were none, as with the Hsp70:CHIP complex, which 
may attest to the air-water interface denaturation events. Changing the surface properties of solution 
have also allowed samples such as peroxiredoxin to adapt many more conformations in solution. 
Though this process of cryo-EM sample preparation remains one of trial-and-error, much like in 
crystallography, various techniques for optimization exist to attempt to obtain a better image of the 
protein particles. The goal is to exhaust both the developments of both sample preparation, data 
acquisition and processing and use the throughput of EM to obtain large datasets and computationally 
sort through the conformational heterogeneity. 
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